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Foreword 
This dissertation describes the work performed under the supervision of 
Cláudio M. Gomes in the Protein Biochemistry Folding and Stability 
Laboratory at the Instituto de Tecnologia Química e Biológica, from 
September 2006 to October 2010. 
The studies presented herein aim at understanding the role of metal ions 
in modulating the conformation and stability of proteins. Two types of model 
systems have been used: iron-sulfur (FeS) proteins having permanently 
bound FeS cofactors, and the S100 proteins, which bind calcium, zinc and 
copper ions reversibly. 
The first chapter presents the state of the art on fundamental aspects of 
protein folding. Then, two experimental parts include the studies on iron-
sulfur and S100 proteins. Part I includes an overview of the biology of iron-
sulfur clusters and their interplay with protein folding and stability followed 
by three chapters presenting results on the characterization of different FeS 
proteins (rubredoxin, Rieske ferredoxin and seven iron ferredoxin). Part II 
first reviews the roles of metal ions as modulators of protein conformations, 
stability and amyloidogenesis and introduces the S100 proteins. Then, the 
four following chapters address the modulation of the conformation and 
stability of S100A2 by metal ions and the newly identified amyloidogenic 
properties of the S100 family are presented, including the roles of metal ions 
and the proof of concept for the functional and pathological interplay of 
S100B and Aβ amyloidogenesis. The last chapter highlights the conclusions 
of the major findings reported and future perspectives. 
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Dissertation abstract 
Metal ions are cofactors in about 30% of all proteins, where they fulfill 
catalytical and structural roles. Due to their unique chemistry and 
coordination properties they effectively expand the intrinsic polypeptide 
properties (by participating in catalysis or electron transfer reactions), 
stabilize protein conformations (like in zinc fingers) and mediate signal 
transduction (by promoting functionally relevant protein conformational 
changes). However, metal ions can also exert have deleterious effects in 
living systems by incorporating in non-native binding sites, promoting 
aberrant protein aggregation or mediating redox cycling with generation of 
reactive oxygen and nitrogen species. For this reason, the characterization of 
the roles of metal ions as modulators of protein conformation and stability 
provides fundamental knowledge on protein folding properties and is 
instrumental in establishing the molecular basis of disease. In this thesis we 
have analyzed protein folding processes using model protein systems 
incorporating covalently bound metal cofactors – iron-sulfur (FeS) proteins – 
or where metal ion binding is reversible and associated conformational 
readjustments – the S100 proteins. 
The Rieske [2Fe-2S] domain occurs either as part of electron transfer 
system in respiratory (bc1) or photosynthetic (b6f) complexes or as a 
component in soluble dioxygenase systems. Despite the functional plasticity, 
the all-β Rieske fold is highly conserved, being modified by extensions and 
mutations modulating the cluster redox or pH properties or introducing 
features like disulfide bridges. In this respect, we have identified a Rieske 
ferredoxin featuring a cysteine pair present in only a subset of Thermoprotei 
archaea and unrelated to the conserved cysteines forming a disulfide in the 
vicinity of the respiratory and photosynthetic clusters. By using a 
combination of thiol colorimetric quantification and the FeS cluster visible 
and infrared absorption fingerprints we have determined that in the 
 x 
Acidianus ambivalens protein the cysteines form a disulfide bridge in the as-
isolated protein and established the conditions where the disulfide could be 
selectively reduced (5 mM TCEP) without affecting the overall protein 
conformation or the redox state of the FeS cluster. Disulfide reduction was 
found to regulate protein stability (ΔTm = 9°C), FeS cluster reduction 
potential (ΔE0 = +29 mV) and affect the cluster’s pH-dependent properties, 
being a putative regulatory element in this protein. 
The folding properties of the hyperthermostable zinc-containing seven 
iron ([3Fe-4S][4Fe-4S]) ferredoxin from A. ambivalens (Tm = 122°C in water 
at pH 7) have been thoroughly studied. Recently, this has revealed the 
formation of a molten globule conformation upon thermal unfolding at pH 
2.5. This conformation was proposed as a candidate for the template upon 
which the FeS clusters are assembled during protein biosynthesis. Molten 
globule formation has been shown to include, zinc and FeS dissociation and 
tertiary structure changes but a detailed description of the conformational 
changes occurring is missing. By monitoring the thermal denaturation of 
ferredoxin at pD 2.5 and 12 using singular value decomposition (SVD) of 
second derivative FT-IR spectra we determined the thermal denaturation 
profiles of each secondary structure type of ferredoxin. Further, we identified 
a spectral component describing ferredoxin’s unfolding at acidic and basic 
conditions. This component was associated with the formation of the molten 
globule and not of the amorphous unfolded state at basic conditions. The 
structural state represented by this component undergoes cold unfolding at 
experimentally accessible temperatures. This is the first description of such 
event for this protein and constitutes the opportunity of studying cold 
unfolding of an FeS protein in the absence of external perturbations like co-
solvents. 
We have built on the knowledge of the folding and stability of rubredoxins 
by studying the thermal denaturation of the Desulfovibrio gigas protein. 
xi 
Despite its mesophilic origin, this protein exhibited a high stability, with only 
around ~30% of the FeS clusters disintegrating at 95°C, in an EDTA-
insensitive process. By monitoring thermal unfolding using FT-IR coupled 
with spectral band fitting we have described the partial unfolding occurring 
at 95°C in terms of the secondary structure changes taking place. We have 
identified two thermal unfolding regimes. In the 25-60°C range α-helices and 
β-sheets unfold. Starting at 60°C, turns accumulate and β-sheet content 
increases, forming around 30 and 50% of the protein’s secondary structure 
at 95°C, respectively. We hypothesize that the highly structured 
conformation forming at high temperature is correlated with rubredoxin 
high thermostability. 
The S100 proteins are major components in the vertebrate Ca2+ signal 
buffer/transducer network regulating cell cycle, cell growth, differentiation 
and mobility. S100 proteins are small (10-12 kDa) homo- or heterodimers 
which bind Ca2+ in EF-hand domains. Zn2+ and/or Cu2+ can also bind 
elsewhere in some proteins. Ca2+ binding induces a conformational change 
which exposes a protein docking site.  
Human S100A2 is a unique family member because it binds Ca2+ and Zn2+, 
accumulates in the nucleus, interacts with p53 in a metal-dependent manner 
and has been assigned a tumor suppression role. The multiplicity of metal 
binding sites (2 Ca2+ and 2 Zn2+ sites per monomer), metal-dependent 
activation, and S100A2’s role in human pathology makes this protein a model 
to study metal-dependent conformational changes and the eventual tuning of 
conformational stability. We have examined the role of the Zn2+ sites in 
modulating protein conformation and stability by using S100A2 variants 
with Zn2+ binding site mutations. Circular dichroism analysis has shown that 
the protein conformation is prone to subtle readjustments upon Ca2+ and 
Zn2+ binding, keeping the same α-helical-rich fold. The conformational 
stability of the S100A2 variants was assessed by CD and FT-IR monitored 
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urea and thermal unfolding in different metallation states (apo, Ca2+, Zn2+). 
Thermal denaturation experiments indicated that Zn2+ destabilizes and Ca2+ 
stabilizes the protein conformation. These results suggest an opposite role 
for Ca2+ and Zn2+ according to which Ca2+ activates and stabilizes the protein, 
and Zn2+ inhibits and destabilizes S100A2, a mechanism with possible 
implications in cancer progression. 
Recently, S100 proteins have been shown for the first time to form 
amyloid fibrils in proteinaceous inclusions associated with pre-carcinogenic 
inflammatory foci in the prostate named corpora amylacea. These 
S100A8/A9 amyloid fibrils could be reconstituted in vitro in the presence of 
Ca2+ or Zn2+ but not in metal-free conditions. Since S100 family members 
share sequence and structural homology, we hypothesized that other S100 
proteins could also be amyloidogenic. By using the Zyggregator and WALTZ 
algorithms, equivalent amyloid prone regions were detected in most human 
S100 proteins. Following this observation, we incubated several S100 family 
members (S100A2, S100A3, S100A4, S100A6, S100A12 and S100B) in 
amyloid formation prone conditions (pH 2.5, 57°C) while monitoring amyloid 
formation by extrinsic thioflavin T (ThT) fluorescence. With the exception of 
S100A12, all other proteins formed amyloid species. The AFM morphological 
characterization of the S100 amyloid species revealed that S100A2, S100A6 
and S100B formed amyloid oligomers and S100A3 formed amyloid fibrils. 
For S100B, FT-IR monitored amyloid formation assays revealed that native 
α-helices and coiled regions convert to β-sheets and turns. 
S100 proteins exhibit rich metal binding properties. In addition, S100A6, 
S100A12, S100B accumulate in corpora amylacea in the brain and are 
overexpressed in neurodegenerative diseases like Alzheimer’s, Parkinson’s 
and Amyotrophic Lateral Sclerosis. By using a combination of ThT, FT-IR and 
AFM monitored amyloidogenesis assays we showed that the S100 amyloid 
formation kinetics and structure is sensitive to the presence of Ca2+, Zn2+ and 
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Cu2+, major players in the chemical biology of the glutamatergic synapse in 
the central nervous system. Cu2+ promoted S100A12 amyloid formation and 
had the opposite effect towards S100B. For S100A6, Ca2+ completely 
inhibited amyloidogenesis, a process which could be reverted by adding 
EDTA. Additionally, Ca2+ reverted or alleviated the cytotoxicity of apo S100 
amyloids. 
Cytotoxicity of S100 amyloids and the modulator role of metal ions is 
relevant in the framework of the reported involvement of S100 proteins in 
neurodegenerative processes. Due to the co-accumulation of S100B and Aβ in 
Alzheimer’s disease, we analyzed the possibility of cross-talk between the 
amyloidogenic processes of both proteins. By carrying out cross-seeding 
experiments we found that preformed Aβ fibrils seed amyloid formation by 
S100B. Conversely, S100B oligomers, but not fibrils from the unrelated 
protein lysozyme, seed Aβ amyloid formation. Overall, our data suggest a 
cross-talk between Aβ and S100 deposition, cytotoxicity and 
neurodegeneration, a possibility unexplored in the literature and with 
relevant biomedical implications. 
  
 xiv 
 
 
xv 
Resumo da dissertação 
Os iões metálicos são cofactores em cerca de 30% de todas as proteínas, 
desempenhando funções catalíticas e estruturais. Devido às suas 
propriedades químicas e de coordenação ímpares, alargam as propriedades 
intrínsecas dos polipéptidos a que se ligam (participando em catálise e 
reacções de transferência electrónica), estabilizam certas conformações 
proteicas (como nos dedos de zinco) e servem de mediadores em processos 
de transdução de sinal (através da promoção de alterações conformacionais 
funcionalmente relevantes). No entanto, os iões metálicos podem também ter 
efeitos prejudiciais nos sistemas vivos, ligando-se a locais não nativos, 
promovendo agregação proteica ou mediando ciclos redox que geram 
espécies reactivas de oxigénio e azoto. Assim, a caracterização das funções de 
iões metálicos enquanto modeladores da conformação e estabilidade 
proteica permite obter conhecimento sobre as propriedades fundamentais 
do enrolamento e é instrumental na determinação da base molecular de 
certas doenças. Nesta tese analizámos processos de enrolamento proteico 
utilizando sistemas modelo que incorporam cofactores metálicos 
covalentemente ligados – proteínas de ferro-enxofre (FeS) – ou em que a 
ligação de iões metálicos é reversível e está associada a alterações 
conformacionais – proteínas S100. 
O domínio Rieske [2Fe-2S] ocorre quer como integrante de sistemas de 
transferência electrónica em complexos respiratórios (bc1) ou fotossínteticos 
(b6f) quer como componente de sistemas dioxigenase solúveis. Apesar da sua 
plasticidade funcional, a estrutura Rieske β é altamente conservada, sendo 
modificada por extensões e mutações que modelam as propriedades redox 
ou dependentes do pH do centro FeS ou que introduzem características como 
ligações perssulfureto. Neste sentido, identificámos uma ferredoxina Rieske 
que inclui um par de cisteínas presente apenas num subgrupo de arquea 
Thermoprotei não relacionado com as cisteínas conservadas que formam 
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uma ligação persulfureto próxima dos centros FeS respiratórios e 
fotossintéticos. Utilizando uma combinação de quantificação colorimétrica de 
tióis e os espectros de absorção no visível e infravermelho característicos, 
determinámos que as cisteínas na proteína de Acidianus ambivalens formam 
um perssulfureto e estabelecemos as condiçõs em que o perssulfureto pode 
ser reduzido selectivamente (5 mM TCEP) sem afectar a conformação 
proteica ou o estado redox do centro FeS. A redução do perssulfureto regula 
a estabilidade proteica (ΔTm = 9°C), potencial redox do centro FeS (ΔE0 = +29 
mV) e afecta as propriedades dependentes do pH, sendo um possível 
elemento regulatório nesta proteína. 
As propriedades de enrolamento da ferredoxina hipertermostável de sete 
ferros ([3Fe-4S][4Fe-4S]) com um centro de zinco de A. ambivalens (Tm = 
122°C em água a pH 7) foram estudadas em detalhe no passado. Mais 
recentemente, identificou-se a formação de um molten globule após 
desnaturação térmica a pH 2.5. Esta conformação foi sugerida como 
candidata à estrutura em que os centros FeS são incorporados durante a 
biossíntese da proteína. Mostrou-se igualmente que a sua formação 
compreende a dissociação do zinco e do centro FeS bem como alterações da 
estrutura secundária mas a descrição das alterações conformacionais 
envolvidas está em falta. Através da monitorização da desnaturação térmica 
da ferredoxina a pD 2.5 e 12 utilizando a decomposição em valores 
singulares (SVD) da segunda derivada dos espectros de FT-IR determinámos 
os perfis de desnaturação térmica para cada tipo de estrutura secundária. 
Além disso, identificámos um componente espectral que descreve a 
desnaturação da ferredoxina em condições ácidas e alcalinas. Este 
componente foi associado com a formação do molten globule e não do estado 
desnaturado amorfo que se forma em condições alcalinas. O estado 
estrutural representado por este componente sofre desnaturação por frio a 
temperaturas acessíveis experimentalmente. Esta é a primeira descrição de 
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tal evento para esta proteína e constitui a oportunidade de estudar a 
desnaturação por frio de uma proteína FeS na ausência de perturbações 
externas como co-solventes. 
Contribuímos para o conhecimento do enrolamento e estabilidade de 
rubredoxinas estudando a desnaturação térmica da proteína de Desulfovibrio 
gigas. Apesar da sua origem mesofílica, a proteína é altamente estável, com 
apenas 30% dos centros FeS a desintegrarem-se a 95°C, um processo 
insensível ao EDTA. Monitorizando a desnaturação térmica através de FT-IR 
juntamente com o ajuste de bandas espectrais, descrevemos a desnaturação 
parcial que ocorre a 95°C em termos de alterações na estrutura secundária. 
Identificámos dois regimes de desnaturação. Na gama 25-60°C ocorre a 
desnaturação de hélices α e folhas β. A partir de 60°C, acumulam-se voltas e 
folhas β, que constituem aproximadamente 30 e 50% da estrutura 
secundária da proteína a 95°C, respectivamente. Assim, colocamos a hipótese 
de que a conformação altamente estruturada que se forma a alta 
temperatura está correlacionada com a estabilidade térmica da rubredoxina. 
As proteínas S100 são componentes principais na rede de tamponização e 
transdução de sinais de Ca2+ em vertebrados, regulando o ciclo, crescimento, 
diferenciação e mobilidade celulares. As proteínas S100 são pequenos (10-12 
kDa) homo ou heterodímeros que ligam Ca2+ em domínios EF-hand. Zn2+ 
e/ou Cu2+ também se podem ligar em locais distintos em algumas proteínas. 
A ligação de Ca2+ induz uma alteração conformacional que expõe uma zona 
de ancoragem de proteínas. 
A proteína S100A2 humana é um membro ímpar desta família porque liga 
Ca2+ e Zn2+, acumula-se no núcleo, interage com o p53 numa forma 
dependente de metais e tem uma função supressora de tumores. A 
multiplicidade de locais de ligação a metais (2 locais de Ca2+ e Zn2+ por 
monómero), activação dependente de metais e o papel da S100A2 em 
patologias humanas tornam esta proteína um modelo para o estudo de 
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alterações conformacionais dependente de metais e o consequente 
ajustamento da estabilidade. Examinámos o papel dos locais de Zn2+ na 
modelação da conformação e estabilidade proteica utilizando variantes da 
S100A2 com mutações ao nível dos locais de Zn2+. Uma análise por dicroismo 
circular mostrou que a conformação desta proteína é propensa a ligeiros 
reajustamentos em resposta à ligação de Ca2+ e Zn2+, mantendo a mesma 
estrutura rica em hélices α. A estabilidade conformacional das variantes de 
S100A2 em diferentes estados de metalação (apo, Ca2+, Zn2+) foi quantificada 
através de desnaturação por temperatura e ureia monitorizada através de CD 
e FT-IR. As experiências de desnaturação térmica indicaram que o Zn2+ 
desestabiliza e o Ca2+ estabiliza a conformação da proteína. Estes resultados 
sugerem um papel antagónico para o Ca2+ e o Zn2+ segundo o qual o Ca2+ 
activa e estabiliza a proteína e o Zn2+ inibe e desestabiliza a S100A2, um 
mecanismo com possíveis implicações na progressão do câncro. 
Recentemente, foi mostrado pela primeira vez que as proteínas S100 
formam fibras amilóides em inclusões proteicas associadas com focos pré-
inflamatórios na próstata denominadas corpora amylacea. Estas fibras 
amilóides de S100A8/A9 podem ser reconstituidas in vitro na presença de 
Ca2+ ou Zn2+ mas não em condições livres de metais. Dado que as proteínas 
S100 partilham homologia estrutural e de sequência, colocámos a hipótese 
de que outras proteínas S100 também pudessem ser amiloidogénicas. 
Utilizando os algoritmos Zyggregator e WALTZ, foram identificadas regiões 
com propensão amiloidogénica na maioria das proteínas S100 humanas. Na 
sequência desta observação, incubámos vários membros da família S100 
(S100A2, S100A3, S100A4, S100A6, S100A12 e S100B) em condições que 
favorecem a formação de amilóide (pH 2.5, 57°C) enquanto monitorizávamos 
a formação de amilóide através da fluorescência extrínseca de tioflavina T 
(ThT). Com a excepção da S100A12, todas as outras proteínas formaram 
espécies amilóides. A caracterização morfológica das espécies amilóides 
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S100 por AFM revelou que a S100A2, S100A6 e S100B formaram oligómeros 
amilóides e que a S100A3 formou fibras amilóides. A formação de amilóides 
de S100B monitorizada por FT-IR revelou que hélices α e regiões 
desestruturadas nativas se convertem em folhas β e voltas. 
As proteínas S100 possuem ricas propriedades de ligação a metais. Além 
disso, a S100A6, S100A12 e S100B acumulam-se em corpora amylacea no 
cérebro e são sobre-expressas em doenças neurodegenerativas como 
Alzheimer, Parkinson e Esclerose Lateral Amiotrófica (ALS). Através da 
utilização da combinação de ensaios de amiloidogénese monitorizados por 
fluorescência de ThT, FT-IR e AFM, mostrámos que a cinética de formação de 
amilóides S100 e a respectiva estrutura é sensível à presença de Ca2+, Zn2+ e 
Cu2+, elementos principais da química biológica da sinapse glutamatérgica no 
sistema nervoso central. O Cu2+ promoveu a formação de amilóide S100A12 e 
teve o efeito oposto relativamente à S100B. Relativamente à S100A6, o Ca2+ 
inibiu completamente a amiloidogénese, um processo que pôde ser revertido 
pela adição de EDTA. Para além disto, o Ca2+ reverteu ou diminuiu a 
citotoxicidade dos amilóides S100 apo. 
A citotoxicidade dos amilóides S100 e o papel modelador dos iões 
metálicos é relevante no âmbito do anteriormente reportado envolvimento 
das proteínas S100 em processos neurodegenerativos. Devido à co-
acumulação de S100B e Aβ na doença de Alzheimer, analizámos a 
possibilidade de inter-relação entre os processos amiloidogénicos de ambas. 
Através de experiências de cross-seeding descobrimos que fibras Aβ pré-
formadas funcionam como sementes para a formação de amilódes S100B. 
Por outro lado, oligómeros S100B, mas não fibras da proteína não 
relacionada lisozima, são sementes na formação de amilóide Aβ. 
Globalmente, os resultados sugerem uma inter-relação entre a deposição de 
Aβ e proteínas S100, citotoxicidade e neurodegeneração, uma possibilidade 
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anteriormente não explorada na literatura e com relevantes implicações 
biomédicas. 
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Abbreviations 
AD Alzheimer’s disease 
AFM Atomic force microscopy 
ALS Amyotrophic lateral sclerosis 
ANS 1-anilino-8-naphthalene-sulfonic 
acid 
APP Amyloid precursor protein 
ATR Attenuated total reflectance 
Aβ Amyloid β 
CAPS N-cyclohexyl-3-
aminopropanesulfonic acid 
CD Circular dichroism 
Cm Midpoint denaturant 
concentration 
DLS Dynamic light scattering 
DNA  Deoxyribonucleic acid 
DTT Dithiothreitol 
E0 Standard reduction potential 
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme-linked immunosorbent 
assay 
EPR Electron paramagnetic resonance 
ESI-MS Electrospray ionization mass 
spectrometry 
Fd Ferredoxin 
FeS Iron-sulfur 
FRET  Förster resonance energy transfer 
FT-IR Fourier transform infrared 
spectroscopy 
GuHCl Guanidinium hydrochloride 
HEPES 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
Kd Dissociation constant 
KPi Potassium phosphate 
MCT Mercury cadmium telluride 
MES 2-(N-morpholino)ethanesulfonic 
acid 
mRNA Messenger ribonucleic acid 
NAD+ Nicotinamide adenine dinucleotide 
NADPH Nicotinamide adenine dinucleotide 
phosphate 
NMR Nuclear magnetic resonance 
PAGE Polyacrylamide gel 
electrophoresis 
PD Parkinson’s disease 
PrP Prion protein 
RAGE Receptor for advanced glycation 
endproducts 
Rd Rubredoxin 
SDS Sodium dodecyl sulfate 
SOD Superoxide dismutase 
SVD Singular value decomposition 
TCEP Tris(2-carboxyethyl)phosphine 
ThT Thioflavin T 
Tm Midpoint denaturation 
temperature 
T-ramp Temperature ramp 
TSE Transition state ensemble 
USE Unfolded state ensemble 
UV Ultraviolet 
WST Water soluble tetrazolium 
ΔG Gibbs free energy variation 
ΔΔG ΔG variation 
ε Extinction coefficient 
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1.1. The protein folding problem 
The biological activity of proteins frequently depends on the ability of the 
polypeptide to acquire a very defined and unique tree-dimensional structure. 
This is not surprising as catalysis, signal transduction, ligand binding and 
molecular interactions – the main functions of proteins – all require a 
stringent spatial arrangement of the polypeptide chain: the native structure. 
This structure is attained through protein folding, the physical process by 
which a polypeptide folds into its characteristic and functional three-
dimensional structure from a random coil [1]. Protein folding is a 
fundamental process in biology due to the high dependence of practically all 
biological processes on the protein machinery. However, even in the cellular 
environment, a fraction of all synthesized proteins fail to fold into the native 
structure [2]. This inability may bring about severe biological consequences 
such as the so-called misfolding diseases [3] which are associated with 
degradation prone-conformations (such as in cystic fibrosis [4-5]), misfolded 
protein with an aberrant activity (like in phenylketonuria [6] or fatty acid 
metabolism disorders [7]) or protein deposition in the form of insoluble 
amyloid fibrils (characteristic of neurodegenerative diseases as Alzheimer’s 
[8], Parkinson’s [9] or Huntington’s [10]). 
Since Anfinsen’s seminal work on ribonuclease [1] we know that proteins 
can fold spontaneously to their lowest free energy structure without the 
intervention of additional entities. This means that all information specifying 
the three dimensional structure of a protein is encoded solely on its amino 
acid sequence. This observation has profound implications in biology. It 
means that the sole knowledge of the amino acid sequence in a protein 
should be enough for unequivocally determining its folded structure in any 
given medium and, consequently, its interaction and catalytic properties and 
the folding mechanism. However, this task is not trivial due to the many 
degrees of freedom arising from the polymeric nature of proteins, the 
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heterogeneity of amino acid side chains, the multiplicity of interactions 
stabilizing the folded conformation and an incomplete mechanistic 
understanding of the protein folding process. Accordingly, this task is 
referred as the Protein Folding Problem, from which three main questions 
arise [11]: 
1. What is the energetics stabilizing folded proteins? 
2. What is the folding mechanism? 
3. Can the protein structure be predicted from the sole knowledge of the 
amino acid sequence? 
Topics 1 and 2 are discussed in sections 1.2 and 1.3, respectively. The 
large structural biology data currently available highlights the complexity of 
the protein fold problem [12]. Although the interactions determining the 
native state are the same for all proteins and this determines a restricted 
number of secondary structure elements, there is an enormous number of 
possible spatial arrangements (Figure 1.1). Moreover, protein size and 
oligomerization status offer further diversification potential. However, 
proteins occupy a discrete portion of the conformational space: the number 
of protein folds – the topological arrangements of secondary structure 
elements – is restricted (Figure 1.1). 
Despite the inherent complexity of protein folding, in recent years, 
computational modeling coupled with single molecule studies have 
contributed with significant progress to a mechanistic description of protein 
folding process at the molecular level. In this framework, the experimental 
contribution has been limited because most experimental determinations 
rely in ensemble measurements which intrinsically average fine structural 
information. Useful strategies are single molecule FRET and force 
spectroscopy. Computational studies have yielded more quantitative 
information. The great challenge in modeling protein folding is two-fold: 
first, the large amount of atoms in the simulation with the concomitant large 
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Figure 1.1 – Three-dimensional 
representation of the protein 
conformational space. Each sphere 
represents a protein fold family 
among compact globular proteins. 
The structures were placed in space 
according to their pair-wise 
structure alignments. The structures 
cluster according to SCOP protein 
fold classes. Representative 
structures are shown to highlight 
the structure variability and 
different secondary structure 
arrangements using the same 
restricted number of basic elements. 
From [12]. 
conformational space; second, the timescale of protein folding requires 
highly computer intensive calculations. Earlier studies based in minimalistic 
Gō-type models have been complemented by more realistic off-lattice 
models. Increasing computer power, including distributed computing 
projects such as Rosetta@home of the Foldit game [13], allow routine full 
atomistic molecular dynamics and ab initio structure prediction studies. 
Currently folding simulations have reached the millisecond timescale [14]. 
The quality of the protein structure prediction algorithms is assessed 
periodically in the CASP competition – critical assessment of protein 
structure prediction – against experimentally determined protein structures. 
Progress is significant and automatic protein structure prediction is a 
possibility in a not too distant future. 
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1.2. Stabilization of the folded state 
1.2.1. Overall view 
The folding status (folded/unfolded) of proteins is dictated by the balance 
between two energetic parameters. On the one hand, the unfolded state has 
high conformational entropy because proteins are linear polymers of tens to 
hundreds of amino acid residues; on the other side, the multiplicity of 
interactions involving side chains, the backbone and the solvent constitute an 
enthalpic gradient towards the folded state. Folding is then driven by the 
enthalpy of interactions forming while interacting groups are brought into 
proximity. The thermodynamic forces responsible for the folding of proteins 
to their native conformations were first described by Kauzmann [15]: 
hydrophobic interactions, hydrogen bonds and electrostatic interactions [16-
17]. These interactions are sometimes referred as “weak interactions” in 
protein folding. This is because of their small nominal magnitude. However, 
the very significant number of individual interactions in folded proteins 
accounts for a high overall energetic term which keeps the native protein 
structure. In some cases, the folded conformation is further stabilized by 
additional contributions arising from disulfide bridges, oligomerization, 
cofactor binding or post-translational modifications. Together, all these 
molecular interactions contribute to building up all levels of protein 
structure. 
1.2.2. The hydrophobic effect 
The major contribution to folding comes from the hydrophobic effect, 
arising from the backbone, aromatic and aliphatic side chains [15, 18]. In the 
cell, proteins fold in a highly dielectric aqueous environment [19]. Water 
forms entropically costly “water cages” around hydrophobic areas [20], 
driving hydrophobic self-association which minimizes the entropic penalty. 
The outcome is that native protein structures frequently exhibit a highly 
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packed hydrophobic core surrounded by a polar shell facing the solvent [21]. 
The hydrophobic contribution to protein folding can be determined through 
mutagenesis [22] or by the free energy change of transferring an amino acid 
side chain from water to a hydrophobic solute [23]. Average stabilization 
values are 1.3 kcal/mol per buried methyl group or 1-2 kcal/mol per 
aromatic ring interaction [22]. The vast hydrophobic areas buried during 
protein folding account for the stabilizing importance of the hydrophobic 
effect. 
1.2.3. Hydrogen bonds 
Hydrogen bonds are also important stabilizing features in protein 
structures. The backbone and several amino acid side chains have hydrogen 
bond donor and acceptor groups. Further, the solvent can also be included in 
hydrogen bonding patterns. The contribution of hydrogen bonds to the 
overall protein stabilization is very relevant. About two thirds of all residues 
form peptide hydrogen bonds in the native state [24]. It is the involvement of 
the backbone in repetitive interactions that drives secondary structure 
formation [25]. The stabilization by hydrogen bond averages to 1.3 kcal/mol 
[26-27]. For geometric reasons, the same hydrogen bond donor or acceptor 
can participate in multiple hydrogen bonds, creating hydrogen bond 
networks. 
1.2.4. Ion pairs 
The most individually stabilizing interaction in protein folding is the 
electrostatic interaction between charged amino acid side chains, called ion 
pairs. Ion pairs are usually located at the protein surface, being favored by 
the aqueous polar environment. A single ion pair can contribute with up to 3-
5 kcal/mol to stability [28]. This value is close to the typical stability of the 
native versus the unfolded state (ΔGN-U), meaning that in some proteins 
breaking a single ion pair may result in protein unfolding. Despite their 
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individual magnitude, the average number of ion pairs in proteins is small. 
Consequently, they are not major driving forces in protein stabilization [18]. 
1.2.5. Covalent modifications 
Disulfide bridges are cross-links which effectively restrict the 
conformational space, decreasing protein conformational entropy and 
increasing protein stability [29-30]. The most significant effects occur with 
disulfides bridging distant polypeptide regions. For avoiding the formation of 
aberrant disulfides – which form off-pathway folding species – organisms 
have developed specialized enzymatic mechanisms [31]. Prokaryotes 
produce a family of disulfide bond proteins (Dsb) which assist oxidative 
protein folding – with the concomitant cysteine thiol oxidation – and correct 
aberrant disulfides [32]. In eukaryotes, the endoplasmic reticulum is the 
oxidative cellular compartment where disulfide formation is regulated by 
protein disulfide isomerase (PDI) and Ero1 [33]. 
Similarly to disulfide bridges, the binding of cofactors also cross-links 
different parts of the polypeptide and favors folding. Proteins can bind a 
broad range of organic or inorganic cofactors in a covalent or non covalent 
manner. For example, zinc finger domains can only fold to their native 
structure in the presence of the metal ion [34]. Cytochrome c requires its 
covalently bound heme for folding and function [35-36]. Calcium is 
frequently associated with conformational fine-tuning [37]. Also, the 
contribution from post-translational modifications such as glycosylation, 
phosphorylation and lysine methylation is relevant well [16]. 
1.2.6. Two state protein folding thermodynamics 
The native state is then stabilized by the combination of multiple mutually 
supportive weak interactions. The outcome is that the folded conformations 
of proteins are only marginally stable even under the most favorable 
conditions [38-39]: typically ~5-15 kcal/mol, in the range of just a few non 
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Figure 1.2 – Two state unfolding. Denaturing conditions (chemical denaturant or 
temperature) unfold a two state folder in a cooperative manner. At any condition, only the 
native (N) and/or unfolded (U) state are detected and interconvert. The native state is a 
unique state while the unfolded state ensemble groups a broader set of conformations. 
covalent interactions. No energetic component is preponderant in the overall 
stabilization. Even the simplest protein folding energetic potentials must 
include multiple energetic components to reproduce protein folding [17]. 
Small single domain proteins usually unfold reversibly [1] and according 
to a simple two state process. This means that the only conformations 
detectable are the native and the unfolded state. These two interconvert and 
no intermediately folded state is populated at detectable levels (Figure 1.2). 
Due to the cooperative nature of protein folding, such a protein is perturbed 
by an increasingly denaturing environment, the conformation initially 
changes very little [40]. Then, for a limited range of conditions, the protein 
unfolds completely. In this simple unfolding scenario, the same unfolding 
profile will be obtained independently of the technique used to probe it [40]. 
The thermodynamics of two state reversible unfolding is characterized as 
a function of the native (N)/unfolded (U) equilibrium constant, ܭ௘௤: 
ܭ௘௤ =
ሾܰሿ
ሾܷሿ 
from which the free energy variation is obtained 
∆ܩܰ−ܷ = ܩܰ − ܩܷ = −ܴܶ ݈݊(ܭܰ−ܷ) 
Un
fo
ld
ed
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n
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where R and T are the gas constant and absolute temperature, respectively. 
The thermodynamic characterization of lysozyme unfolding at pH 7 
carried out by Privalov and co-workers [41] illustrates the complex 
relationship between the thermodynamic parameters that determine protein 
stability. The opposing effects of denatured state conformational entropy 
(TS0) and native stabilizing interactions (H0) individually comprise several 
hundred kcal/mol. However, both contributions have similar temperature 
trends and compensate each other, implying marginal protein stability. The 
Gibbs free energy of folding exhibits a temperature dependence (∆ܩேି௎(ܶ)) 
 
 
Figure 1.3 – Temperature-dependent thermodynamic folding parameters for lysozyme 
at pH 7. The enthalpic (H) and entropic (TS) contributions are very large and of similar 
magnitude for the folded (A) and unfolded (B) states. The most populated state is the lowest 
energy one (C). The energetic difference between the folded and unfolded states is small and 
results in marginal protein stability (D). At the point where ΔGN-U is null, there is equal amount 
of protein in both the folded and unfolded states. This temperature is referred to as the 
midpoint denaturation or melting temperature (Tm). From [41]. 
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expressed by the Gibbs-Helmholtz equation (Figure 1.3). If the heat capacity 
(∆Cp୒ି୙) and apparent enthalpy (∆H୒ି୙
ୟ୮୮ ) difference between the native and 
the unfolded states is assumed temperature-independent, the equation has 
the following formula: 
∆ܩேି௎(ܶ) =  ∆ܪேି௎
௔௣௣ ൬1 − ܶ
௠ܶ
൰ + ∆ܥ݌ேି௎(ܶ − ௠ܶ) − ܶln (
ܶ
௠ܶ
) 
The Gibbs-Helmholtz equation expresses the fact that ∆ܩேି௎ is maximal 
at some temperature and that there are two temperatures where it equals 
zero (i. e. proteins can be denatured by heat or by cold). Heat denaturation 
occurs because of the enthalpic compensation of stabilizing interactions by 
temperature. Cold denaturation is due to the decreased hydrophobic 
contribution at lower temperatures [42]. Experimentally, usually only heat 
denaturation is observed because the cold denaturation temperature is 
frequently below the water melting temperature. Nevertheless, this has been 
observed for a few proteins [43]. 
1.2.7. Engineering protein stability 
Several studies have shown that the stability of naturally occurring 
proteins is not optimized and can be improved by mutagenesis [39, 44], 
sometimes paralleled with function enhancement [44-47]. However, in the 
extreme case, increased stability may generate a highly compact and stiff, 
non functional native state [39]. This suggests that marginal protein stability 
is the evolutionary response to the need to achieve the native state (i. e. to 
have a minimum energy state [1]) while preserving (i.) the protein dynamics 
required for catalysis, conformational plasticity, protein recognition and 
proteolytic susceptibility [39], a key element in cellular protein turnover 
[48]; and (ii.) an energetic buffer which allows protein evolution [49] (Figure 
1.4). 
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Figure 1.4 – Protein evolution. (A) Along evolutionary time, proteins accumulate mutations 
which impact folding and stability. The marginal conformational stability of proteins implies 
that only a subset of all allowed mutations are tolerated. Mutations outside this neutral zone 
may are deleterious because they affect the protein’s ability to fold (destabilizing mutations) 
or to be functionally dynamic (over-stabilizing mutations). (B) Molecular chaperones rescue 
the folding of misfolded species and create an enhanced “neutral area” from where new 
functions may arise. From [49]. 
1.3. Protein folding models 
Since the discovery that the protein native structure is determined by its 
amino acid sequence, much effort has been made in elucidating the 
mechanistics of protein folding. The first milestone in this field was set by 
Cyrus Levinthal in the late 1960s [50]. He elegantly pointed out that if a small 
99 peptide bond protein would randomly sample just three rotamers of each 
of its 198 phi and psi angles in the typical timescale of molecular rotations – 
1 picosecond - it would take 1075 years to fold – much more than the age of 
the universe. However, proteins fold in a biologically relevant timescale 
(typically in the microsecond to second timescales [51]). This became known 
as Levinthal’s Paradox. It encloses a fundamental aspect of protein folding: 
the range of accessible conformations during folding is restricted. For solving 
this paradox, Levinthal postulated the existence of a pathway consisting of a 
well-defined and restricted sequence of protein conformational changes 
bridging the unfolded to the folded state [52] – the sequential model of 
protein folding. However, no mechanistic description to describe what the 
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folding pathway could be was put forward. Several models about protein 
folding have however been conceived since then (Figure 1.5). 
In the late 1970s Levitt had already identified the caveat in Levinthal’s 
paradox: the search for the native state is not unbiased. He noted that protein 
folding could be reproduced in silico as a random search if native-like 
interactions are considered to be on average more stabilizing than non-
native ones. Thus, according to this random search model [53] the folding 
pathway is analogous to solving a jigsaw puzzle, where the order of the steps 
is not relevant but the end result is always the same native state [54]. More 
recently, the kinetics and thermodynamics of the folding of the villin 
headpiece domain has been successfully modeled using this formalism [55]. 
Kim and Baldwin proposed the framework model [53]. This model 
considers that secondary and tertiary structural elements form 
independently of one another. Secondary structure elements build up in the 
beginning of the folding reaction and progressively assemble into the native 
tertiary structure. 
The hydrophobic collapse model [56] hypothesizes that folding initiates 
by a rapid polypeptide collapse driven by hydrophobic side chain self-
association, resulting in the formation of an intermediate state devoid of 
secondary structure and with non-native tertiary structure, i. e. a molten-
globule-like state. The structural reorganization of the molten globule from 
the restricted conformational space available – accounting for the folding 
energy barrier – would give rise to secondary structure and the native fold. 
The validation of this model is complex because it relies on the structural 
characterization of early, short-lived folding intermediates. Nevertheless, it 
appropriately describes the folding kinetics of globular proteins such as 
myoglobin [57], α-lactalbumin [58], barstar [59] and staphylococcal nuclease 
[60]. 
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Karplus and Weaver proposed the diffusion-collision model [61-62]. In 
this case, the folding protein is considered to be composed of several 
independent marginally stable secondary structure microdomains each one 
exhibiting fast conformational dynamics. During folding individual 
microdomains collide and eventually adhere and coalesce to give rise to the 
native tertiary structure. 
The classical nucleation model proposes that the folding reaction is 
guided by the formation of a marginally stable nucleus containing correct 
secondary and tertiary structural elements. The place of nucleation in the 
folding reaction was matter of dispute: Wetlaufer proposed that nucleation 
would comprise the folding onset [63] and Baldwin proposed that nucleation 
would be the limiting factor [64]. In any case, the nucleus templates 
formation of further structure around it, restricts the available 
conformational space and speeds folding without implying the existence of 
folding intermediate states [65]. In the 1990s Monte Carlo simulations of a 
lattice model by Shakhnovich and co-workers [66] supported that nucleation 
limits folding. Once the nucleus is assembled, the native conformation is 
promptly formed. This discovery permanently associated the study of 
protein folding with that of the transition state. The nucleation model 
describes the folding of two state folders but fails to describe folding 
processes where intermediates accumulate [67]. 
In the 1990s, Fersht and co-workers established that the folding of 
chymotrypsin inhibitor 2 (CI2) – a 64 residue two state folder – could only be 
described by a new folding model: the nucleation-condensation model [68-
70]. This model postulates the existence of a marginally stable nucleus 
composed mainly by adjacent residues early in folding. The rate limiting step 
is the eventual stabilization of this small nucleus by long range interactions. 
This extended nucleus is not formed in the transition state but represents the 
best formed part of the structure at this point [71]. Nucleation is coupled to 
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Figure 1.5 - Protein folding models. 
condensation of tertiary structure around it. Since the proposal of this model, 
other proteins were shown to adopt compatible folding kinetics [72]. 
1.4. Protein folding kinetics 
Protein folding is a structural event. Nevertheless, it can be appropriately 
described by standard chemical reaction kinetics theory. The starting state – 
the unfolded state ensemble – is regarded as a “reagent” and the end state – 
the native state – as a “product”. The reaction mechanism, energetics and 
kinetics can be described by monitoring the interconversion of the two 
entities, possibly through some intermediate states. Like a reaction, protein 
folding is a diffusive process, i. e. an unfolded polypeptide will spontaneously 
acquire the most stable accessible conformational state given the solvent 
conditions through a stochastic search. 
Folded State
Unfolded State
Unfolded State
Unfolded State
Unfolded State
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The classical way of studying protein folding in vitro is through 
temperature-, pressure-, acid- or denaturant-induced renaturation [71]. The 
folded and unfolded states frequently exhibit distinct spectroscopic 
properties. Coupling renaturation (by manual or stopped flow mixing, 
temperature or pressure jumps) to spectroscopic detection allows 
monitoring the transition between the two states and describing folding [73]. 
Information about folding can also be obtained by studying the analogous 
unfolding transition. A summary of the main techniques used in studying 
protein folding – not just the kinetics – is given in Table 1.1. 
The conformational search inherent to protein folding implies that only 
the lowest energy states (typically the native state) are unique and well 
defined, all others (e. g. the unfolded and transition states) being in fact an 
Table 1.1 – Experimental techniques useful for the study of protein folding. From [73]. 
Technique Timescale Information content 
Intrinsic tryptophan fluorescence ≥ ns Tryptophan environment 
Far UV CD ≥ µs Secondary structure content 
Near UV CD ≥ µs Aromatic residue packing 
Raman spectroscopy ≥ µs Solvent accessibility, aromatic residues’ conformation 
Infrared spectroscopy ≥ ns Secondary structure content 
ANS binding ≥ µs Hydrophobic surface exposure 
FRET ≥ ps Molecular ruler 
Fluorescence correlation 
spectroscopy ≥ ps Diffusion, size and shape 
Fluorescence anisotropy ≥ µs Shape and size 
Small-angle X-ray scattering ≥ µs Radius of gyration 
Absorbance ≥ ns Chromophore environment 
Real-time NMR ≥ min Structure 
Native-state hydrogen exchange h Global stability 
Pulsed H/D exchange by NMR ≥ ms Solvent accessibility 
Pulsed H/D exchange by ESI-MS ≥ ms Solvent accessibility 
NMR relaxation ~ms Denatured state structure, conformational changes 
Protein engineering Probe 
dependent 
Residue-specific information 
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ensemble of distinct states. Then, the aforementioned states are accurately 
named the unfolded state ensemble (USE) and the transition state ensemble 
(TSE). The reason for the occasional language simplification is due to the fact 
that these states are most frequently experimentally accessible though their 
statistically averaged properties. The TSE is defined as the set of 
conformations such that folding trajectories starting from each one of them 
have a 50% probability of either reaching to the folded state before unfolding 
and reaching the unfolded state before folding [74]. 
Protein folding is a cooperative process [75]: the establishment of native 
or native-like contacts facilitates further interactions. This speeds folding 
[76] and stabilizes the native state once it is formed, as full unfolding 
requires the cumulative loss of the interaction in the cooperative network. In 
the extreme case, as it is frequently found in small globular proteins, 
cooperativity leads to two state folding [77] where the only detected 
populated states are the native and the unfolded ones, which interchange 
between themselves during folding. In this situation, protein folding kinetics 
is monoexponential. The surprisingly fast protein folding rates are achieved 
through a combination of factors: 
1. Presence of residual structure in the fully unfolded state which 
restricts the accessible conformational space during folding; 
2. The folding pathway comprises metastable intermediates which work 
like hubs directing folding to the native state [78]; 
3. The funneled energy landscapes biases folding to the native state. 
There would be no native state search problem if each of the amino acids 
could find its native conformation independently of the others or if only 
nearest-neighbor interactions were involved. This would reduce the protein 
folding problem to an analog of the helix-coil transition. What makes the 
search problem difficult is that long-range interactions are involved. It is the 
presence of long-range effects that make the folding transition cooperative 
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(pseudo-first order), an essential element of the stability and kinetics of 
proteins [75, 79]. 
In the framework of the success of the nucleation formalism in describing 
the folding of small globular proteins, the folding transition state has been 
routinely probed by a protein engineering method named Φ-value analysis 
[71]. It consists in analyzing the effect of single point mutations in the 
protein’s folding behavior and determining a thermodynamic parameter – 
the Φ-value – defined as 
Φ =
−ܴܶ ݈݊ ൬݇௠௨௧݇௪௧ ൰
∆∆ܩேି஽
≈ ∆∆ܩ‡ି஽∆∆ܩேି஽
 
where ݇௠௨௧ and ݇௪௧ are the folding rates of the mutant and wild type 
proteins, respectively, ∆∆ܩேି஽ is the change in folding free energy upon 
mutation and ∆∆ܩ‡ି஽ is the change in activation free energy upon mutation 
(Figure 1.6). The approximation is valid for non-disruptive (i. e. having a 
small perturbation) mutations. The Φ-value then accounts for the degree of 
native-like interactions at the mutated position in the transition state. A unity 
value means that the perturbation extent is the same in the native and 
transition states, indicating that the specified residue has all native 
interactions formed in the native state. A value close to zero means that the 
residue has the same interactions in the denatured and in the transition 
state. Structural interpretations of Φ-values have been routinely put forward, 
identifying residues with Φ-values equal to 1 or 0 as being fully structured or 
unstructured in the transition state, respectively. However, controversy 
exists about the interpretation of Φ-values outside these values. Fractional 
Φ-values have been interpreted as the indication of alternative folding 
pathways [71] and non-classical Φ-values (Φ<0, Φ>1) have been interpreted 
as reflecting the differential perturbation of secondary and tertiary structural 
elements [80]. 
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Figure 1.6 – Φ-value analysis of protein folding. The putative folding energy diagrams for 
two point mutants are sketched. (A) The mutation does not perturb the interactions and, 
consequently, the energetics of the selected amino acid residue in the unfolded nor in the 
transition states. Nevertheless, the mutation is destabilizing. The Φ-value is then zero. (B) The 
mutation affects a residue which is part of the folding nucleus. The transition state is then 
destabilized in the same amount as the native state and the Φ-value equals 1. From [71]. 
Proteins which were selected by evolution to fold into a biologically 
relevant structure are able to satisfy the local structure propensity of amino 
acid residues (dictated by their respective rotamers) and intramolecular 
interactions (responsible for stabilizing the native state) without 
contradicting each other. Of course this can only occur in native or native-like 
structures, guiding the folding process. This situation is called the “minimal 
frustration” of protein folding [81-82]. 
So, protein folding is a highly complex mechanism. Part of the complexity 
comes from the definition of the starting point, the unfolded state. Unlike the 
native state, the unfolded state is a broad collection of conformationally 
distinct states with high entropy – the denatured state ensemble. It 
contributes with structural heterogeneity to the starting state, and 
determines a lot of the random search for the native state. The inherent 
stochasticity of protein folding results in different parts of the protein being 
folded at different times in the folding reaction, almost independently of each 
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other. These folding units forming in one single cooperative step are called 
“foldons” [81-82]. Since every intermediate en route to the native state has a 
different conformation, it also has a specific energy. The stochastic 
fluctuation between sequential folding intermediates gives rise to a 
distorted, rugged funnel, populated by a myriad of energetic basins (or 
kinetic traps, following a kinetic analysis) which stabilize misfolded 
intermediates and slow down folding. To overcome these traps, local or 
global unfolding must occur. Some basins can be transposed within kBT. 
Deeper ones can become conformational dead-ends from which the protein 
cannot be rescued without external assistance (e. g. by molecular 
chaperones), despite the favorable thermodynamics. Folding intermediates 
have been detected experimentally for many systems including hen lysozyme 
[83], cytochrome c [84] among others. 
The extreme case of kinetically-controlled folding is achieved for proteins 
whose native state – determined by its biological activity – is not the lowest 
energy one but rather a metastable higher energy state trapped by a large 
activation energy barrier. This is possible for proteins which include 
prosegments in the newly-synthesized polypeptide which are subsequently 
proteolytically excised. Such post-translational processing occurs in insulin 
[85], α-lytic protease [86], pepsin [87] and the serpins [88]. 
1.5. Protein folding energetics – the landscape view 
A rigorous solution to Levinthal’s Paradox, describing both the 
thermodynamics and the kinetics of folding, comes from the statistical 
analysis of the energetics of the folding mechanism. This consists in 
considering the energy of the folding protein sampled from the whole set of 
conformers it can assume – a multidimensional “conformational space”. 
Proteins can then be viewed as folding according to the dependence of 
conformation on energetics – the “energy landscape”. The unfolded state 
ensemble collapses and reconfigures into multiple inter-convertible 
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conformations. The exact sequence of conformational transitions is 
stochastically determined – like the jigsaw puzzle concept [54]. However, 
since the Gibbs free energy (ΔG) of each conformation is different and the 
native state has the lowest energy – Anfinsen’s thermodynamic hypothesis – 
the energy landscape is biased towards the native state. The formation of 
stabilizing interactions precludes the sampling of competing conformations 
greatly restricting the accessible conformational space. On the other hand, 
incorrect local folds tend to be eliminated by more stable conformations 
arising in the fluctuations inherent to this diffusive process [82, 89]. The 
energetic gradient also implies that not all conformations are equally likely in 
the folding pathway, solving Levinthal’s paradox, and that native-like 
intermediates may act as hubs guiding folding [90]. This situation has been 
pictured by Onuchic and co-workers as a funneled energy landscape [91]. 
The folding funnel determines protein folding kinetics and 
thermodynamic properties. Its shape is a function of the medium 
composition. Events such as solvent change, external perturbations (e. g. 
temperature, pressure), protein association or ligand binding change the 
shape of the folding funnel and, ultimately, protein conformation. This is the 
thermodynamic basis for protein allostery, protein association, protein 
conformational changes and protein unfolding. 
The bottleneck inherent to the folding funnel acts to speed folding. In 
small globular proteins this produces a single exponential folding kinetics 
(Figure 1.7) [77]. However, the many degrees of freedom in protein folding 
produce a folding funnel which is not smooth but rather rugged, with many 
energetic – i. e. kinetic – traps. These local minima illustrate the situation 
where non-native interactions may be locally stabilizing but are not 
compatible with achieving the global energy minimum. In other words, the 
folding energy landscape incorporates some “energetic frustration” (Figure 
1.8D) [92-94]. However, the fast and cooperative folding of most natural 
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Figure 1.7 - A schematic folding 
funnel of acylphosphatase. The 
great conformational space 
accessible to the unfolded state is 
progressively restricted as the 
protein lowers its free energy 
through folding. The energetic 
gradient progressively biases the 
conformational search to the 
native state, although multiple 
folding pathways are still 
accessible. Once the folding 
transition state barrier, depicted 
as a saddle point, is overcome by 
the formation of the folding 
nucleus (depicted as yellow 
spheres in the structure) folding is 
fast and productive. From [96]. 
proteins shows that energetic traps have been smoothed by evolution 
rendering naturally occurring proteins “minimally frustrated” [89, 95]. 
Growing evidence supports the hypothesis that the folding energy 
landscape may in fact include additional folding funnels accounting for 
misfolded species [97]. Due to their simplicity, the folding of naturally 
occurring small single domain proteins is frequently associated with smooth 
energy landscapes, giving rise to single exponential folding kinetics. In the 
framework of landscape theory it is possible to envisage an extreme situation 
where a determined polypeptide sequence folds to the native state without 
encountering significant energetic barriers throughout the folding funnel 
(Figure 1.8B), a situation termed “downhill folding” [98]. In such a scenario, 
folding kinetics is non-exponential and all conformers are en route to the 
native state, making them accessible to experimental study, including 
structural characterization. Downhill folding is a sort of limit situation for 
real folding [98] as it can be captured theoretically by coarse-grained Gō-type 
models [99]. Here, the polypeptide is modeled as a string-and-bead structure 
where amino acid residues – the beads – can only occupy defined positions in 
a three dimensional cubic lattice and interact if they occupy contiguous 
positions in space. 
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Figure 1.8 - Protein folding funnels. (A) Levinthal’s funnel. All folding pathways are equally 
likely and there is no folding cooperativity in the search for the native state. (B) Downhill 
folding funnel. Smooth energy landscape without kinetic traps. (C) Folding funnel for a protein 
with an obligatory on-pathway folding intermediate. (D) Highly frustrated folding funnel, with 
many kinetic traps and alternative folding routes. From [100]. 
1.6. Conformational states – a unified view of protein folding 
The highly complex interaction network in proteins coupled with the 
large conformational space accessible results in a series of conformational 
states being accessible to proteins. Unlike the classical view of protein folding 
whereby a polypeptide is synthesized in the ribosome in the unfolded state 
and eventually attains the monomeric or oligomeric native state, several 
intermediate or off-pathway states do exist and have been shown to be 
relevant in the biologic context of protein folding. Partially folded 
intermediates may expose hydrophobic patches which drive self-
aggregation. Misfolded or aggregated protein may be recognized by cellular 
quality control systems and degraded. It is believed that, given appropriate 
conditions, every protein has the potential of acquiring the β-sheet rich 
aggregation-prone amyloid conformation, which may polymerize into fibrils 
(Figure 1.9) [96]. 
The exception to this panorama are proteins which, notwithstanding the 
possibility of having local persistent structure, the majority of the 
polypeptide chain is in a random coil-like conformation: the so-called 
intrinsically unstructured proteins or natively unfolded proteins. These 
proteins are not able to acquire a compact native state because of having a 
high charge density. These proteins are not without functional significance. 
A B C D
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Figure 1.9 – Protein conformational states. From the moment a polypeptide is synthesized 
in the ribosome, it can adopt a multitude of conformations apart from the unfolded and native 
states. Intermediately folded states may be aggregation- or degradation-prone. The β-sheet 
rich amyloid state is an aggregated state which is thought to be accessible to all proteins. 
Artificially, proteins can be superconcentrated and forced to adopt a crystalline state. From 
[96]. 
Their high conformational dynamics renders them promiscuous protein 
binders. So, these proteins fulfill mainly protein network integration roles, 
working like hubs binding proteins from different signaling pathways and 
contributing to signal transduction [101-104]. 
1.7. Protein folding in the cell 
In the biologic context of protein folding – newly synthesized proteins 
exiting the ribosome – multiple extrinsic factors affect folding. First, protein 
synthesis is vectorial – the N-terminus is synthesized prior than the C-
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terminus – and the synthesis rate is slow (~2-4 amino acid residues per 
second in eukaryotic systems [105]), likely constituting the rate-limiting 
factor in protein folding in vivo. Since protein folding is dictated by long 
range interactions which may involve interactions between the N- and C-
terminus, especially in multidomain proteins (e. g. [106]), and shape the 
folding energy landscape [107] non-native interactions may occur during 
protein synthesis. Secondly, protein biosynthesis occurs in the context of 
densely packed polysomes (Figure 1.10), further favoring interaction of 
aggregation-prone solvent-exposed hydrophobic residues. To minimize 
improper interactions, ribosomes are oriented around the mRNA molecule in 
a pseudohelical arrangement which minimizes the interactions between 
vicinal nascent chains [108]. The ribosome exit channel is hydrophilic [109] 
and favors co-translational folding [110] of at least α-helical elements [111-
113]. Cell environment is highly crowded, with macromolecular 
concentrations reaching as much as 400 mg/ml [114-116]. The excluded 
volume effect favors protein misfolding and aggregation [116-118]. However, 
it also biases the folding landscape towards compact conformations [119], 
restricting the accessible conformational space and speeding folding in some 
situations [116-117, 120-121]. As a response, cells accumulate compatible 
solutes, also known as osmolytes [122], sometimes up to molar 
concentrations, which favor protein hydration and, consequently, 
hydrophobic burial and folding. To cope with the challenges of protein 
folding, biological systems have evolved a specialized protein quality control 
machinery (Figure 1.11) aimed at aiding or correcting folding – the molecular 
chaperones – or, ultimately, degrading terminally misfolded or aggregated 
proteins [123]. 
Molecular chaperones recognize and reversibly bind nascent polypeptides 
or non-native protein conformations (hydrophobic amino acid stretches 
[125] which are buried in the folded state or unstructured protein regions), 
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Figure 1.10 – Polysomes.
Several ribosomes transcribing a
single mRNA molecule (in the
center). The newly synthesized
polypeptides are depicted as red
or green threads on the exterior
of the polysome. The high protein
density favors aggregation of the
misfolded polypeptides. To
overcome this problem,
polypeptides exit the ribosomes
at opposing faces. From [108]. 
Figure 1.11 - Protein
quality control systems. As
the newly synthesized
protein exits the ribosome,
surveillance mechanisms act
to detect, correct and
ultimately degrade misfolded
species. Holding chaperones
prevent protein aggregation;
folding chaperones assist the
folding and unfolding
chaperones act on
aggregated or misfolded
protein to promote further
folding cycles or degradation
by proteases. From [124]. 
reduce aggregation propensity and assist folding. They do not integrate the 
final native structure. Some proteins are facultative or obligatory [125] 
chaperone substrates needing their assistance to be rescued from 
intermediate states [67] and fold on biologically relevant timescales [126]. 
Molecular chaperones act by either stabilizing the nascent chain in the 
ribosome or by downstream action [127-129]. The first group of chaperones 
stabilizes cytosolic proteins by binding to the large ribosome subunit and 
eventually to hydrophobic protein sequences, maintaining an extended non-
aggregated protein state until enough polypeptide has been synthesized for 
productive folding to occur. This group includes the bacterial trigger factor, 
the eukaryotic RAC (ribosome-associated complex, an Hsp70 system) and the 
archaeal and eukaryotic NAC (nascent chain-associated complex). 
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Downstream-acting chaperones do not bind the ribosome and assist co- or 
post-translational folding. These include members of the Hsp70 family (DnaK 
in bacteria, Hsc70 in higher eukaryotes [125]) and further downstream 
systems like the chaperonins (Hsp60 family: GroEL in bacteria, thermosome 
in archaea and TRiC/CCT in eukarya [130-132]) and Hsp90 [133]. Broad-
specificity chaperones such as members of the Hsp70 or chaperonin families 
primarily recognize hydrophobic amino acid side chains and promote their 
folding through ATP-dependent binding-release-rebinding cycles. If a protein 
is terminally misfolded and cannot be rescued by chaperone action, the 
polypeptide is degraded. In archaea, eukaryotes and some bacteria, the most 
important proteolytic system is the ubiquitin-proteasome pathway [134]. It 
involves tagging the misfolded protein with multiple ubiquitin chains 
through the sequential action of three ligases and subsequent proteolytic 
degradation by the proteasome, a multiprotein complex. 
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Part I – Iron-sulfur clusters and protein stability 
2. Iron-Sulfur Clusters as a model of protein conformational 
stabilizers 
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2.1. Iron-sulfur clusters: chemistry and function 
Despite the extraordinary structural diversity of proteins, amino acids are 
not able to undergo redox transitions (with the notable exception of 
tyrosine), catalyze certain reactions and provide enough conformational 
stabilization in certain proteins. For this reason, proteins incorporate 
cofactors which render them functional versatility and additional 
stabilization. Iron-sulfur (FeS) clusters are ubiquitous and biologically 
essential inorganic cofactors of iron and sulfur thought to have been 
instrumental prebiotic catalysts and one of the oldest protein cofactors [1]. 
They usually present di- tri- or tetra-iron nuclearities, though more complex 
ensembles in which a cuboid cluster is bridged to another component such as 
nitrogenase’s cofactor cluster ([Mo7Fe-9S]) and P-cluster ([8Fe-7S]) are 
biologically relevant (Figure 2.1) [2]. Protein binding occurs most frequently 
through cysteine side chains. [2Fe-2S] clusters can also present a mixed 
coordination where one of the iron atoms is coordinated by two cysteines 
and the other by two histidine side chains, forming the so-called Rieske 
cluster [3]. Glutamine, serine or arginine are less common ligands [4]. 
FeS clusters can be assembled in vitro from the spontaneous reaction of 
iron salts with thiolates and sulfide [5] at millimolar concentrations. 
However, these concentrations are toxic for cells. The in vivo assembly and 
insertion of FeS clusters in the appropriate apoproteins is a highly regulated 
and still not completely elucidated process involving desulfurase enzymes 
for the acquisition of sulfur from cysteine, iron chaperones for the delivery of 
iron, scaffold proteins for the assembly of the cluster and transfer enzymes 
(reviewed in [6]). There are several biosynthetic machineries including the 
NIF system of nitrogen fixing organisms like Azotobacter vinelandii, the ISC 
system of eukaryotic mitochondrial FeS cluster biosynthesis and the 
bacterial SUF system which operates in bacteria in conditions of iron 
limitation or oxidative stress, archaea, cyanobacteria and plant chloroplasts. 
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Figure 2.1 – Structure of iron-sulfur clusters. Iron is shown in orange, inorganic sulfur in 
yellow and molybdenum as blue/green. The protein ligand atoms are white spheres. The 
figure contains the mononuclear iron in Desulfovibrio gigas rubredoxin ([1Fe], 2DSX) and the 
clusters in Synechocystis sp. PCC 6803 ferredoxin ([2Fe-2S], 1OFF), Acidianus ambivalens 
seven-iron ferredoxin ([3Fe-4S] and [4Fe-4S], 2VKR) and Azotobacter vinelandii nitrogenase 
([Mo7Fe-9S and [8Fe-7S], 1N2C). Clusters are drawn approximately on the same scale. 
Eukaryotes express the cytosol-specific CIA machinery, homologous to the 
mitochondrial ISC system [7]. 
FeS clusters are highly versatile protein cofactors. They bind to proteins 
of different folds and sizes, are present in all cellular compartments and are 
required for a great variety of protein functions [8-10]. The polypeptide 
chain modulates the intrinsic properties of the clusters, tuning them for the 
desired functions. This includes the protection of the FeS cluster from its 
intrinsic oxygen sensitivity to highly stable forms in some proteins [11]. 
Clusters from different nuclearities can undergo interconversions. Examples 
of this situation include the conversion of [3Fe-4S] clusters to [4Fe-4S], the 
oxidative decomposition of [4Fe-4S] to [3Fe-4S] clusters [12-13] and the 
proposed assembly of [4Fe-4S] from [2Fe-2S] clusters in the FeS clusters 
biogenesis scaffold proteins. 
[1Fe] [2Fe-2S] [3Fe-4S] [4Fe-4S]
[Mo7Fe-9S] [8Fe-7S]
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Table 2.1 – Functions of biological FeS proteins*. From [8]. 
Function Proteins Cluster type
Electron transfer Ferredoxins, redox enzymes [2Fe-2S], [3Fe-4S], [4Fe-4S] 
Coupled electron/proton transfer Rieske protein [2Fe-2S] 
 Nitrogenase [8Fe-7S]
Substrate binding and activation (de)hydratases [4Fe-4S] 
 Radical SAM enzymes [4Fe-4S]
 Acetyl-CoA synthase Ni-Ni-[4Fe-4S], [Ni-4Fe-5S] 
 Sulfite reductase [4Fe-4S]-siroheme
Fe or cluster storage Ferredoxins [4Fe-4S] 
 Polyferredoxins [4Fe-4S]
Structural Endonuclease III [4Fe-4S] 
 MutY [4Fe-4S]
Regulation of gene expression SoxR [2Fe-2S] 
 FNR [4Fe-4S]/[2Fe-2S]
 IRP [4Fe-4S]
 IscR [2Fe-2S]
Regulation of enzyme activity Glutamine PRPP amidotransferase[4Fe-4S] 
 Ferrochelatase [2Fe-2S]
Disulfide reduction Ferredoxin:Thioredoxin reductase[4Fe-4S] 
 Heterodisulfide reductase [4Fe-4S]
Sulfur donor Biotin synthase [2Fe-2S]
*SAM, S-adenosylmethionine; Acetyl-CoA, Acetyl coenzymeA; FNR, fumarate and nitrate 
reduction; IRP, iron-regulatory protein; IscR, iron-sulfur cluster assembly regulatory protein; 
PRPP, phosphoribosylpyrophosphate. 
 
Most biological roles of FeS clusters are based on the ability of iron to 
accept or donate electrons, cycling between the ferrous (Fe2+) and ferric 
(Fe3+) oxidation states. FeS clusters may shuttle between two oxidation 
states, making them one-electron acceptors/donors. The redox potential of 
FeS clusters is highly sensitive to the ligand environment in the polypeptide 
and can be tuned for specific functional requirements where they conduct 
electrons from one active site to another, like the ones in hydrogenases or 
oxygenases. The most notable example of electron transfer via FeS clusters 
occurs in respiratory chain complexes. Complex I features a FeS cluster 
“wire” which couples NADH oxidation to ubiquinone reduction (Figure 2.2) 
[14]. Similarly, complex II employs three FeS clusters to transfer electrons 
resulting from the oxidation of succinate to ubiquinone. Complex III includes 
a single Rieske-type [2Fe-2S] cluster which transfers electrons from 
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Figure 2.2 – FeS 
clusters in the electron 
transfer pathway in 
respiratory complex I. 
Structure of the Thermus 
thermophilus complex 
(3M9S). Seven 
conserved FeS clusters 
(one [2Fe-2S] and six 
[4Fe-4S] clusters) in 
close proximity act as a 
“wire” transferring 
electrons originating 
from the oxidation of 
NADH to NAD+ at the 
cytoplasm boundary to 
the quinone oxidation site near the membrane region. The total electron transfer pathway, in 
green, is around 8 nm. The two FeS clusters not included in the electron transfer pathway are 
thought to prevent the generation of reactive oxygen species and perform structural roles. 
Protein is shown as a surface representation; FeS clusters are depicted as spheres. The flavin 
mononucleotide cofactor at the NADH oxidation site has been omitted for clarity. From [14]. 
ubiquinone to cytochrome c1. Electrons coming from the oxidation of fatty 
acids enter the mitochondrial respiratory chain via the electron transfer 
flavoprotein:ubiquinone oxidoreductase [15]. Steroid biosynthesis by 
mitochondrial cytochrome P450 requires electrons from NADPH which are 
transferred by adrenodoxin, a [2Fe-2S] cluster protein [16]. The exquisite 
electron transfer properties of FeS clusters are the reason for why they are 
necessary for enzymes breaking string multiple bonds such as nitrogenase, 
sulfite and nitrite reductases. 
Other chemical reactions where FeS clusters are involved do not involve 
redox transformations. The first step in the tricarboxylic acid cycle, the major 
source of reducing equivalents in aerobic respiration, is the conversion of 
citrate to isocitrate, a step catalyzed by the mitochondrial [4Fe-4S] cluster 
enzyme aconitase. The cluster is bound by three cysteine sulfurs. The fourth 
coordination position is occupied by an hydroxyl anion in the enzyme’s 
resting state and is the substrate binding site during the stereo-specific 
catalysis [17] (Figure 2.3). 
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Figure 2.3 – [4Fe-4S] cluster in human aconitase. (A) In the resting state (3B3X), aconitase 
binds four of the FeS cluster iron atoms (shown as orange spheres). The remainder 
coordination position is occupied by a water or hydroxide molecule. (B) During catalysis 
(1AR3) the substrate binds the fourth iron which provides the scaffold for the stereospecific 
conversion of citrate to isocitrate (shown as sticks). 
FeS clusters can also be metabolic precursors. It is believed that the 
formation of high nuclearity ([3Fe-4S] and [4Fe-4S]) FeS clusters is 
hierarchic, occurring at the expense of lower nucelarity [2Fe-2S] clusters in 
the biosynthetic scaffold proteins [8]. Biosynthesis of the molybdenum 
cofactor (MoCo) present in aldehyde oxidase and xanthine dehydrogenase 
involves molybdenum cofactor biosynthesis protein 1 (MOCS1), a protein 
containing a [4Fe-4S] and [3Fe-4S] clusters [18]. It has been suggested that 
one of the two [4Fe-4S] clusters in lipoate synthase serves as the source of 
sulfur in the formation of lipoic acid [19]. Nucleic acid metabolism is highly 
dependent on FeS enzymes. Humans have three FeS enzymes in this 
pathway: dihydropyrimidine dehydrogenase (DPYD), 
phosphoribosylpyrophosphate amidotransferase (PPAT) and xanthine 
dehydrogenase (XDH) [10]. Curiously, the sole [4Fe-4S] cluster in PPAT does 
not seem to be required for activity but rather for amino-terminal processing 
and stabilization [20-21]. FeS proteins are also involved in DNA and RNA 
synthesis and processing. ATP binding cassette protein E1 binds two [4Fe-
4S] clusters and is involved in protein translation initiation, rRNA processing, 
ribosomal assembly [22]. The BACH1 helicase, the PRIM2 DNA primase [23], 
A B
H2O
H2O
Isocitrate
Cys385
Cys448 Cys451
Cys385
Cys448
Cys451
Chapter 2 
40 
the ERCC2 helicase, the NTHL1 DNA endonuclease [24] and the MUTYH DNA 
glycosidase are all [4Fe-4S] proteins. At the level genetic regulation FeS 
clusters also play a role. The E. coli FNR transcription factor is responsible for 
the transcription of genes involved in anaerobic energy transduction systems 
which senses the oxygen concentration through its [4Fe-4S] cluster which 
converts to [2Fe-2S] in the presence of oxygen, leading to the dissociation of 
the active FNR dimer and gene transcription inhibition [25]. 
Iron metabolism requires the action of several FeS proteins: 
ferrochelatase – the iron chaperone which inserts Fe2+ in protoporphyrin IX 
to yield heme – has a [2Fe-2S] cluster. The synthesis of the major iron 
metabolism proteins – ferritin (storage) and transferrin (transport) – is 
controlled by the amount of iron in the cell which is sensed by the cytosolic 
aconitase, a bacteria and eukaryotic bifunctional protein containing a [4Fe-
4S] cluster like its mitochondrial homolog. In high-iron conditions, the 
protein is free in the cytosol and ferritin is synthesized by the cell; transferrin 
mRNA is unstable and is rapidly degraded. Under conditions of low iron, the 
[4Fe-4S] cluster dissociates from the protein which then binds Iron-
responsive elements (IREs) in mRNA. This represses ferritin mRNA 
translation and stabilizes transferrin mRNA, which drives protein synthesis. 
2.2. Iron-sulfur, protein folds and structural plasticity 
FeS clusters are harbored in nearly 50 unique protein folds [26]. Over 
90% of these folds harbor low-potential [2Fe-2S] or [4Fe-4S] clusters. FeS 
clusters are highly versatile in the sense that the interaction between the 
polypeptide and the cluster determines which kind of cluster binds to the 
protein and the polypeptide determines the redox potential and reactivity of 
the cluster. Additionally, the biological importance of FeS clusters is based on 
their ability to cycle between redox states, coordination configurations and 
nuclearity and stabilize the native conformation of proteins. 
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Figure 2.4 - Rubredoxin fold.
Desulfovibrio gigas rubredoxin (2DSX).
The iron atom is shown as a sphere and
the cysteine ligands as sticks. 
Figure 2.5 - [2Fe-2S] ferredoxin. From
Anabaena PCC 7119 (1CZP). 
2.2.1. Rubredoxin 
Rubredoxin is a ~50 amino acid 
residue bacterial and archaeal protein 
containing a single tetrahedrally-
coordinated mononuclear iron (Figure 
2.4). It is involved in electron transfer, 
sometimes replacing ferredoxin [27]. The 
highly conserved fold belongs to the α+β 
family, with 2 α-helices and 2-3 β-strands. 
The rubredoxin fold occurs in 
multidomain proteins like desulforedoxin 
[28], ruberythrin [29] and superoxide 
reductase [30] and in the FeS cluster 
domain of Rieske proteins [31]. In the latter case, the iron binding site 
accommodates the Rieske [2Fe-2S] cluster without fold distortion. A 
rubredoxin iron site can be converted into a [2Fe-2S] site and vice versa by 
specific point mutations [32-33]. 
2.2.2. [2Fe-2S] plant- and vertebrate-type ferredoxin 
These proteins constitute a 
functionally diverse group. Plant-type 
ferredoxins carry electrons resulting from 
water oxidation at photosystem I to 
several enzymes. The bacterial (e. g. 
putidaredoxin) and vertebrate (e. g. 
adrenodoxin) ferredoxins donate 
electrons to hydroxylating enzymes like 
cytochrome P450. The ISC FeS 
biosynthesis machinery includes a 
ferredoxin electron transporter of this 
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Figure 2.6 – Rieske fold. Soluble
domain of the bovine mitochondrial
Rieske protein in cytochrome bc1
(1RIE). The disulfide bridge connecting
the two cluster binding loops is depicted
as sticks. The membrane anchor is not
included in the structure. 
type. This type of ferredoxins has a low potential cluster (-150 to -450 mV). 
These proteins are small (~100 residues) belonging to the α+β fold class. 
The [2Fe-2S] cluster is located close to the surface in a loop region. The 
opposite side of the protein forms a ubiquitin-like motif with a four stranded 
β-sheet and helical segments (Figure 2.5). This type of ferredoxin occurs as a 
domain in larger dehydrogenase, reductase and oxidase enzymes. The 
apically located [2Fe-2S] cluster is not essential for protein stability. The 
stabilizing contributions for the polypeptide and the cluster itself are mainly 
based in the opposite, secondary structure-rich part of the protein [34]. 
2.2.3. Rieske [2Fe-2S] ferredoxin 
Rieske proteins contain a [2Fe-2S] 
cluster where one of the iron atoms is 
coordinated by two cysteine side chains 
and the other by two histidine side 
chains. They are obligatory components 
of the membrane-bound respiratory 
(cytochrome bc1) and photosynthetic 
(cytochrome b6f) electron transfer 
complexes. Soluble Rieske proteins, 
named Rieske ferredoxins, are 
components of oxygenase enzymatic 
systems or electron carriers. 
Despite having a cluster with the same 
nuclearity as [2Fe-2S] plant- and 
vertebrate-type ferredoxins, Rieske 
proteins have a distinct fold and specific functions. The Rieske fold consists 
of three stacked β-sheets, of which the upper one contains the cluster ligands 
in two loops, each one containing a cysteine and a histidine residue. In 
respiratory and photosynthetic Rieske proteins the cluster binding loops are 
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Figure 2.7 – Thioredoxin-like [2Fe-
2S] fold. From Aquifex aeolicus
(11M2D). Dimeric structure. The FeS
cluster is shown in ball and sticks. The
ligands are shown as sticks. 
further cross-linked by a disulfide bridge (Figure 2.6) which is crucial for 
protein stability and activity, since mutations in the intervening cysteines 
precludes cluster formation. The cluster histidine ligands are solvent 
exposed and are responsible for the highly pH-dependent redox potential of 
the Rieske cluster. Membrane-bound Rieske proteins have an N-terminal 
hydrophobic extension which is inserted in the membrane. Soluble Rieske 
proteins have the same fold as the soluble domain of the membrane-bound 
counterparts with the exception of having an helical segment removed. The 
fold around the cluster is highly similar to the rubredoxin one. The unique 
[2Fe-2S] coordination implies upshifted redox potentials (+100 to +400 mV 
for respiratory and photosynthetic proteins and around -100 mV for 
dioxygenase components). 
2.2.4. Thioredoxin-like [2Fe-2S] ferredoxin 
Thioredoxin-like ferredoxins are only 
found in bacteria as components of 
hydrogenase and NADH:ubiquinone 
oxidoreductase [35] and have been 
proposed to be involved in nitrogen 
metabolism [36]. Unlike thioredoxin, the 
β-sheet is wrapped by α-helices on one 
side (Figure 2.7). The other side of the 
sheet is involved in homodimerization in 
the Aquifex aeolicus protein. The redox 
potential of the [2Fe-2S] cluster is around 
-300 mV.  
2.2.5. High-potential [4Fe-4S] protein 
[4Fe-4S] high-potential iron proteins (HiPIP) are mostly found in 
photosynthetic bacteria [37] where they donate electrons to the tetraheme 
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Figure 2.8 – High Potential Iron-
sulfur protein (HiPIP). From 
Allochromatium vinosum (1B0Y). 
Figure 2.9 - [4Fe-4S] dicluster 
ferredoxin. From Clostridium 
pasteurianum (1CLF). 
cytochrome [38]. Their name is derived 
from the [4Fe-4S] cluster reduction 
potential (+100 to +400 mV) [26], 
resulting from the incorporation of the 
cluster in the protein’s hydrophobic core. 
The most distinctive structural feature of 
these proteins is the little secondary 
structure content in their globular 
conformation (Figure 2.8). 
2.2.6. Di-cluster [4Fe-4S] ferredoxin 
These proteins are involved in 
anaerobic metabolic pathways and in the 
most reducing steps of photosynthetic 
and aerobic electron transport chains due 
to the low reduction potential of the [4Fe-
4S] clusters (distinct for each one, ranging 
from -150 to -700 mV) [26]. The 
reference for these proteins is Clostridium 
pasteurianum ferredoxin. The [4Fe-4S] 
clusters contribute significantly to protein 
stability because of the tight wrapping of 
the polypeptide around them. The two 
clusters make up the protein core in a 
small protein (55 amino acid residues) 
and this precludes the necessity of additional stabilizing forces. The structure 
has a pseudo two-fold symmetry, with each half harboring a cluster. This 
protein fold is the only one harboring a pair of clusters rather than just one. 
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The ferredoxin fold has been proposed to be one of the most primitive ones 
due to its simple amino acid composition [39]. The high stability of some fold 
representatives (e. g. [40]) also agrees with the thermophilic origin of life. 
The characteristic topology for these proteins, (βαβ)2, is referred to as the 
ferredoxin fold (Figure 2.9). This fold constitutes a core structure from 
where several modular variations exist. These include the C-terminal 
extensions in Pseudomonas aeruginosa [41] and Azotobacter vinelandii [42], 
the N-terminal extensions of Sulfolobales including an additional Zn2+ site 
[43-44] or a stabilizing hydrophobic core [45] or bacterial ferredoxins in 
which one of the clusters has been lost [42, 46-47]. 
2.3. Folding and stability of iron-sulfur proteins 
One must analyze two aspects when considering the conformational 
interplay between FeS clusters and proteins. One the one hand, FeS clusters 
are intrinsically oxygen sensitive [48] and need an appropriate ligand 
environment to be stabilized; on the other hand, the incorporation of the 
cluster is frequently a long range polypeptide cross-linker which is essential 
for protein stability. FeS clusters are usually embedded in a single protein 
domain, which provides the relatively rigid and stabilizing ligand 
environment. Solvent exposure of FeS clusters emerges from functional 
requirements, like in soluble electron carriers or in sensor or regulatory 
proteins. 
Despite the significant variety of folds able to accommodate FeS clusters, 
each fold usually cannot bind different clusters because of strict steric 
restrictions. The exceptions are the superimposable rubredoxin and Rieske 
folds around the [2Fe-2S] cluster. Nevertheless, cluster swapping only occurs 
under mutagenic perturbations. Nitrogenase contains a native [4Fe-4S] 
cluster [2] which can be cleaved into [2Fe-2S] clusters but as a result of 
protein denaturation [49] or by glycerol-induced decomposition in the Mg2+-
bound state [50]. 
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Apart from their functional role, FeS clusters are key structural elements 
stabilizing the native protein conformation [40, 51]. Their multi-ligand 
coordination establishes long range cross-links in the polypeptide, restricts 
conformational entropy, favors folding and stabilizes the native state. Many 
FeS proteins are not able to acquire the native or native-like fold in the 
absence of the cognate FeS clusters [52] or require the conversion between 
different cluster nuclearities for functional roles [25]. 
2.4. Folding and stability of Acidianus ambivalens FeS proteins 
One of the most intriguing open topics in the protein folding field 
currently is the understanding of the molecular determinants of protein 
stability. That is, what are the amino acid sequence features and the 
interactions involved in selecting and maintaining the native conformation. 
In the case of cofactor-binding proteins, this issue is enlarged by considering 
the effect of the cofactor and polypeptide-cofactor interactions. Three main 
strategies have been adopted to tackle this issue: 
1. Comparative analysis of the folding properties of wild type and single 
point amino acid mutants; 
2. Study of the folding properties of single protein domains or small 
peptides derived from actual proteins; 
3. Study of the folding properties of intrinsically highly stable proteins. 
Under the framework of the third strategy, proteins originating from 
extremophiles – organisms thriving at extreme temperature, pH, salinity or 
pressure conditions – are obvious research models because it is assumed 
that the organism’s survivability is set by the least stable of its components. 
The majority of extremophilic organisms are Archaea, which constitute the 
deepest branch in Woese’s tree of life [53-54]. The adaptation to extreme 
conditions together with the primordial origin of these organisms has been 
linked to the origin of life on Earth. In this sense, archaeal FeS proteins are 
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Figure 2.10 – Seven iron ferredoxin
from Acidianus ambivalens. The
structure includes the [3Fe-4S] and
[4Fe-4S] clusters and the Zn2+ site. PDB:
3VKR.
unique models for addressing the molecular determinants of protein 
stabilization because of their primordial origin and features (e. g. the (βαβ)2 
ferredoxin fold is considered to be one of the oldest folds), spectroscopically 
active cofactors and small size of the FeS binging domains. Some organisms 
such as thermoacidophilic Sulfolobales family members intrinsically express 
such high amounts of FeS proteins that they can be spectroscopically 
detected in intact cells [55]. This has allowed the unequivocal identification 
of [3Fe-4S][4Fe-4S] ferredoxins in vivo and the establishment that [3Fe-4S] 
clusters are physiologically relevant and not decomposed [4Fe-4S] clusters. 
Two members of the Sulfolobales family have been extensively studied in 
terms of the folding properties of their FeS proteins, namely ferredoxins: 
Acidianus ambivalens and Sulfolobus metallicus. These ferredoxins have a fold 
identical to that of the canonical dicluster [4Fe-4S] ferredoxin, but one of the 
clusters is replaced for a [3Fe-4S] one (Figure 2.10). The family of seven-iron 
ferredoxins is intrinsically very stable. For the Thermus thermophilus 
homolog Tm = 114°C and Cm = 6.5 M GuHCl at pH 7 [56]. Ionic interactions 
were suggested to be a major stabilization due to substantial decreased 
stability at lower pH [56-57]. Despite their small size, seven-iron ferredoxins 
unfold irreversibly. Two mechanisms are 
thought to contribute to this outcome: 
first, the clusters constitute a 
considerable part of the protein 
hydrophobic core, which is densely 
packed in thermostable proteins; second, 
the clusters should decompose after 
release from the polypeptide, precluding 
reversibility. 
Acidianus ambivalens is a 
thermoacidophile growing optimally at 
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Figure 2.11 – Unique features of the Acidianus ambivalens [3Fe-4S][4Fe-4S] ferredoxin. 
(A) dicluster [4Fe-4S] ferredoxin from Clostridium pasteurianum (1CLF). (B) [3Fe-4S][4Fe-4S] 
ferredoxin from Acidianus ambivalens (2VKR). The N-terminal extension is shown in orange 
and the Zn2+ ion as a yellow sphere. (C) Backbone superimposition of the two structures. The 
C. pasteurianum structure is in black and the A. ambivalens is in blue/orange. Only the FeS 
clusters of the A. ambivalens protein are shown. The clusters from the C. pasteurianum protein 
are superimposable. 
80 °C and pH 2.5 [58]. It expresses a [3Fe-4S][4Fe-4S] ferredoxin whose fold 
is identical to that of the canonical dicluster [4Fe-4S] ferredoxin, except for 
the presence of an N-terminal extension harboring a His/Asp Zn2+ site 
(Figure 2.11). 
The folding properties of this protein have been extensively studied and a 
comprehensive view of the unfolding process has been achieved. The relative 
contribution of the polypeptide versus the clusters has been analyzed taking 
advantage of the distinct spectroscopic properties of both. At pH 7 the 
protein is highly stable and remains folded even in 8 M GuHCl [59]. The Tm is 
~120°C in the 5.5 to 8 pH range [57]. Changing pH to the protein’s isoelectric 
point (pH 3.5), in which the electrostatic contributions for protein 
stabilization are minimized, the protein undergoes a conformational change 
which does not affect the FeS clusters. The latter then unfold at a higher 
temperature than the polypeptide (Tm = 72°C versus 52°C). Below pH 2 the 
FeS clusters disintegrate spontaneously [57]. Overall, these observations 
A B C
Clostridium pasteurianum Acidianus ambivalens Superimposition
N
C
C
N
Zn2+Zn2+
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show that the FeS clusters in this ferredoxin are essential for the 
maintenance of the native conformation. 
Thermal denaturation of the ferredoxin at pH 2.5 yields a FeS- and Zn2+-
less stable molten globule conformation which unfolds reversibly and is only 
marginally less stable than the holo state (ΔΔG ~1.5 kcal/mol) [60]. Much 
evidence exists in the literature suggesting that molten globule states may be 
ubiquitous folding intermediates [61] and that FeS protein molten globule 
like conformations are good candidates for being the acceptors of FeS 
clusters from the biosynthetic machinery. The association of conformational 
plasticity with the mechanism of FeS clusters insertion into apoproteins is 
further highlighted in IscU, the scaffold protein from where pre-formed FeS 
clusters are transferred to the target apoproteins. It hosts a [2Fe-2S] cluster 
[62] and adopts a dynamic molten globule-like state which is relevant in the 
context of protein-protein interactions [63]. Accordingly, and together with 
the stability of this state, the molten globule state was surmised to be the 
likely conformational state where the FeS clusters are incorporated in the 
apoprotein [60]. 
Sulfolobus metallicus was found to express identical amounts of two [3Fe-
4S][4Fe-4S] ferredoxins – an observation repeated in A. ambivalens [64] – 
sharing most biochemical and spectroscopic features [11] but differing in the 
Acidianus ambivalens-like N-terminal extension (Figure 2.12). Ferredoxin A 
(FdA) includes the His/Asp Zn2+ site also found in the A. ambivalens protein. 
The ferredoxin B isoforms (FdB) differs in this region by several polar-to-
hydrophobic and charged-to-hydrophobic substitutions which create a 
compact hydrophobic core. The kinetic stability of the two proteins is similar, 
with no changes after 72 h incubation at 70°C [11]. Surprisingly, the Zn2+-
binding isoforms was found to be less temperature stable (105.9°C versus 
113.1°C at pH 7), revealing that an evolution-selected hydrophobic 
contribution can be more stabilizing than the extrinsic Zn2+ cross-linking 
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[45]. This is however uncommon in Archaea, as in A. ambivalens the Zn2+-
containing isoform is less stable than the Zn2+-lacking one (108°C versus 
116°C, respectively, at pH 7) [57, 64]. 
 
Figure 2.12 – N-terminal extension in Sulfolobus metallicus ferredoxin isoforms. The 
central figure shows the common fold of FdA and FdB. The square-delimited region is blown 
up in the lateral panels. In FdA the region comprises the conserved His/Asp Zn2+ ligands. In 
FdB this region is filled with tightly packed bulky hydrophobic side chains. From [45]. 
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3.1. Summary 
Rieske proteins and Rieske ferredoxins are present in the three domains 
of life and are involved in a variety of cellular processes. Despite their 
functional diversity, these small iron-sulfur proteins contain a highly 
conserved all-beta fold, which harbors a [2Fe-2S] Rieske center. We have 
identified a novel subtype of Rieske ferredoxins present in 
hyperthermophilic Archaea, in which a two cysteine conserved SKTPCX(2-3)C 
motif is found at the C-terminus. We establish that in the Acidianus 
ambivalens representative, RFd2, these cysteines form a novel disulfide bond 
within the Rieske fold, which can be selectively broken under mild reducing 
conditions insufficient to reduce the [2Fe-2S] cluster or affect the secondary 
structure of the protein, as shown by visible CD, absorption and ATR FT-IR. 
RFd2 presents all EPR, visible absorption and visible CD spectroscopic 
features of the [2Fe-2S] Rieske center. The cluster has a redox potential of 
+48 mV (25°C and pH 7) and a pKa of 10.1 ± 0.2. These shift to +77 mV and 
8.9 ± 0.3 respectively upon reduction of the disulfide. RFd2 has a melting 
temperature near the boiling point of water (Tm = 99°C, pH 7.0) but it 
becomes destabilized upon disulfide reduction (ΔTm = -9°C, ΔCm = -0.7 M 
GuHCl). This example illustrates how the incorporation of an additional 
structural element such as a disulfide bond in a highly conserved fold such as 
that of the Rieske domain, may fine-tune the protein for a particular function 
or for an increased stability. 
3.2. Introduction 
Iron sulfur (Fe-S) proteins are ubiquitous in all life domains and are 
involved in many fundamental cellular processes, from electron transfer, to 
catalysis, to regulation of gene expression. The simpler Fe-S proteins, despite 
their low structural complexity and small size (<150 amino acids), are able to 
harbor clusters with different nuclearities ([2Fe-2S], [3Fe-4S], [4Fe-4S]), or 
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even combinations of clusters, as in the di-cluster ferredoxins ([3Fe-4S][4Fe-
4S] and [4Fe-4S][4Fe-4S]). In these proteins the inorganic moieties are 
generally found in a single domain, having rather conserved topologies [1]. 
The protein fold and the Fe-S clusters have an intertwined contribution on 
the structural stability of these proteins: whereas polypeptide scaffolding 
provides a relatively rigid and protective ligand environment for cluster 
binding, the chemical stability of the Fe-S cluster itself plays a key stabilizing 
effect over the structure.  
The conserved folds of simple Fe-S proteins are in some cases decorated 
by additional structural elements that somehow broaden and shape the 
structural and functional landscape of these proteins. Examples include N- 
and C-terminal amino acid extensions within dicluster ferredoxins [2-3], 
insertion of a structural zinc site [4], and incorporation of a disulfide bond 
within the fold [5-7]. For instance, di-cluster [3Fe-4S][4Fe-4S] ferredoxins 
[3] contain a N-terminal extension, which modulates the protein stability 
either by hosting an additional His/Asp zinc center [4, 8] or by creating a 
stabilizing hydrophobic core [9]. Also, a disulfide bond has been shown to 
contribute significantly to the stability of the [2Fe-2S] plant-type ferredoxin 
from the hyperthermophilic bacterium Aquifex aeolicus, as its presence 
increases the melting temperature from 113 to 121°C [6]. One last example is 
given from the respiratory-type Rieske proteins, in which a strictly 
conserved disulfide in the immediate vicinity of the [2Fe-2S] cluster (within 
5 Å) stabilizes the cluster binding loops and modulates the redox potential 
[10].  
In this context, Rieske proteins are interesting examples of the functional 
and structural diversity within a family of proteins that share the same basic 
all-beta fold [1, 11]. These proteins have the distinct feature of harboring a 
[2Fe-2S] cluster coordinated by two cysteine and two histidine residues. Like 
in other Fe-S proteins, a considerable diversity is allowed at the level of the 
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primary structure without disturbing the structural topology whereas the 
type of amino acid side chains and the electrostatic environment found 
around the [2Fe-2S] Rieske cluster modulate the redox potential of the 
center. This results in a broad range of functional potentials, from around -
150 mV for the soluble Rieske ferredoxins from the dioxygenase components 
[12], to up to +400 mV for the photosynthetic or respiratory Rieske domains 
[13-14]. Subsequently to a thorough phylogenetic analysis [11, 15], the 
diversity of Rieske proteins was considerably expanded, in particular in what 
concerns the soluble Rieske type ferredoxins, as many novel sequences were 
identified mostly within phyletically distant organisms from the Archaea 
domain. Subsequent analysis using complete genome data has allowed to 
establish the existence of evolutionarily related sequences within the 
Thermoprotei, an Archaeal class comprising hyperthermoacidophilic 
organisms belonging to the Sulfolobus and Caldisphaera genus [16]. The 
genes identified encode for proteins with the typical Rieske fingerprint, but 
with very little amino acid identity towards other Rieske proteins. Here we 
report a novel structural feature within the all-beta Rieske fold, which was 
identified upon studying one of these as yet uncharacterized archaeal Rieske 
ferredoxins from Acidianus ambivalens (EMBL FN557298). It consists of a 
disulfide bond within the Rieske fold, whose redox status influences the 
properties of the [2Fe-2S] center and simultaneously stabilizes the protein. 
This particular disulfide is a novel feature within Rieske proteins, and is 
unrelated to the disulfides described in respiratory and photosynthetic 
Rieske domains [17] and in the archaeal respiratory-type SoxF [5] and 
sulredoxin [18] proteins, which have distinct locations in the fold. This 
finding illustrates how minor structural modifications modulate protein 
function and stability and is key to rationalize the evolutionary adaption of 
simple Fe-S proteins to distinct conditions and to understand how relatively 
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simple folds may be fine tuned for a particular function or for an increased 
stability. 
3.3. Materials and methods 
3.3.1. Sequence comparison 
Homologous Rieske amino acid sequences were extracted from the non 
redundant protein database using BLAST and A. ambivalens Rieske 
Ferredoxin 1 (Genbank 22204177) and Rieske ferredoxin 2 (RFd2), 
Sulfolobus tokodaii Sulredoxin and S. solfataricus ARF as seeds. All organisms 
were included in the search. We have considered the hits with E-values of 
less than 10-10 significant. Sequences were aligned using ClustalX [19], 
MAFFT (at http://align.bmr.kyushu-u.ac.jp/mafft/online/server/) [20] , 
GeneDoc [21], and CINEMA 
(http://www.bioinf.manchester.ac.uk/dbbrowser/CINEMA2.1/) [22]. 
Dendrograms were calculated using the MAFFT server and displayed using 
PhyloWidget (http://www.phylowidget.org/). The nucleotide sequence of 
the rfd2 gene was submitted to the EMBL database and was assigned the 
accession number FN557298. 
3.3.2. Chemicals 
All reagents were of the highest grade available commercially. 
Guanidinium hydrochloride (GuHCl) was obtained from Promega and the 
accurate concentration of its solutions was determined by refractive index 
measurements. 8-anilino-1-naphthalenesulfonic acid (ANS), Tris(2-
carboxyethyl)phosphine hydrochloride (TCEP) and 5,5′-Dithiobis(2-
nitrobenzoic acid) (DTNB) were purchased from Sigma. 
3.3.3. Cloning, expression and purification 
Acidianus ambivalens DSMZ 3772 was grown aerobically and 
anaerobically according to published procedures [23]. The gene encoding the 
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Rieske ferredoxin 2 (RFd2) was PCR-amplified from A. ambivalens genomic 
DNA using the following N-terminal and C-terminal primers TATTT CATGA 
TTAAG ACAAT TCTTT ATGAA and AAACA ACTCG AGTGT ACCTT TTCTA 
GGTAA TTC, respectively. The N-terminal primer swapped the native 
presumable GTG start codon for an ATG. The 336 bp PCR product was 
digested with BspHI and XhoI and ligated into the NcoI/XhoI-digested vector 
pET28a (Novagen, now Merck -Biosciences, Darmstadt, Germany) thus 
adding two amino acid codons for the XhoI restriction site and a C-terminal 
His-Tag to the native protein (..LEHHHHHH). The protein was produced after 
IPTG induction at an OD600nm of 0.6-1 in E. coli BL21 CodonPlus RIL DE3 cells 
(Stratagene, now Agilent Technologies) grown overnight at 37˚C in LB 
medium supplemented with 1/1000 vol. of a 100 mM ferric chloride in 100 
mM citric acid solution. 40 g of E. coli cells were resuspended after 
harvesting in a 400 ml of 40 mM potassium phosphate (KPi) buffer pH 8 
containing 300 mM NaCl and 10 mM imidazole. The cells were broken using 
a continous French press (Constant Systems Ltd., Daventry, UK) followed by 
two centrifugation steps (15 min at 15,000 x g and 60 min at 150,000 x g, 
respectively). 200 ml of the clear supernatant were applied to a 20 ml Ni-
NTA column (Qiagen, Hilden, Germany) equilibrated with the same buffer 
and connected to an FPLC (Pharmacia, now GE Health Care, Freiburg, 
Germany). The column was washed with 3 volumes of 50 mM imidazole and 
finally eluted with 500 mM imidazole, both in the same buffer. The colored 
fractions were combined and dialyzed against 40 mM KPi pH 8. The sample 
was subsequently dialyzed against 70 mM Tris-HCl pH 7.7 150 mM NaCl and 
loaded to a calibrated Sephadex G-50 column (2 x 50 cm) previously 
equilibrated with the same buffer. Rieske eluted as a pure sample as verified 
by SDS-PAGE [24] and the typical UV-vis absorption spectrum. This pink 
stock solution was concentrated to around 1-2 mg/ml by ultrafiltration using 
a 5 kDa cut-off membrane (Amicon Ultra, Millipore), flash frozen at liquid 
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nitrogen temperature and stored at -20°C for subsequent studies. Protein 
was quantified using Bradford’s method [25]. 
3.3.4. Disulfide reduction 
The Rieske ferredoxin was purified in the oxidized state. Full reduction 
was achieved with excess ascorbate or sodium dithionite at room 
temperature. Spectra were obtained with 4.6 μM (0.06 mg/ml) (far UV CD) or 
15.2 μM (0.2 mg/ml) (near UV/visible CD and absorption) protein 
concentration in 2 mM KPi pH 7. Low buffer concentrations are required to 
minimize absorption in the far UV region. Other reduced Rieske samples 
were obtained by incubating 7.6 μM protein with 5 mM DTT or 5 mM TCEP, 
during 1 h in 50 mM KPi pH 7 at room temperature. 
3.3.5. Spectroscopic methods 
UV/Vis spectra were recorded in a Shimadzu UVPC-1700 spectrometer 
equipped with cell stirring and a Julabo water bath-coupled thermostated 
cell support. Unless otherwise indicated, UV/Visible absorption spectra were 
recorded at room temperature. Circular dichroism (CD) measurements were 
performed on a Jasco J-815 spectrometer and fluorescence measurements 
were acquired on a Cary Varian Eclipse instrument, both possessing peltier-
thermostated cell supports. Attenuated total reflectance Fourier transform-
infrared (ATR FT-IR) spectra were acquired in a Bruker IFS 66/S 
spectrometer equipped with a nitrogen-cooled MCT detector using the 
water-thermostatized Harrick BioATRcell II cell. EPR spectra were acquired 
on a Bruker EMX spectrometer equipped with an ESR 900 continuous-flow 
helium cryostat at 10 K, 9.39 GHz microwave frequency, microwave power 
2.4 mW and modulation amplitude 1 mT. 
3.3.6. Conformational stability 
The conformational stability of Rieske was assessed by performing 
temperature- or chemical-induced denaturation while following several 
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spectroscopic properties: i. visible absorption, which reports on the [2Fe-2S] 
cluster integrity; ii. tyrosine fluorescence, which reports on tertiary contacts; 
and iii. ANS fluorescence, which reports on the exposure of hydrophobic 
patches. Protein was prepared as 7.6 μM in 50 mM KPi pH 7. Data treatment 
was performed as described in [26]. 
For thermal-induced denaturation, we incubated the Rieske ferredoxin 
with no reductant, 5 mM TCEP or 5 mM DTT plus 0 or 2.5 M GuHCl at 25°C. 
Then, we performed 1°C/min temperature ramps (25-92°C) while measuring 
the UV/visible absorption spectrum or tyrosine fluorescence at 304 nm. 
Fluorimeter was set up to excite at 275 nm using 10 nm excitation and 
emission slits and 600 V PMT voltage. Refolding was assessed by 
equilibrating the sample at 4°C overnight (absorption) or 25°C for 5 minutes 
(fluorescence). 
GuHCl-induced chemical denaturation curves were obtained by 
incubating the Rieske ferredoxin with 0 or 5 mM TCEP and different 
concentrations of GuHCl during at least 3h at room temperature. The 
denaturation curve corresponds to the normalized variation of fluorescence 
intensity at 304 nm or absorbance at 330 nm. The chemical denaturation was 
further dissected by incubating the same samples with 10 fold molar excess 
ANS for at least 30 min at room temperature. In this case, the folding status 
was probed by the ANS emission band (λexc = 350nm). 
3.3.7. ATR FT-IR spectroscopy 
For ATR FT-IR, the Rieske ferredoxin was concentrated by ultrafiltration 
to 0.8 mM (10.5 mg/ml) in 40 mM Tris-HCl pH 7 and then centrifuged 30 min 
at 12000 x g to remove aggregates. Spectra were acquired at 20°C and 4 cm-1 
resolution with 0 or 5 mM TCEP after 3 h equilibration. The amide I band was 
deconvoluted by fitting its Fourier self deconvolution with Lorentzian curves 
centered at the second derivative maxima and minima. Band assignment was 
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Figure 3.1 - UV-Visible absorption
spectrum of RFd2 in the presence and
absence of 5 mM TCEP. 15.2 μM (0.2 
mg/ml) RFd2 was incubated in 50 mM
KPi pH 7 in the presence or absence of 5
mM TCEP for at least 1.5 h at room
temperature. The 5 mM TCEP sample
spectrum remained unchanged for at
least 5 h. 
performed using the reference data in [27]. The secondary structure was 
estimated by the Lorentzian integrals. 
3.3.8. Redox potentiometry 
The reduction potential of the [2Fe-2S] Rieske cluster was determined at 
20°C and with 7.6 μM protein concentration in 50 mM KPi pH 7 with and 
without 5 mM TCEP. The redox state of the Rieske [2Fe-2S] cluster was 
probed by the absorbance change at 490 nm. The following redox mediators 
were used: 1,2-naphtoquinone-4-sulfonic acid (+215mV, 0.6μM), 1,2-
naphtoquinone (+180mV, 0.6μM), trimethylhydroquinone (+115mV, 0.6 μM), 
phenazine methosulfate (+80mV, 0.6μM), 1,4-naphtoquinone (+60mV, 0.6 
μM), 5-hydroxy-1,4-naphtoquinone (+30mV, 0.6μM), methylene blue 
(+11mV, 0.79μM), menadione (0mV, 0.6 μM), indigo tetrasulfonate (-30 mV, 
0.4 μM), indigo trisulfonate (-70mV, 0.55 μM), 2,5-hydroxy-p-benzoquinone 
(-130mV, 0.23 μM), 2-hydroxy-1,4-naphtoquinone (-152mV, 0.4μM; all 
potentials are in respect to the standard hydrogen electrode). Additionally, 
catalase (0.002 mg/ml), glucose oxidase 
(1.6 U/ml) and glucose (0.86 mM) were 
added to ensure O2-free conditions. The 
fully oxidized protein was titrated 
anaerobically with buffered sodium 
dithionite. The sample with 5 mM TCEP 
was incubated 3 h at room temperature, 
after which time the [2Fe-2S] center had 
been reduced. The oxidized center was 
regenerated by bubbling with air. UV-
Visible absorption spectra were recorded 
during the spontaneous re-reduction of 
the cluster. Several oxidation-reduction 
cycles were performed and the reduction 
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behavior did not change, despite the progressively lower re-reduction rates 
(~20-35 mV/min) due to reductant oxidation by oxygen. The titration curve 
includes datapoints from several reduction cycles. The midpoint reduction 
potential was determined by fitting a Nernst curve (n=0.7, 0 mM TCEP; n=1, 5 
mM TCEP) to the normalized variation of absorption at 490 nm. The lower 
than unity value for the n value for a one electron acceptor center is within 
the experimental uncertainty and likely reflects a slight off-equilibrium in 
that set of measurements since the visible absorption spectrum of both 
samples is identical (Figure 3.1). 
3.3.9. pH titration 
The pKa of the Rieske cluster was determined by investigating the pH-
associated changes of the visible CD spectrum. 11.4 μM protein samples were 
prepared in a buffer solution composed of MES, HEPES, tricine, taurine and 
CAPS (10 mM each) and 50 mM NaCl with and without 5 mM TCEP poised at 
different pH values. The samples were equilibrated overnight at room 
temperature before measuring the near UV/visible CD spectrum at 25°C. One 
pKa was determined by fitting the Hendersson-Hasselbalch formalism to the 
average normalized CD variation at 338, 378, 417, 434 and 485 nm (0 mM 
TCEP sample) or 338, 378, 462 and 485 nm (5 mM TCEP sample). 
3.3.10. Iron quantification 
Fe2+ was quantitated in Rieske ferredoxin samples using the chromogenic 
ferrous iron chelator TPTZ (2,4,6-tripyridyl-s-triazine) using a protocol 
adapted from [28]. Briefly, iron was released from Rieske by degradation in 
0.9 M HCl. The protein fraction was removed by precipitation in 8% 
trichloroacetic acid. The remaining iron solution was buffered in 16% 
ammonium acetate and reduced with 0.9% hydroxylamine hydrochloride. 
The Fe2+ concentration was then determined by the rise in Abs593 nm upon 
adding 320 μM TPTZ using a calibration with iron standards. 
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3.3.11. Thiol quantification 
Four Rieske samples were prepared in 100 mM KPi pH 8: oxidized native, 
5 mM TCEP reduced, denatured in 6 M GuHCl plus 2 mM EDTA, and 
denatured in 6 M GuHCl, 2 mM EDTA and 5 mM TCEP. Protein concentrations 
ranged from 23-69 μM and samples were incubated between 60 and 90 
minutes. After incubation, TCEP-containing samples were desalted (HiTrap 
Desalting, GE Healthcare) in Argon-saturated 100 mM KPi pH 8-50 mM NaCl 
buffer. Then, the thiol content was determined by adding 2 mM DTNB and 
recording the quantitative formation of TNB2- (ε412 = 14150 M-1.cm-1). All 
procedures were carried at room temperature. 
3.4. Results and discussion 
3.4.1. RFd2 is a representative of a subtype of Rieske ferredoxins 
The protein used in this study, Rieske ferredoxin 2 (RFd2), was identified 
from a search on the A. ambivalens genomic data (A. Kletzin et al., 
unpublished) using Rieske protein sequences as seeds. Among the hits was 
also the previously characterized Rieske ferredoxin 1 [16]. The native RFd2 
is a 106 amino acid protein with a theoretical mass of 12053 Da, and an 
isoelectric point of 8.9, whereas the length of the recombinant protein is 114 
aa, including the His-Tag (13118 Da, pI = 8.6). Subsequent database analysis 
using BLAST has allowed the identification of 8 significant hits (E-value ≤ 10-
17) related to RFd2, all from unannotated hypothetical proteins from the 
Sulfolobales and Caldisphaerales orders within the Archaeal class of the 
Thermoprotei, which comprises hyperthermophilic organisms. Sequence 
alignment (Figure 3.2 and Supplementary Figure S3.1) and phylogenetic 
analysis (Figure 3.3) suggest that the latter cluster is a novel subgroup within 
the Rieske family. This group has two prominent features: one is a N-
terminal truncation in a stretch which should include the β1 strand of the 
Rieske fold, and the other is the presence of an additional cysteine pair in a 
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SKTPCX(2-3)C motif at the C-terminal segment (Figure 3.2), in a position that 
maps into a loop region in the dioxygenase-type Rieske structures [12, 29]. 
The sequence conservation and close proximity of these additional cysteines 
is suggestive of a structural role, which may involve formation of a disulfide 
bond or involvement in coordinating an additional metal ion, such as zinc for 
example. 
The rfd2 gene was cloned, expressed in E. coli and the protein was purified 
to homogeneity using chromatographic methods. The resulting pink protein 
elutes as a monomer on gel filtration chromatography and migrates in 15% 
 
Figure 3.2 - Multiple sequence alignment of Rieske ferredoxins and ferredoxin domains. 
Rieske ferredoxins. RFd2, Rieske ferredoxin cluster RFd2; ARF, archaeal Rieske ferredoxins; 
lines with C-C denote the RFd2 disulfide bridge and the hypothetical disulfide bridge in the 
Sulredoxins. The latter is homologous to the disulfide from Rieske proteins from membrane-
bound electron transport proteins (bc1- and b6f-complexes); numbers with species names 
denote the Genbank accession numbers. 
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Figure 3.3 - Phylogenetic tree of Rieske ferredoxins calculated from the alignment 
shown in. Supplementary Figure S3.1. GI numbers from Genbank 
(http://www.ncbi.nih.gov); RFd2, cluster of RFds similar to the protein described in this work; 
ARF, archaeal Rieske ferredoxin. 
SDS-PAGE gels as having 14.7 kDa (Figure 3.4). Iron quantitation using the 
TPTZ methods determined 2.4±0.1 (n=3) iron ions per molecule, which is 
compatible with the presence of an intact [2Fe-2S] cluster in the purified 
protein. 
 
Figure 3.4 - Molecular weight and oligomeric state determination of purified RFd2. A: 
Gel filtration chromatogram (Sephadex G-50). Inset: 15% SDS-PAGE analysis of purified 
Rieske ferredoxin. The protein migrates as being 14.7 kDa. MW: molecular weight markers. B: 
molecular weight determination of the native protein using a calibration of the gel filtration 
column. 
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3.4.2. Spectroscopic characterization of the Fe-S cluster in RFd2 
The presence of a [2Fe-2S] Rieske was clearly confirmed by subsequent 
biophysical analysis using UV-visible absorption, visible circular dichroism 
and EPR spectroscopies. The identity of the Rieske [2Fe-2S] center was 
unambiguously revealed by its characteristic EPR spectrum in the reduced 
form. It consists of a rhombic signal characterized by g values gx = 1.80, gy = 
1.90 and gz = 2.01 (Figure 3.5A). The average g-value is 1.905, typical for 
[2Fe-2S] clusters containing nitrogen ligands and significantly lower than the 
value around 1.96 for plant type [2Fe-2S] clusters. As expected for an integer 
spin system, no signal was observed in the as prepared, oxidized protein. The 
UV-visible absorption spectrum exhibits characteristic bands at 337, 456 and 
570 nm, and a shoulder at 490 nm (Figure 3.5B). The circular dichroism 
spectrum in the visible region denotes positive peaks at 418 and 483 nm and 
negative peaks at 379, 436, 528 and 569 nm (Figure 3.5C). Altogether, the 
features observed by these two techniques are typical of Rieske clusters [5-
6]. The Rieske center is readily reduced by dithionite (Figure 3.5BC, dotted 
lines) and partly reduced by ascorbate (Figure 3.5BC, dashed lines), 
indicating that the redox potential of the center has a positive value (see 
below). 
 
Figure 3.5 - Spectroscopic analysis of the Rieske cluster. Panel A: EPR spectrum of the 
dithionite reduced Rieske ferredoxin at 10 K, 9.39 GHz microwave frequency, microwave 
power 2.4 mW and modulation amplitude 1 mT. Panel B: UV/visible absorption spectrum of 
the oxidized (—) and ascorbate (----) and dithionite (….) reduced protein; Abs337nm/Abs277nm = 
0.64. Panel C: visible CD spectrum of the oxidized and ascorbate and dithionite reduced 
protein. 
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3.4.3. The cysteines in the C-terminal SKTPCX(2-3)C motif form a 
disulfide bridge 
In order to address a possible role for the additional pair of cysteines 
(Cys-74 and Cys-78) from the SKTPCX(2-3)C motif in disulfide formation, we 
have quantified the free thiols (-SH) in RFd2, under different conditions, 
using the DTNB assay (Figure 3.6). 
The protein contains a total of four cysteine residues, two of which are 
involved in the coordination of the [2Fe-2S] Rieske cluster (Cys-29 and Cys-
50). The as prepared protein was found to contain no free thiols (<0.1 
SH.mol-1), which shows that under these conditions cysteines are unavailable 
to the DTNB reagent (Figure 3.6, Scheme 1). On the other extreme, in a 
preparation in which the RFd2 was unfolded under reducing conditions and 
cluster disassembly was further promoted by the presence of EDTA, a total of 
3.5±0.3 SH.mol-1 were quantified. This corresponds to all cysteines in the 
protein becoming available to the DTNB reagent (Figure 3.6, Scheme 4). On 
the other hand, under the same denaturing conditions, if the reductant is 
omitted, only 1.6±0.2 SH.mol-1 are quantified. This indicates that under these 
 
Figure 3.6 - Thiol quantitation and schematic representation of the different tested 
conditions. 
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Figure 3.7 - Circular dichroism spectra of RFd2. Far-
UV (A) and near-UV (B) regions. 
conditions, the cluster binding cysteines become available whereas Cys-74 
and Cys-78 are not, thus confirming that they are involved in a disulfide 
(Figure 3.6, Scheme 3). Additional control experiments were carried out in 
which the cluster binding cysteines and those from the SKTPCX(2-3)C motif 
were selectively reduced. This was possible since we have observed that 
incubation of RFd2 with 5 mM TCEP is enough to reduce the disulfide bond 
(1.5±0.2 SH.mol-1, Figure 3.5, Scheme 2) without reducing the Fe-S cluster, as 
the visible absorption spectrum remains unchanged even after 5 h of 
incubation (Figure 3. 1). This provides a tool to generate a protein form in 
which this disulfide is selectively broken (RFd2SH). In summary, the cysteines 
within the C-terminal SKTPCX(2-3)C motif are involved in a disulfide bridge, 
which is novel within the Rieske fold. The other types of disulfides known in 
Rieske proteins, further discussed below, are both found in respiratory 
Rieske domains, namely on the prototypic complex III domains [17] and on 
the SoxF protein from Sulfolobus acidocaldarius [5, 30]. 
3.4.4. The Rieske fold and secondary structure are not disrupted 
upon disulfide reduction 
To fully characterize the role of the redox status of the disulfide bridge in 
the folding and conformation of RFd2, we have carried out a structural 
analysis using biophysical 
methods. Circular dichroism 
spectroscopy was inadequate 
for such a study as the high 
content in β sheets of the 
Rieske fold accounts for a 
relatively featureless 
spectrum in the far-UV 
region, with a minimum 
around 200 nm, typical of 
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Figure 3.8 - ATR FT-IR analysis of
the Rieske ferredoxin secondary
structure. Self deconvoluted spectra
of Rieske (black dashes) in 40 mM
Tris pH 7 plus 0 mM TCEP (A) or 5
mM TCEP (B). The spectra were fitted
with the sum of Lorentzian curves
(red solid line). The assignment of
each band (black solid lines) is
depicted: β-sheets (β), unordered
structures (R), α-helices (α), β-turns
(T) and intermolecular β-sheets (Ag).
proteins with high amounts of random coil and no significant amounts of α-
helices, while showing the expected tertiary structure fingerprint on the 
near-UV region (Figure 3.7). However, the multiple vibrational modes 
associated with β structures produce highly informative infrared absorption 
spectra. For the purpose, we have used ATR FT-IR to identify and estimate 
the relative amounts of each type of secondary structure elements in RFd2 
preparations with the disulfide in the oxidized (RFd2SS) and in the reduced 
states (RFd2SH). This was achieved by deconvoluting the amide I band and 
carrying out assignments according to established fingerprints. This analysis 
showed that the spectra are nearly identical in both preparations (Figure 
3.8). The secondary structure of the oxidized protein (Figure 3.8A) is 
composed of 43% β-sheets, 25% random coil, 18% turns and 8% α-helices, 
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Table 3.1 - Assignment and relative contributions of the RFd2 amide I band secondary 
structure components, in the intact (RFd2SS) and broken disulfide (RFd2SH) forms. 
Band ࣏෥ 
(cm-1) 
RFd2SS RFd2SH 
Assignment 
Area (%) 
1626 8 8 
β-sheets 
1632 14 14
1638 13 12
1680 6 6.5
1687 2 2 
1691 0.5 1 
1644 12 11 Unordered structure (random) 1650 12 12
1656 8 9 α-helices
1661 5.5 5 
β-turns 1666 6.5 7 
1673 6.0 7 
1614 1 1 Intermolecular β-sheets 
(aggregation) 1621 4.5 4.5
 
which is in a fair agreement with the calculations made in the available 
Rieske structures. Around 6% of the secondary structure can be accounted as 
intermolecular β-sheet contacts, which are usually associated with 
aggregation. These are, however, not significant in the overall structural 
content. The secondary structure changes brought about by disulfide 
reduction (Figure 3.8B) are marginal and are within the deconvolution error 
(Table 3.1). Therefore, reduction of the disulfide does not result in partial 
unfolding or in a loss of secondary structure. 
3.4.5. The properties of the Rieske [2Fe-2S] cluster are influenced 
by the redox status of the disulfide 
Redox potentiometry was used to determine the oxidation-reduction 
potential of the [2Fe-2S] Rieske cluster, using visible absorption to monitor 
the reduction state of the center during an anaerobic reductive titration 
using dithionite. The process was reversible and a redox potential of +48 mV 
(pH 7) was determined (Figure 3.9, open circles). Taking advantage of the 
fact that the disulfide bond can be broken while the Rieske cluster remains 
oxidized, we have tested if the redox properties of the cluster would be 
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influenced by the status of the disulfide. We have therefore carried out a 
redox titration on the disulfide-reduced RFd2 (RFdSH) and we have observed 
that the apparent redox potential of the Rieske increases around 30 mV, to an 
E0= +77 mV (pH 7) (Figure 3.7, closed circles). These redox potentials are 
intermediate between those of prototypic dioxygenase-type Rieske 
Ferredoxins (E0 ≈ -180 mV, [31]) and respiratory and photosynthetic Rieske 
domains (E0 ≈ +300 mV, [17]), and this wide range have been suggested to 
result from differences in solvent accessibility, hydrogen bonds and spatial 
distribution of ionizable side chains around the center, among different types 
of Rieske proteins [29, 32]. The status of the disulfide bond influences also 
the redox properties of the [2Fe-2S] cluster, as its reduction results in a +30 
mV increase in the potential. This effect may arise from a change in the 
hydrogen bond network around the cluster as a result of disulfide reduction. 
Further investigation of these factors in RFd2 will be possible when a crystal 
structure becomes available, as the structural model of the protein produced 
by I-TASSER [33] does not allow such detailed analysis. 
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by UV/visible absorption.
The reduced fraction 
corresponds to the 
absorbance variation at 490 
nm. The fits are Nernst 
curves for E0 = +48 mV and 
n=0.7 (Oxidized Rieske) or 
E0 = +77 mV and n = 1 (5 
mM TCEP reduced). 
Folding and Stability of Rieske ferredoxin RFd2 
75 
 
Figure 3.10 - Near UV/visible CD monitored pH titration of the Rieske ferredoxin. The 
pH titration was carried out on Rieske buffered in a complex buffer composed of MES, HEPES, 
tricine, taurine and CAPS (10 mM each) and 50 mM NaCl set at different pH values in the 
absence (A) or presence (B) of 5 mM TCEP. Arrows indicate the spectral variation at 
increasing pH values. pKa values were extracted by fitting Handersson-Hasselbalch equations 
for a single protonation to the averaged normalized CD signal at 338, 378, 417, 434 and 485 
nm (0 mM TCEP, ?) or 338, 378, 462 and 485 nm (5 mM TCEP, ?) (C). 
We have also investigated the influence of the redox status of the disulfide 
on the pKa values of the histidine ligands of the [2Fe-2S] cluster, which can 
be estimated from the analysis of the pH dependence of the visible CD 
spectrum of the Rieske center, according to a well established procedure 
[10]. We have used the variation of the visible CD spectra of RFd2, in the as 
prepared and in presence of 5 mM TCEP, from pH 6.2 to 11.2 (Figure 3.10). 
The data could be fit with a single transition at a pKa = 10.1 ± 0.2 (0 mM 
TCEP sample) or pKa = 8.9 ± 0.3 (5 mM TCEP sample), which are 
intermediate between the values reported for bc1 Rieske proteins [34] and 
Rieske ferredoxins [32] in the oxidized [2Fe-2S]2+ state. The determined 
values probably correspond either to a single or to an average of the two 
expected transitions from the two protonatable histidines, which could not 
be resolved. The decreased pKa in the disulfide reduced state reflects the 
double protonation event following the disulfide cleavage and constitutes 
additional evidence to the proximity of the intervening cysteines to the [2Fe-
2S] cluster which is responsible for the dependence of the cluster properties 
with the redox status of the disulfide. We have confirmed that the spectral 
changes observed are due to pH-dependent modifications at the [2Fe-2S] 
cluster and not by a perturbation in the secondary structure or folding, as the 
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far UV CD spectra in both assays were not altered at the pH extremes (not 
shown). The presence of the C-terminal hexahistidine could result in a shift 
of the pKa values compared to the native, tag-less protein. However, this 
hypothetical perturbation is minimized because the N-terminus and the 
[2Fe-2S] cluster are located in opposite sides of the Rieske fold. 
3.4.6. The stability of RFd2 is influenced by the redox state of the 
disulfide 
A role of the disulfide in the protein conformational stability was 
investigated performing chemical and thermal unfolding experiments under 
conditions in which the disulfide was formed and broken. We have 
monitored the RFd2 folding using the intrinsic fluorescence of tyrosine 
residues as a probe of the conformational state of the protein, as the protein 
contains no tryptophan. The chemical stability was determined as a function 
of the concentration of guanidinium hydrochloride (GuHCl) in the disulfide 
oxidized and reduced states (Figure 3.11). 
From the difference in the apparent midpoint denaturant concentrations 
(Cm=3.7 M for RFd2SS versus Cm=3.0 M for RFd2SH) it is clear that the disulfide 
increases the chemical stability of the protein. We further explored an effect 
of this bond o n the thermal denaturation of the protein. As many other 
proteins from hyperthermophilic origin, RFd2 unfolds near or above the 
boiling point of water, as no transition is observed when the temperature is 
increased from 25 to 95°C. In order to overcome this problem, a series of 
thermal denaturation transitions were determined in the presence of GuHCl 
at different concentrations, all below that of the midpoint chemical 
denaturation (Cm). Under these conditions, the protein becomes destabilized 
by the presence of denaturant but the majority of the molecules are in the 
folded conformation thus allowing the determination of a apparent Tm at 
different GuHCl concentrations, with the disulfide intact and broken (Figure 
11BC). Linearization plots can then be used to extrapolate the Tm in the 
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Figure 3.11 - Conformational stability of RFd2. Panel A: Chemical denaturation with GuHCl.
Panel B and C: Determination of the midpoint denaturation temperature ( ) of the Rieske
ferredoxin in the absence (B) and presence (C) of 5 mM TCEP, at different GuHCl
concentrations. Panel D: Extrapolation plots for determination of the Tm in H2O. 
absence of denaturant, which is determined from the y-axis intercepts 
(Figure 3.11D). Using this strategy, we have determined that RFd2 has a TmH2O 
of 99°C, which is lowered to 91°C when the disulfide is broken. The integrity 
of the Rieske [2Fe-2S] cluster was also monitored upon thermal and chemical 
perturbation using visible absorption spectroscopy and identical results 
were obtained indicating that protein unfolding and cluster disintegration 
are intertwined events. Altogether, the chemical and thermal unfolding data 
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clearly show that the disulfide involving Cys-74 and Cys-78 does play an 
important contribution in structural stabilization. 
3.5. Conclusions 
Rieske proteins are present in the three domains of life, and are found to 
be involved in electron transfer processes associated with different cellular 
processes, including respiration, photosynthesis and dioxygenase systems 
[17, 35]. In recent years, studies on Rieske proteins from phylogenetically 
distant organisms, such as hyperthermophilic Archaea [15] have revealed 
proteins with particular features which enlarge the structural and functional 
diversity of Rieske domains. In fact, there are proportionally less Rieske 
proteins known in Archaea (~100) than in Eukarya (>450) or in Bacteria 
(>3500), as currently listed in Pfam [36]. Here we report the characterization 
of a new subtype of soluble Rieske ferredoxin of hyperthermophilic origin: in 
the essential this protein contains all typical fingerprints of Rieske domains 
in respect to the biophysical properties of its [2Fe-2S] cluster. However, it 
harbors a disulfide bond at the C-terminal region which has not yet been 
identified among the Rieske family, whose redox status affects the stability of 
the protein fold and of the iron-sulfur cluster, the redox properties of the 
latter and the pH-associated properties of the cluster ligands. Upon its 
disruption, a decrease in the chemical (ΔCm = -0.7 M GuHCl) and thermal 
(ΔTm = -9°C) stabilities is observed, an increase in the redox potential of the 
[2Fe-2S] center (ΔE0 = +31 mV) and a decrease of the pKa of the histidine 
ligands (1.2 units), likely as a result of a rearrangement of the electrostatic, 
hydrogen bonding and covalent network around the metal cluster 
environment. 
Rieske proteins are believed to have the same structural fold, which 
consists of two all-beta subdomains: one conserved small domain which has 
a rubredoxin-like fold, and a larger domain which consists of 6 beta-stands 
packed in either sandwich of two 3-stranded sheets or closed barrel [17]. 
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RFd2 typifies a new subtype of Rieske ferredoxins in which the Rieske fold is 
decorated by a novel disulfide bond which involves a cysteine pair located at 
the protein C-terminus, within a SKTPCX(2-3)C motif. This motif appears as an 
insertion within a region that corresponds to a loop in dioxygenase Rieske 
proteins, and is present in five other sequences from Archaea, which share a 
rather high amino acid identity (~37-52%) among themselves, but not 
against other types of Rieske proteins (<15%). The disulfide bond now 
identified within this family is a novel structural feature in the Rieske fold, 
and is unrelated to the disulfides described in respiratory and photosynthetic 
Rieske domains [17] and in the archaeal respiratory-type SoxF [5] whose 
cysteines are intertwined within the FeS binding motif (CXHXXC…CPCH), and 
the one presumed to be present of sulredoxin [18]. 
The novel disulfide described within the conserved Rieske fold may 
underlie a stabilization strategy complementary to others found in highly 
thermostable proteins, which include extensive hydrogen bond and salt 
bridge networks, oligomerization, reduction of loop lengths, formation of 
tightly packed hydrophobic cores. In fact, the destabilization observed upon 
disulfide reduction is likely a consequence of the clipping effect exerted by 
the bond, as the motif containing the disulfide is inserted in a loop, which is 
also present in a shorter version in the dioxygenase Rieske ferredoxins. 
Insertion of disulfide bonds to cross-link different parts of the polypeptide 
chain with stabilizing effects is a frequent stabilizing strategy of local 
structures, and in fact thermophiles are predicted to contain a higher density 
of disulfide bonds than mesophiles [37]. Apart from the discussed examples 
within the Rieske family, other small iron-sulfur proteins also have a 
disulfide bond included on the protein structure. Those are the cases of the 
[3Fe-4S] ferredoxin II from Desulfovibrio gigas [7], the [4Fe-4S] ferredoxin 
from Thermotoga maritima and the plant-type [2Fe-2S] ferredoxin from 
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Aquifex aeolicus [6]. However, with the exception of the latter, the influence 
of disulfide on the protein stability has not been systematically investigated. 
Overall, the work here reported illustrates how minor structural 
modifications modulate protein function and stability, and contributes to an 
understanding of how relatively simple folds may be fine-tuned. Further, the 
characterization of a subtype of Rieske proteins present in organisms rooting 
deeply on the tree of life is determinant to understand the evolutionary 
aspects of this fold, which is ubiquitous in nature. 
3.6. Supplementary figure 
 
Supplementary Figure S3.1- Multiple alignment of the Rieske ferredoxins and 
ferredoxin domains used for calculation of the dendrogram (Figure 3.3). RFd2, Rieske 
ferredoxin cluster RFd2; ARF, archaeal Rieske ferredoxins; lines with C-C denote the RFd2 
disulfide bridge and the hypothetical disulfide bridge in the Sulredoxins. The latter is 
homologous to the disulfide from Rieske proteins from membrane-bound electron transport 
proteins (bc1 and b6f complexes); numbers with species names denote the Genbank GI 
numbers. 
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Ferredoxin was purified by Sónia S. Leal (ITQB). 
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4.1. Summary 
Acidianus ambivalens ferredoxin is a model thoroughly studied in respect 
to the biophysical characterization of the interplay of its iron-sulfur (FeS) 
clusters and zinc ions with protein conformation and stability. The molten 
globule state where ferredoxin rests after thermal denaturation at pH 2.5 
constitutes a proposed candidate for the template conformation where FeS 
clusters are incorporated during protein maturation. Here we report a 
structural analysis of the ferredoxin molten globule. By performing a 
temperature-dependent FT-IR study of the denaturation of ferredoxin at pD 
2.5 and 12 we have described protein denaturation events and molten 
globule formation in terms of the variation of secondary structure. We have 
identified a common structural component spectrum describing ferredoxin’s 
core structure and thermal denaturation at acidic and basic pD. This study 
also showed that cold unfolding can be accessible to the apo states of 
ferredoxin, opening new possibilities for the use of this protein as a model 
for the study of this phenomenon. 
4.2. Introduction 
Iron-sulfur (FeS) clusters are inorganic protein cofactors occurring in the 
three domains of life which are required for biological activity, functional 
regulation and conformational stabilization. The [3Fe-4S][4Fe-4S] ferredoxin 
(Fd) from Acidianus ambivalens (Figure 2.10) constitutes a system with 
unique properties for the analysis of the interplay between FeS clusters, 
protein stability and conformational states. First, its primordial (βαβ)2 fold 
[1] and cofactors [2] along with its high thermostability (Tm = 122°C at pH 
7.0, [3]) should provide insights into basic protein stabilization strategies. 
Second, the core fold is expanded by a 30 amino acid N-terminal extension 
containing a structural Zn2+ site which can act as an additional stabilization 
factor [4]. Third, a high resolution X-ray crystal structure which includes the 
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intact FeS clusters is available (Figure 2.11) [5]. Finally, multiple intrinsic 
spectroscopic probes have allowed a comprehensive description of the 
folding and stability properties of this protein [3, 6-9]. 
Recently it has been shown that the A. ambivalens ferredoxin forms a 
stable molten globule state at pH 2.5 in vitro [7]. Acidification yields a protein 
conformation in the holo state with a native-like conformation, which upon 
thermal denaturation sits in an apo molten globule state with compactness 
identical to that of the native conformation, similar secondary structure 
content, no tertiary contacts and enhanced exposed hydrophobic surfaces. 
The stability of the molten globule was shown by its ability to unfold 
reversibly upon thermal or chemical denaturation. The accessibility of a 
stable, partially structured conformation is especially relevant in the context 
of FeS proteins. FeS clusters are required for correct folding as they are 
placed in the hydrophobic core of the (βαβ)2 fold [5]. Although excess iron 
(Fe3+) and sulfide (S2-) can spontaneously be incorporated in ferredoxins in 
vitro resulting in cluster assembly [10-11], the millimolar concentrations 
required are not physiological and thermally unfolded ferredoxin does not 
reincorporate the disintegrated clusters [6]. FeS clusters biosynthesis is a 
tightly regulated process wherein de novo assembled clusters are thought to 
be transferred from scaffold proteins to the corresponding apo proteins, a 
process likely involving some binding promiscuity due to the large number of 
FeS acceptors. In fact, the IscU scaffold protein is a molten globule-like 
protein [12] and such states have been surmised to be the likely 
conformation for the acceptor proteins [7]. 
The high β-sheet content of A. ambivalens ferredoxin [5] is an intrinsic 
probe that can be used to obtain structural data using Fourier transform 
infrared spectroscopy (FT-IR), a technique highly sensitive to this type of 
secondary structures [13]. We have built on the knowledge on the stability 
and formation of the molten globule of ferredoxin by performing FT-IR 
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monitored temperature denaturation assays at pD 2.5. Equivalent thermal 
denaturation experiments at pD 12 – where ferredoxin unfolds irreversibly 
to a non molten globule conformation – were carried out as a control. By 
deconvoluting temperature-resolved spectral data, we have quantified 
secondary structure changes taking place during holo ferredoxin unfolding, 
molten globule formation and during reversible molten globule unfolding. 
Overall, our results allow proposing a model describing the main 
conformation changes occurring in a temperature-dependent manner. 
4.3. Materials and methods 
4.3.1. Ferredoxin and chemicals 
Acidianus ambivalens ferredoxin (Fd) was purified as described before 
[14] and concentrated to 1.09 mM (12.5 mg/ml) by ultrafiltration. Then, the 
solvent was evaporated under a flow of dry nitrogen and replaced by 20 mM 
glycine or 50 mM potassium phosphate (KPi) in D2O. pD was adjusted to 2.5 
or 12, respectively, using the formula pD = pH + 0.4 (at 25°C) [15]. Any 
undisolved solutes – which were not visually apparent – were pelleted by 
centrifuging 25 minutes at 12000 g at 4°C. Final protein concentration was 
1.1 mM (12 mg/ml). All chemicals were of the highest grade commercially 
available. 
4.3.2. Thermal denaturation 
The thermal denaturation of ferredoxin was monitored by Attenuated 
Total Reflectance Fourier Transform Infrared spectroscopy (ATR FT-IR) 
using a Bruker IFS 66/S spectrometer equipped with a nitrogen-cooled MCT 
detector using the thermostatized Harrick BioATR cell II and recording 
spectra in the amide I (1600-1700 cm-1) and amide II (1500-1600 cm-1) 
regions. Temperature was modified in the 20-94°C range in a discontinuous 
fashion, according to Figure 4.1: spectra were accumulated during 1 minute 
(97 accumulations), temperature was raised 2°C during around 45 seconds 
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and sample was equilibrated 15 seconds. Overall temperature change rate 
was 1.1°C/min. Spectral resolution was 2 cm-1, scanner velocity was 20.0 kHz 
and aperture was 12 mm. To study the molten globule state forming at pD 
2.5 after thermally denaturing holo ferredoxin, the sample was re-
equilibrated at 20°C and a second temperature ramp was performed 
immediately with the same sample. The same strategy was employed with 
the pD 12 sample for comparative purposes. To determine midpoint 
denaturation temperatures (Tm), the second derivative of FT-IR spectra were 
calculated and sigmoidal curves were fitted to the temperature trend of local 
maxima and minima. Alternatively, the normalized variation at specific 
wavenumbers was fitted to sigmoidal curves or the sum of two sigmoidal 
curves. Pre- and post-transition baselines were corrected assuming linear 
dependence on temperature [16]. Assignment of secondary structure 
elements to wavenumbers was carried out using published reference values 
[13].  
 
Figure 4.1 – Outline of the temperature denaturation experiments on A. ambivalens 
ferredoxin. Protein solutions at pD 2.5 or pD 12 were sequentially submitted to two 20-94°C 
temperature ramps (rate = 1.1°C/min) while ATR FT-IR spectra were recorded in a 
temperature-dependent manner. 
4.3.3. Singular value decomposition 
The series of spectra obtained during each temperature ramp were 
deconvoluted using the singular value decomposition (SVD) algorithm 
implemented in Matlab [17]. This allowed identifying spectral components 
changing their intensity as temperature was varied as well as their 
temperature variation profiles. 
94°C
20°C
Spectra Acquisition
Time
Spectra Acquisition
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4.4. Results 
We have studied the thermal denaturation of Acidianus ambivalens 
ferredoxin (Fd) by recording ATR FT-IR spectra in the amide I (1600-1700 
cm-1) and amide II (1500-1600 cm-1) bands during thermal denaturation. 
These spectral regions are sensitive to protein secondary structure. Most 
importantly, the amide I band arises due to quantitative contributions from 
distinct secondary structure features [13]. This implies that absorption 
variation at specific wavenumbers is associated with secondary structure 
conversion. To increase sensitivity we have used deuterated buffer solutions. 
Deuteration shifts the water absorption peak at the amide I/II region and 
increases the relative contribution of protein absorption to the recorded 
spectra. Fd was prepared at pD 2.5 or 12 and each preparation was subjected 
to two sequential temperature ramps (T-ramps, Figure 4.1). Our goal is to 
analyze the molten globule formation occurring after thermal denaturation 
at pH 2.5 and its conformational and stability properties. pD 12 preparations 
are controls, as under these conditions ferredoxin denatures to a non molten 
globule state. The spectra recorded during temperature ramps are shown in 
Figure 4.2. This extreme of pH had to be used as a control rather than pH 7 as 
Fd is a hyperstable protein whose midpoint unfolding temperature (Tm) is 
above 100°C in the range pH 4.5 to pH 9.5 [9]. At pH 7, ferredoxin thermal 
unfolding below the boiling point of water requires the use of chemical 
denaturants such as guanidinium hydrochloride [9] or guanidinium 
thiocyanate [6], whose contribution to infrared absorption is significant, 
because of the high concentrations required. 
During thermal denaturation at pD 2.5, a band at 1625 cm-1 develops 
(Figure 4.2A). Absorption at this wavenumber is typical for β-sheet 
structures and is frequently an indication of aggregation. Calorimetric data 
had previously indicated this possibility [7]. During the second T-ramp 
(Figure 4.2C), which corresponds to the denaturation of the molten globule, 
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Figure 4.2 – ATR FT-IR monitored temperature ramps of Acidianus ambivalens 
ferredoxin. Spectra obtained along the 20-94°C temperature range at pD 2.5 (A, C) or pD 12 (B, 
D). The ferredoxin samples at either pD were subjected to two successive temperature ramps.
(A, B) first temperature ramp. (C, D) second temperature ramp. 
no significant spectral changes occur. This indicates that no significant 
secondary structure changes take place and is in agreement with far UV CD 
data [7]. Thermal denaturation at pD 12 does not yield significant spectral 
changes (Figure 4.2CD). The noise in the spectra acquired at 94°C on the first 
T-ramp precludes more detailed analyses. The major spectral variations can 
be better assessed in Figure 4.3. In all cases, absorption variations in the 
amide II region are not discussed in structural terms because of the 
significant contribution of side chains in this region. 
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Figure 4.3 – Amide I and amide II bands before and after thermal denaturations. (A) pD 
2.5. (B) pD 12. 
The temperature-induced increase in β-sheet structures (1625 cm-1, 
Figure 4.2A) can be used to quantify protein denaturation. We have used the 
absorption variation at 1625 cm-1 (pD 2.5) or 1643 cm-1 (amide I maximum 
absorption wavenumber at pD 12) to determine the overall midpoint 
denaturation temperature (Tm, Figure 4.4). 
 
Figure 4.4 – Thermal denaturation profiles extracted from absorbance changes in the 
amide I band. (A) Temperature-dependent absorbance changes at 1625 cm-1 (pD 2.5) or 
1643 cm-1 (pD 12). (B) Determination of the Tm value from the absorbance change at 1625 cm-
1 for the first temperature ramp of ferredoxin at pD 2.5. Raw data (A) was compensated for the 
slopy pre- and post-transition baselines (see materials and methods). 
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Only the first T-ramp at pD 2.5 yielded a cooperative transition at Tm = 
55°C. Due to the intrinsic complex nature of the amide I band, resulting from 
multiple contributions in this region, difference spectroscopy analysis 
provided limited information. Alternatively, we have analyzed the second 
derivatives of the temperature-dependent FT-IR spectra. This technique 
enhances the fine structure of spectra and enhances low intensity 
overlapping bands which appear as second derivative minima [18]. By 
performing this analysis to our set of thermal denaturation experiments, we 
were able to accurately describe the absorption variation at specific 
wavenumbers (Figure 4.5). Further, by assigning each wavenumber to a 
particular type of secondary structure, we were able to interpret in detail the 
structural changes taking place during thermal denaturation (Table 4.1). 
Although all temperature profiles indicated in Table 4.1 have structural 
correlates, direct connections can be established with the profiles derived 
from negative second derivative peaks (bold in Table 4.1), which correspond 
to positive peaks in the original spectra. The Tm values for the first thermal 
denaturation at pD 2.5 group around two distinct values: 43-47°C (for α-
helices, coil and turns) and 53-59°C (for β-sheets). Denaturation of β-sheets 
occurs at the same temperature where aggregation and iron-sulfur cluster 
loss is reported to occur [7], whereas the denaturation events at lower 
temperatures were not detected by other spectroscopic techniques. 
Concentration-dependent effects can be excluded a priori as previous 
biophysical studies were reported in a broad range of concentrations, from 
the micromolar (e. g. circular dichroism, [7]) to the millimolar (e. g. NMR, [8]) 
ranges. The second T-ramp, which corresponds to the denaturation of the 
molten globule formed after the first thermal denaturation, yields complex 
denaturation curves arising from the lower signal to noise ratio, as most 
secondary structure is lost upon molten globule formation (low secondary 
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Figure 4.5 – Second derivative FT-IR spectra for the thermal denaturation of ferredoxin 
(Left column) Second derivative spectra. (Right column) Normalized temperature-dependent 
second derivative changes at local maxima and minima. Tm values were extracted from fitting 
single or the sum of two sigmoidal curves to raw data (Table 4.1). (A-B) pD 2.5, 1st T-ramp; (C-
D) pD 2.5, 2nd T-ramp; (E-F) pD 12, 1st T-ramp; (G-H) pH 12, 2nd T-ramp. 
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structure content is a structural feature of molten globule states). At pD 12 
denaturation is highly cooperative and involves all secondary structure 
elements around 50°C. Denaturation is mostly irreversible as judged by the 
lower absolute values of second derivatives. In the second T-ramp all 
contributions are not arising from spectral peaks (i. e. are positive second 
derivative peaks) or are not reproducible (including the aggregation Tm at 
48°C, which was detected in only one of three replicates). 
As FT-IR spectra were acquired as a function of temperature, the 
succession of spectra can be analyzed by single value decomposition (SVD) 
[17]. This is an algebraic data reduction procedure which decomposes the 
succession of spectra into components with distinct temperature variation 
and the respective temperature profile. Importantly, the algorithm clusters 
the contribution of noise into separate components. The main components 
Table 4.1 – Midpoint denaturation temperatures (Tm) for different secondary structure 
elements of ferredoxin. Values are extracted from the temperature profile of local spectra 
second derivative maxima or minima. Secondary structure assignment was performed 
according to their typical absorption wavenumbers [13].Temperatures are shown as average 
± standard deviation of 2 to 4 independent measurements. Arrows indicate positive (?) or 
negative (?) second derivative peaks. Not coop.: transition is not cooperative. 
 1st Temperature Ramp 2nd Temperature Ramp 
Assignment Band ࣏෥ (cm-1) 
pD 2.5 pD 12 Band 
࣏෥ (cm-1) 
pD 2.5 pD 12 
Tm (°C) Tm (°C) 
β-sheets 
? 1636 
? 1629 
? 1625 
49 ± 5 
53 ± 3 
59 ± 1 
47 
 
 
? 1642
? 1640 
? 1625 
? 1625 
 
27 + 78 
 
Not coop. 
52 ± 1
 
69 ± 7 
 
α-helices ? 1660? 1653 
44 ± 1
47 ± 3 
50±2
47 
? 1659
? 1653 
 
43 ± 7 
48 ± 0
 
Turns 
? 1699
? 1691 
? 1678 
? 1673 
46 ± 1
47 ± 3 
43 
58 ± 0 
49±1
49±1 
47 
58±0 
? 1692  48 
Aggregation ? 1685? 1615 
46 ± 2
57 ± 3 
48±1
 
? 1685
? 1614 
 
Not coop. 
48
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Figure 4.6 – Singular value decomposition of A. ambivalens ferredoxin FT-IR monitored 
thermal denaturation. (Left column) Component spectra computed from the temperature-
dependent change in FT-IR spectra. (Right column) Temperature profiles of spectral 
components. (A-B) pD 2.5, 1st T-ramp; (C-D) pD 2.5, 2nd T-ramp; (E-F) pD 12, 1st T-ramp; (G-H) 
pH 12, 2nd T-ramp. Wavenumber secondary structure assingnment is indicated. α, α-helices; β, 
β-sheets; T, turns; Agg, intermolecular β-sheets, aggregation fingerprint; Coil, random coil. 
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calculated after SVD analysis were compared with the characteristic spectra 
of particular types of secondary structure as well as with the temperature 
profiles. The results of this analysis are shown in Figure 4.6. 
The structural features being represented by SVD components can be 
determined by examining local (second derivative) minima. In the original 
spectra, these represent peak zones which are associated with secondary 
structure elements. Overall, most temperature-induced secondary structure 
changes are captured by the first two components. Accordingly, we have 
simplified further analyses by considering only these components. The 
structural characterization of each component as well as the Tm values for 
their unfolding are listed in Table 4.2. 
Inspection of Table 4.2 reveals that distinct conformational changes are 
involved in ferredoxin’s thermal unfolding. At pD 2.5 α-helices, β-sheets and 
turns are involved in all unfolding events. α-helices unfold during holo-
ferredoxin denaturation. The second thermal denaturation only involves β-
sheet and turn structures and occurs at lower temperatures (44°C versus 51 
and 60°C) and with lower cooperativity even though the structural elements 
involved are the same. This is in accordance with the stabilizing effect of the 
FeS clusters. Thermal unfolding at pD 12 is more complex, with more 
Table 4.2 – Structural and stability characterization of SVD components. Not coop.: not 
cooperative. Aggregation: intermolecular β-sheets. 
  pD 2.5 pD 12 
 Component Tm (°C) Structure Tm (°C) Structure 
Ramp 1 
1 51 
α-helices
β-sheets 
Aggregation 
51 β-sheets Turns 
2 60 β-sheetsTurns 54 
α-helices
Coil 
Ramp 2 
1 Not coop. β-sheets Aggregation 60 
α-helices
Coil 
Turns 
2 44 β-sheets Turns 48 
β-sheets
Aggregation 
Turns 
Molten globule formation by Acidianus ambivalens ferredoxin 
97 
structural transitions occurring. Nevertheless, the secondary structures and 
transition temperatures (Tm) are similar for the first and second temperature 
ramps. 
It is clear that some components occur in several conditions. This includes 
components which occur in the independent assays carried out at pD 2.5 and 
pD 12. For example, the second component of both thermal denaturations at 
pD 2.5 are identical among themselves and to component 1 from the first 
thermal denaturation at pD 12 (Figure 4.6). In fact, this component presents 
multiple second derivative minima and these occur at wavenumbers 
characteristic to all secondary structure types occurring in ferredoxin (1617 
and 1685 cm-1: intermolecular β-sheets; 1673 cm-1: β-turns; 1653 cm-1: α-
helices; 1635 cm-1: intramolecular β-sheets). The different Tm for this 
common component (44, 51 or 60°C) is then reporting for its pD-dependent 
stability and the overall conformation of ferredoxin. This common SVD 
component indicates that the same conformational changes occur in the 
thermal denaturation assays carried out at dissimilar conditions and may 
thus be suggested as a fingerprint of ferredoxin core structure.  
By performing all pair wise component comparisons we have further 
identified pairs of components which are not identical but share local 
similarity in specific spectral regions (Figure 4.7). Although with lower 
identity than shown before for the fingerprint component, the remaining 
spectral components are represented partially in many of the experimental 
conditions assayed. This suggests that the thermal unfolding pathway is not 
significantly changed between the two pD values assayed and that discrete 
structural events are responsible for the different nature of the final 
“denatured” state at the two conditions: the molten globule at pD 2.5 and the 
featureless unfolded state at pD 12. 
After establishing a structural rationale for the second SVD component at 
pD 2.5, one can gain further insight into ferredoxin thermal denaturation by 
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Figure 4.7 – Global SVD results analysis. Line style indicates spectral similarity (judged by 
second derivative peak position). Solid lines: component spectra are identical; Dashed lines: 
spectra are similar, with most peaks coinciding. 
examining its temperature profile, which reports on the relative abundance 
of the ferredoxin core structure it describes. The temperature profile is not 
monotonic. Apart from the major transition reported in Table 4.2, at lower 
temperatures a compensating (i. e. opposite) conformational transition is 
observed (Figure 4.6), which resembles the cold unfolding transition in other 
proteins [19]. Protein cold unfolding is a fundamental biophysical 
phenomenon which is seldom observed because it frequently occurs at 
temperatures below the freezing point of water. The fingerprint SVD 
component indicates that the core ferredoxin conformation it represents 
undergoes both cold and a heat unfolding in experimentally accessible 
temperatures. The cold unfolding behaviour is also observed at pD 12 
(second component, second temperature ramp, Figure 4.6). The component 
involved in this transition is similar to the one occurring at pD 2.5 but 
spectral differences indicate it represents a different ferredoxin 
conformation. 
4.5. Discussion 
In the current study we have used SVD decomposition of second 
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derivative FT-IR spectra to perform a structural characterization of Acidianus 
ambivalens ferredoxin thermal unfolding. This methodology enabled us to 
describe temperature-induced conformational changes which would not be 
detectable otherwise. Our analysis identified a fingerprint component 
spectrum describing a conformational involved in ferredoxin’s thermal 
denaturation at acidic and basic pD. The formation of the ferredoxin molten 
globule has been described in detail [7] and provides the structural 
framework for the nature of the fingerprint SVD component. The molten 
globule is a semi-compact structure with tertiary structural similarity with 
the native state. The fingerptint component describes these conformational 
changes accurately, by being represented in the thermal denaturation of 
holo-ferredoxin (irrespectively of pD) and of molten globule ferredoxin but 
not in the denaturation of the protein previously unfolded at pD 12. 
Moreover, several SVD components describing thermal unfolding at pD 2.5 
and pD 12 were found to be common or similar, showing conservation of 
unfolding pathways at the two pD conditions. 
A previously unknown aspect in ferredoxin thermal denaturation is the 
involvement of a structural subset undergoind cold denaturation. This 
component – occurring at pD 2.5 and pD 12 – exhibits a complex, multi-stage 
temperature profile which is strikingly similar to the ones arising in cold 
denaturing proteins [19]. Cold unfolding is a general feature of protein 
folding. However, frequently it cannot be experimentally monitored because 
it occurs at temperatures below the freezing point of water. This 
phenomenon has been probed in vitro frequently using alcohols, which 
stabilize the cold unfolding transition. However, the perturbation introduced 
by the co-solvents may affect the protein’s intrinsic stability properties and 
does not constitute a general strategy, suitable for all proteins. In this sense, 
the accessibility of the cold and heat unfolded states in ferredoxin – at least 
at acidic conditions – make it a unique model for describing protein folding 
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and unfolding thermodynamics in experimental conditions not involving 
external perturbations. The conformational plasticity of ferredoxin 
illustrated by the possibility of a conformational subset undergoing cold and 
heat unfolding at experimentally amenable conditions and in a reversible 
manner – the same component is observed in successive thermal 
denaturation assays – may thus be the biophysical basis for stable molten 
globule formation. 
4.6. Conclusions 
We have extended the biophysical characterization of Acidianus 
ambivalens ferredoxin folding properties by using an FT-IR approach. We 
have associated the previously identified aggregation step in ferredoxin 
unfolding with intramolecular β-sheet formation and have described a 
previously undetected low temperature α-helical and β-turn conformational 
transition. Additionally, we have carried out SVD analysis describing 
ferredoxin’s thermal denaturation behavior in acidic and basic conditions. 
Our results suggest that the apo molten globule state of ferredoxin arising 
upon thermal denaturation at pD 2.5 may be a useful model for addressing 
cold protein unfolding, a phenomenon which cannot be studied in most 
proteins without the presence of additives like alcohols. 
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5.1. Summary 
Rubredoxins are good models for the biophysical study of metalloprotein 
folding due to their structural simplicity and amenability to spectroscopic 
analysis. We have characterized the folding and stability properties of the 
rubredoxin from Desulfovibrio gigas using a toolbox of conformation-
sensitive spectroscopic techniques which allow describing secondary and 
tertiary structure changes complementarily: UV/visible absorption, circular 
dichroism (CD) and Fourier transform infrared spectroscopy (FT-IR). We 
show that the mononuclear iron site is thermodynamically and kinetically 
stable, withstanding high temperature and iron sulfur cluster disruption by 
EDTA stripping. We present a temperature-resolved model for the 
conformational changes occurring during rubredoxin unfolding derived from 
FT-IR spectra deconvolution: in the 20-60°C range α-helices and β-sheets 
unfold; above 60°C, aberrant turn structures and β-sheets buildup. The dual 
regime of rubredoxin unfolding with residual structure present at high 
temperature may account for this protein’s high thermostability. 
5.2. Introduction 
Rubredoxins are the smallest and simplest iron-sulfur (FeS) proteins, 
containing a single iron atom coordinated by four cysteine sulfurs occurring 
in the consensus sequence CXXCG–()n–CXXCG, where X indicates any amino 
acid residue. These proteins function as electron carriers in multiple 
metabolic processes, a process where the solvent exposed FeS cluster 
accommodates one electron. Due to their thermostability, [1] simplicity and 
incorporation of a simple metal cofactor, rubredoxins are useful models for 
the study of the molecular determinants of protein thermostability and the 
cross-talk between metal cofactors, protein folding, stabilization and 
function. For these purposes, two rubredoxins have been instrumental: the 
Pyrococcus furiosus (a hyperthermophilic archaeon) and the Clostridium 
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Figure 5.1 – Rubredoxin from
Desulfovibrio gigas. The iron ion is 
shown as a sphere and the cysteine
ligands as sticks. PDB: 2DSX. 
pasteurianum (a mesophilic bacteria) 
proteins. The different stability of both 
proteins together with high resolution 
crystal structures has allowed 
establishing correlations between the 
molecular and stability features of both 
proteins. 
In the current report we carried out a 
preliminary characterization of the 
folding and stability properties of the 
rubredoxin (Rd) from the mesophilic 
sulfate reducing bacteria Desulfovibrio 
gigas (Uniprot P00270-1). This is a 5.7 kDa protein whose structure is known 
from crystallography (Figure 5.1) [2] and NMR spectroscopy [3]. Also, 
theoretical [4] and spectroscopic [5] data are available from the literature, 
including the description of the stabilization of this protein by diglycerol 
phosphate [3]. However, a conformational characterization of the folding 
properties of this protein is lacking. To this purpose we have performed 
thermal denaturation of rubredoxin while monitoring its conformational 
status using absorption, circular dichroism and FT-IR spectroscopies. By 
combining these secondary structure sensitive techniques to spectral 
deconvolution we have observed high polypeptide and iron site 
thermostability and we propose a model describing the conformational 
changes occurring in the thermal unfolding of D. gigas rubredoxin. 
5.3. Materials and methods 
5.3.1. Rubredoxin 
Desulfovibrio gigas rubredoxin was purified as previously described [2]. 
Protein concentration was determined spectrophotometrically using the 
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visible absorption extinction coefficients ε376nm = 8450 M-1.cm-1 and ε493nm = 
6970 M-1.cm-1 [6]. Purity was verified by the absorption ratio between 377 
and 278 nm equaling 0.45. Buffer was 50 mM potassium phosphate at pH 7. 
5.3.2. UV/visible absorption 
UV/visible absorption spectra were recorded using a Shimadzu UV-1700 
spectrophotometer at room temperature. 
5.3.3. Circular dichroism 
CD measurements were recorded in a Jasco J-815 spectropolarimeter 
equipped with a Peltier-controlled thermostated cell support. 0.1 cm (far UV) 
and 1 cm (near UV/visible) pathlength cuvettes were used. Thermal 
denaturation experiments were carried out increasing the temperature from 
25 to 95°C at a heating rate of 1°C/min. Every 5°C spectra were acquired. 
Thermal denaturation was assessed by the CD signal variations at local 
spectra maxima and minima. Midpoint denaturation temperatures (Tm) were 
obtained from sigmoidal fits to the normalized signal variation. Protein 
concentration was 0.1 mg/ml (17.6 µM, far UV) or 0.62 mg/ml (109 µM, near 
UV/visible). Temperature denaturations performed in the presence of EDTA 
(0.5 mM) were carried out at 0.1 mg/ml (17.6 µM, far UV) or 0.47 mg/ml (83 
µM, near UV/visible) rubredoxin. Far UV CD spectra were accumulated 4 
times at 200 nm/min scan rate and 1 s time response. Near UV/visible 
spectra were accumulated 5 times at 1000 nm/min scan rate and 0.5 s time 
response. 
5.3.4. ATR FT-IR spectroscopy 
Attenuated total reflectance Fourier transform infrared spectroscopy 
(ATR FT-IR) measurements were performed using a Bruker IFS 66/S 
spectrometer equipped with a nitrogen-cooled MCT detector using the 
thermostatized Harrick BioATR cell II. Protein was concentrated to 10 mg/ml 
and centrifuged at 12000 g before the temperature ramp to pellet any 
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aggregates forming while concentrating. FT-IR spectra in the amide I (1600-
1700 cm-1) and amide II (1500-1600 cm-1) regions were recorded while 
temperature was increased from 20 to 94°C in a discontinuous fashion: 
spectra were accumulated during 1 minute (97 accumulations), temperature 
was raised 2°C during around 45 seconds and sample was equilibrated 15 
seconds. Overall temperature change rate was 1.1°C/min. Spectral resolution 
was 4 cm-1, scanner velocity was 20.0 kHz and aperture was 12 mm. Spectra 
were analyzed after vector normalization. Spectral variations at specific 
wavenumbers within the amide I band were assigned to secondary structure 
changes [7]. Thermal denaturation was assessed by the temperature 
dependence o absorption of absorption second derivative. Midpoint 
denaturation temperatures were determined from sigmoidal fits to the signal 
variation at local maxima or minima. Spectra deconvolution was performed 
as previously described [7]. Briefly, the amide I band was reconstituted as 
the sum of Gaussian curves centered at second derivative minima. Secondary 
structure content was estimated from gaussian curve integration and band 
assignment [7]. 
5.4. Results 
5.4.1. Spectroscopic fingerprint of rubredoxin 
Rubredoxin has multiple spectroscopic probes, many of those arising from 
the FeS cofactor. In the current study we have employed a toolbox composed 
of UV/visible absorption, circular dichroism and FT-IR spectroscopies. Far 
UV CD and FT-IR provide quantitative information about distinct secondary 
structure elements and are thus excellent methodologies to describe protein 
conformational changes and unfolding processes. By combining these 
techniques with the examination of the tertiary structure (near UV CD) and 
FeS cofactor integrity (visible absorption and visible CD) of Desulfovibrio 
gigas rubredoxin we provide a complete, multi-probe analysis of the stability 
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Figure 5.2 – Spectroscopic fingerprints of native Desulfovibrio gigas rubredoxin. (A) 
UV/Visible absorption spectrum. (B) Circular dichroism spectra. Left scale: far UV region 
(<250 nm). Right scale: near UV/visible region (>250 nm). 
of this simple protein. The combination of visible absorption and visible CD 
spectroscopies to monitor the FeS cluster is especially powerful as the 
absorption signal relates to the FeS cluster integrity and the visible CD signal 
is rich in features and very sensitive to small changes in the cluster micro 
environment. In accordance, we have determined this protein’s spectral 
fingerprints (Figure 5.2). 
The UV-Visible absorption spectrum (Figure 5.2A) is typical for 
rubredoxin, with two bands in the visible region at 376 and 493 nm. Due to 
the chirality of the iron site, these bands are also CD active and give rise to 
multiple bands (Figure 5.2B), typical for the structural environment of the 
mononuclear iron site. The far UV CD spectrum shows two minima: one at 
200 nm, characteristic of random coil-rich proteins and another at 223 nm, 
typical of β-sheet structures. This is in accordance to the native protein 
structure (Figure 5.1, [8]). 
5.4.2. The rubredoxin fold is highly thermostable 
To quantify the thermal stability of rubredoxin we have performed 
thermal denaturation assays monitoring protein unfolding by CD in the far 
UV, near UV and visible regions in the 25-95°C range (Figure 5.3). There 
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Figure 5.3 – Thermal denaturation of rubredoxin. (A) Far UV and (B) near UV/visible CD 
spectra recorded while increasing temperature from 25 to 95°C. Arrows indicate spectral 
changes with temperature. (C) Temperature-induced CD signal variation at specific 
wavelengths. A sigmoidal fit to the 298 nm signal change yields Tm = 57.0°C. (D) UV/visible 
absorption spectra before and after the near UV/visible-monitored thermal denaturation. The 
absorption change at 376 nm suggests a loss of 30% of the iron content. 
were no temperature-induced changes in the far UV CD spectra (Figure 
5.3A), indicating that secondary structure is kept. Tertiary contacts affecting 
the microenvironment around the single tryptophan side chain in this 
protein (CD signal at 298 nm) were disrupted at Tm = 57°C (Figure 5.3C). 
Nevertheless, some of the FeS clusters degraded, as noted by the decrease in 
the visible CD and absorption intensities (Figure 5.3BD). This process was 
irreversible even after extended incubation at room temperature. The 
protein is in fact highly thermostable: FeS cluster disintegration, as assessed 
by the variation in visible CD intensity (Figure 5.3C), is not complete at 95°C. 
The variation in absorption at 376 nm corresponds to a 30% FeS cluster 
disruption. 
To examine the stability of the iron site and its contribution to the overall 
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Figure 5.4 – Thermal denaturation of rubredoxin in the presence of EDTA. 0.5 mM EDTA 
was included in the buffer. (A) Far UV and (C) near UV/visible CD spectra recorded while 
increasing temperature from 25 to 95°C. Arrows indicate spectral changes with temperature. 
Temperature-induced CD signal variation at specific wavelengths in the (B) far UV and (D) 
near UV/visible regions. Sigmoidal fit to the 298 nm signal change yields Tm = 52.4°C. (E) 
UV/visible absorption spectra before and after the near UV/visible-monitored thermal 
denaturation. The absorption change at 376 nm suggests a loss of 33% of the iron content. 
protein stability, we have carried out identical thermal denaturation 
experiments in the presence of 0.5 mM EDTA (Figure 5.4). This chelator 
should facilitate iron removal from rubredoxin, which constitutes an 
opportunity to assess its stabilizing role. EDTA destabilizes rubredoxin’s 
secondary structure: the far UV CD bands at 202 and 213 nm are 
progressively lost at high temperature (>75°C, Figure 5.4AB). Since these 
bands are associated with random coil structures, this suggests full unfolding 
yielding highly dynamic and isotropic conformations. However, the 
destabilizing effect does not seem to be associated with destabilization of the 
iron site. There are no important changes in near UV/visible CD spectra apart 
from the slight destabilization of the 298 nm transition to Tm = 52.4°C (ΔTm = 
4.6°C, Figure 5.4CD). More importantly, FeS cluster loss estimation from 
visible absorption yields 33% (Figure 5.4E), close to the value obtained in the 
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Figure 5.5 – Temperature stability of the rubredoxin iron site. Pairwise comparison of the 
visible CD signals obtained during thermal denaturation of rubredoxin in the presence and 
absence of EDTA. Data compiled from Figure 5.3C and Figure 5.4D. 
absence of EDTA. The inefficiency of EDTA to affect the iron site during 
unfolding can be established by observing the thermal denaturation profiles 
of the visible CD signals in the presence and absence of EDTA (Figure 5.5). 
The pairwise analysis shows that in most cases the unfolding behavior is 
independent of EDTA. The conclusion is that under the conditions tested, the 
FeS cluster does not contribute significantly to protein stability. 
5.4.3. Rubredoxin undergoes CD-undetectable unfolding 
To have a more comprehensive view of rubredoxin’s stability, we have 
monitored its thermal denaturation using FT-IR (Figure 5.6). Like CD, FT-IR 
can provide a quantitative estimation of protein secondary structure content. 
In comparison, FT-IR is more sensitive than CD to the conformation of 
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Figure 5.6 – FT-IR monitored thermal denaturation of rubredoxin. (A) FT-IR spectra in 
the amide I/amide II region. The trend of spectra recorded in the 20-94°C range is shown as 
arrows. (B) Second derivative of absorption spectra. (C) Temperature profile of second 
derivative peaks. (D) UV/visible absorption spectra obtained before and after thermal 
denaturation. Spectra were normalized so that Abs278 = 1. Quantification of iron loss from the 
absorption loss at 276 nm yields 29%. 
proteins containing low helical content and β-sheets, which is the case of 
rubredoxin. 
The FT-IR spectrum of native rubredoxin has a single maximum at 1639 
cm-1 (Figure 5.6A, Figure 5.7AΒ), a wavelength characteristic of β-sheet 
containing proteins [7]. Upon incubation at high temperature, this single 
maximum gives rise to a peak at 1653 cm-1 and a shoulder at 1633 cm-1. To 
extract information about the secondary structure types involved in the 
conformational transitions revealed by the FT-IR absorption spectra, we 
have considered the second derivative spectra (Figure 5.6B). This 
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mathematical manipulation enhances the detection of superimposed local 
peaks originating from different secondary structure contributions [7]. We 
can determine the order of unfolding of each secondary structure element by 
studying the thermal denaturation of the contributions of local maxima and 
minima (Figure 5.6C) and assigning them the secondary structure type with 
characteristic absorption at their wavenumber (Table 5.1). The most 
significant data are the ones originating from second derivative minima as 
they correspond to local maxima in the absorption spectra (i. e. reveal 
components with significant contribution to the overall spectra). 
All secondary structure components undergo thermal transitions in the 
68-79°C range, indicating that unfolding is multi state. The most relevant 
components (second derivative minima, Table 5.1 bold) correspond to α-
helices (1654 cm-1) and β-sheets (1624 cm-1). These results then indicate that 
α-helical loss is the first event in the thermal denaturation of rubredoxin. 
This result is unlike the one obtained using CD, which revealed no significant 
secondary structural changes in the absence of EDTA. The iron loss 
percentage extracted from UV/visible absorption spectra is 29%, in the same 
range as the ones obtained during CD-monitored denaturation. This is an 
indication that the end conformation in all experiments is similar. In this 
way, the extra information provided by FT-IR is related to its enhanced 
Table 5.1 – Thermal stability of secondary structure elements in rubredoxin as assessed 
by FT-IR. The temperature profiles of absorption at second derivative maxima and minima 
were fitted with sigmoidal curves to extract Tm values. Secondary structure assignments were 
preformed as in [7]. Second derivative minima (in bold) correspond to peak areas in the 
absorption spectra. Mix: in this zone there are contributions from β-sheet structures and 
tyrosine side chains. Aggregation: intermolecular β-sheets, frequently associated with 
aggregation. 
࣏෥ (cm-1) 1704 1654 1641 1624 1611 
Assignment Mix α-helices Coil β-sheets Aggregation 
Tm (°C) 73 68 79 77 71 
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sensitivity for this protein’s conformation relatively to CD. 
To have a complementary assessment of secondary structure changes 
occurring during rubredoxin denaturation, we have deconvoluted the FT-IR 
spectra. We have fitted the amide I band with sigmoidal curves centered at 
amide I maxima and minima and have assigned each band to the secondary 
structure element originating it (Table 5.2). By performing band fitting in a 
temperature-dependent manner, we can obtain a detailed temperature-
resolved model of the conformational changes occurring along rubredoxin’s 
thermal unfolding. To benchmark our deconvolution procedure, we have 
compared the structural deconvolution of the spectra at 24 and 94°C with the 
protein’s crystal structure (Figure 5.7AΒ, Table 5.3). Overall, the 
deconvolution yields secondary structure contents compatible with the 
crystal structure, albeit with an overestimation of β-sheets and an 
underestimation of coiled regions. 
From the temperature profile of individual components (Figure 5.7D) one 
can immediately identify the major structural rearrangements during 
thermal unfolding: increase of β-sheet (1643 cm-1) and turns (1661 cm-1). 
Other components have more irregular behaviors. This analysis indicates 
with accuracy the kind of secondary structure remodeling. For example, one 
can distinguish intermolecular from intramolecular β-sheets based in the 
absorption wavenumber. To have a global understanding or protein 
Table 5.2 – Band assignment for the deconvolution of FT-IR spectra. β-sheets and amino 
acid side chains absorb in this region. Discarded for secondary structure quantification. 
Wavenumber (cm-1) Structure 
1684 β-sheets
1661 Turns
1643 Coil
1639 Coil
1644 α-helices
1625 β-sheets
1603 mixed
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Table 5.3 – Deconvolution of rubredoxin’s FT-IR spectra. Comparison of the secondary 
structure content obtained from FT-IR spectra deconvolution with the one in the protein’s 
crystal structure (2DSX [8]). n.a. not discriminated in pdbsum. 
 Structural content (%)
 Crystal 
structure 24°C 94°C 
Helix 12 5 0
β-sheets 15 36 48 
Turns n.a. 1 31 
Coil 73 57 21 
 
 
Figure 5.7 – Deconvolution of temperature-dependent FT-IR spectra. Spectra recorded at 
24°C (A) and 94°C (B). The thick solid lines correspond to the spectral whose components 
were identified as gaussian bands (thin lines) whose sum (dashes) reconstitute the original 
spectra. By using the band assignment in Table 5.2, and the temperature profiles of each 
component band (D), the secondary structure changes with temperature were determined (C). 
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unfolding, one can sum the contributions arising from equivalent secondary 
structure types and study their temperature profiles (Figure 5.7C). This 
pictorial view confirms the results obtained with the second derivative 
approach. The first event in rubredoxin thermal denaturation is α-helical 
loss. At the same time, β-sheet content also decreases with concomitant 
buildup of random coil. Beginning at around 60°C, the trend changes with 
unfolding proceeding according to a distinct regime. Turns accumulate 
(~30%) as well as β-sheets, which return to native-like amounts at 94°C. 
These structures are formed from previously unstructured regions. The 
endpoint conformation is completely devoid of α-helices. 
5.5. Discussion 
In this work we have taken advantage of the combination of multiple 
spectroscopic techniques that probe similar molecular features to 
characterize the thermal unfolding of D. gigas rubredoxin. The dissimilar 
results originating from CD and FT-IR experiments occur because of the 
different sensitivities of each technique. CD spectroscopy is highly sensitive 
to α-helical elements because of their high far UV CD extinction coefficient 
[9]. The sensitivity for random coil structures or β-sheets is lower. In the case 
of rubredoxin this implicated that subtle conformational changes involving 
α-helical loss and gain in turns was undetectable. There is the possibility that 
the optimal (and different) protein concentrations for each technique 
influence results. However, aggregation was not observed in any condition. 
For this possibility, the FeS cluster percentage loss serves as an internal 
control. The similar iron loss in all assays suggests that the end conformation 
is similar, excluding the concentration artifact. 
FT-IR deconvolution allowed a temperature-dependent description of the 
conformational changes composing the thermal unfolding of rubredoxin. 
This included the description of two regimes in the unfolding pathway: a 
lower temperature one (<60°C), wherein α-helices and β-sheets are lost; and 
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a high temperature one (>60°C), where turns and β-sheets accumulate. The 
additional information from CD-monitored thermal denaturation indicated 
that these are not global conformational transitions, as at 94°C far UV CD 
spectra report native-like structure and visible CD spectra indicate that the 
remaining FeS clusters are in an environment spectrally undistinguishable 
from that of the native protein. Nevertheless, a partial unfolding was 
simultaneous to FeS cluster degradation, an irreversible damage. Altogether, 
all data indicate a multi stage unfolding process. 
Curiously, Clostridium pasteurianum rubredoxin seems to have similar 
unfolding properties to the D. gigas protein. It was reported that it undergoes 
major but reversible structural changes below FeS cluster dissociation 
temperatures, including lower compaction and local unfolding in the 50-70°C 
temperature range, the same where the D. gigas protein exhibits the 
unfolding regime change [10]. It has been shown that for the Pyrococcus 
furiosus rubredoxin FeS cluster release is rate determining in protein 
unfolding, unfolding only occurring after this step [11]. The possibility that 
the same process may occur in the D. gigas protein was left unaddressed. 
However, the fact that we have observed modest unfolding transitions and 
incomplete iron dissociation does not exclude this possibility. 
The slight conformational destabilization of rubredoxin due to EDTA is 
likely the outcome of the enhanced iron release during unfolding or direct 
rubredoxin-EDTA binding. Thermal denaturation assays in the presence of 
increasing EDTA concentrations (to detect the concentration thresholds 
where the iron stripping effect would become significant) coupled to the 
examination of the effect of salt (a competitor for EDTA binding to 
rubredoxin) would clarify this issue. In any case, the fact that EDTA does not 
significantly increase iron release from holo-rubredoxin is an indication of 
high kinetic stability of bound iron. 
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Protein thermostability is the outcome of multiple evolutionary 
adaptations [12]. In the case if rubredoxin, a metal-containing protein, 
contributions can be attributed to the polypeptide itself and to the FeS 
cluster. Probably because of their small size and compact fold, rubredoxins 
are quite stable proteins. Regarding the FeS cluster, in the C. pasteurianum 
protein, the Tm for iron release in thermal ramp experiments is 69°C for Fe2+-
Rd and 83°C for Fe3+-Rd [10]. The importance of stabilizing the FeS cluster 
site is highlighted in the P. furiosus protein, which contains an extended 
hydrogen bond network around this region as part of its stabilization 
strategies which enable cell growth at 100°C [13]. In other organisms similar 
adaptations exist. C. pasteurianum encodes a rubredoxin with an increased 
number of hydrogen bonds stabilizing the β-sheet [13]. 
5.6. Conclusions 
In the present report we have described the thermal unfolding of D. gigas 
rubredoxin using UV/visible absorption, CD and FT-IR spectroscopies. 
Rubredoxin is a highly thermostable protein, retaining a significant amount 
of native-like secondary structure at high temperatures. The thermodynamic 
and kinetic stability of the iron mononuclear site seems to be significant as 
judged from the low thermal lability and insensitivity to EDTA. By 
deconvoluting FT-IR spectra obtained along thermal ramps, we have 
described unfolding as a two regime process, wherein at low temperatures 
(<60°C ) α-helices and β-sheet unfold and at higher temperatures (>60°C) 
non-native β-sheets (48%) and turns (31%) buildup. The significant residual 
structure at high temperature may account for some of the protein’s 
thermostability. 
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6.1. Metals in biology 
Although being highly versatile macromolecules, proteins could not fulfill 
all their required functions relying only on the properties of the polypeptide 
chain. Cofactors are frequently involved in protein stabilization, catalysis, 
signal transduction and ligand binding. Transition metal ions work as 
superacids in enzyme active sites and can increase the electrophilicity or 
nucleophilicity of reacting species, increase the acidity of a reacting species 
and promote heterolysis [1]. More importantly, without cofactors 
polypeptides are not able to perform oxygen transport or proper electron 
transfer. In this case, biological systems have evolved to harness and control 
the unique properties of bioavailable metal ions [2-4]. Reciprocally, the 
polypeptide chain fine tunes the cofactor’s properties according to functional 
requirements. Special relevance can be given to metal ion cofactors. More 
than 30% of all proteins incorporate metal ions in their polypeptide chains 
[5-6]. 47% of all enzymes incorporate metals, the majority at the respective 
active sites [1, 7]. Iron-containing compounds have been proposed to be 
primordial energy sources, instrumental in the development of the first cell, 
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biologically relevant elements are in black. From [10]. 
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which then became the first protein cofactors upon amino acid ligand 
coordination [8-9].  
Redox-inert transition metal ions are selected by proteins because of their 
structural stabilization properties. Mg2+ and Zn2+, which are by far the most 
common metal cofactors, fulfill this role (Figure 6.2A). Distinct from Zn2+, 
which is sometimes found permanently bound to proteins, Mg2+ is often 
bound to phosphate groups of substrates for electrostatic reasons and 
interacts with proteins only transiently. Comparatively, Ca2+ is less used. The 
redox-active metal ion most commonly found in redox centers is iron, 
followed by manganese, cobalt, molybdenum, copper and nickel (Figure 
6.2B) [1]. Organic moieties sometimes associate with metal ions as a way of 
controlling their redox properties. This happens with iron and nickel, and 
most frequently with cobalt and molybdenum. 
Wolynes and coworkers have estimated that around 10% of the 
interactions in native proteins are frustrated, meaning that they enclose a 
latent stabilization potential which is not used because of competing 
interactions. The frustrated interactions tend to cluster in the protein 
surface, being associated with protein-protein interaction [11-12] or ligand 
 
Figure 6.2- Metal ions used in catalysis. (A) Proportion of each metal used by all enzymes. 
Only one enzyme uses cadmium. Grey color indicates elements with no biological role. (B) 
Metal utilization among Enzyme Commission (EC) classes: oxidoreductases (blue), 
transferases (yellow), hydrolases (purple), lyases (pink) and ligases (grey). Counts are 
normalized so that the sum of the frequency for all classes equals 100% for each metal. From 
[7]. 
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Figure 6.3 - Escherichia
coli metallome. Total
concentration of selected
metal ions in cells grown
in rich culture medium.
Cells accumulate the
appropriate amount of
each metal ion. From [26]. 
binding regions. Consequently, the underlying energetics is the driving force 
for protein structuring related to these specific associations. 
The unique properties of metal ions make them indispensable for living 
organisms, which however keep metal ion homeostasis through a complex 
machinery which constantly adjusts the metal ion concentration and 
availability according to needs (Figure 6.3). This task is of the utmost 
importance as metal ions have promiscuous binding properties and can be 
engaged in uncontrolled redox reactions. These might lead to oxidation of 
cellular constituents with broad consequences, ranging from inhibition of 
essential enzyme activities, destruction of cellular compartmentalization to, 
ultimately, cell death. Sodium, magnesium and potassium are bulk metal 
ions, present in millimolar concentrations in the free state which keep the 
physiological electrolytic balance. Compartmentalization of each ion ensures 
an appropriate composition of the intracellular and extracellular fluids. The 
free concentration of all other metal ions is kept very low. For example, the 
total intracellular copper concentration in yeast is 70 µM. However, copper 
delivery to SOD1 relies on specialized machinery because free copper 
concentration is not high enough for spontaneous binding to occur despite 
the high binding affinity (Kd ~ 10-15 M) [13]. Similarly, cellular free zinc 
concentrations are on the order of 10-13 – 10-9 M [14] and free calcium 
concentrations around 10-7 M [15-16]. 
Zinc or calcium are intracellular second messengers [17-18], that are 
released from cellular storage upon extracellular stimulus. Dedicated 
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transport and delivery systems exist to insert metal ions in their specific 
proteins – the metallochaperones [19]. For copper, there exist the Atx1-like 
chaperones, the CCS chaperones for superoxide dismutase and the copper 
chaperones for cytochrome c oxidase [19]. Iron is chaperoned by 
ferrochelatase or several scaffold proteins for iron-sulfur cluster assembly 
[20-21]. There is no zinc chaperone system. However, practically all cellular 
zinc is kept bound to metallothioneins, reduced glutathione and other 
proteins. Metallothioneins do also regulate the homeostasis of other 
physiological (e. g. copper, selenium) and xenobiotic (such as cadmium, 
mercury, silver and arsenic) metals which bind cysteine thiol groups (~30% 
of its amino acidic residues) [22]. Other redundant and non-specific metal 
ion homeostatic mechanisms like ion exchange or pumping to specific 
cellular compartments couple the control mechanisms of several metal ions. 
The outcome is that cellular metal homeostasis is a complex mechanism 
wherein the responses to the fluctuation of the concentration of one metal 
ion are coupled to some extent to the response regarding other metal ions 
(Figure 6.4) [23]. 
In the absence of metal delivery systems, metal incorporation is 
determined by free metal concentration [24] and the stability of the metal 
complex, which is generalized by the Irving-Williams series [25]:  
Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ > Zn2+ 
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Figure 6.4 - Intertwined
homeostasis between
different metal ions.
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value < 0.05, ** p-value
<0.01 versus control. From
[23]. 
Metal ions and protein folding 
127 
6.2. Shaping the conformational space: metal ions 
The role of metal ions in protein folding is complex. The first step to 
understand this relationship is addressing how metals bind to proteins in the 
first place. Several binding modes have been described (Figure 6.5). Some 
metalloproteins are able to fold in the absence of the metal ion, which is 
necessary for functional conformational readjustments or catalytical 
purposes, like most calcium-binding proteins (e. g. calmodulin and S100 
proteins). In other cases, the newly synthesized apo protein is not able to 
acquire its native fold. Zinc finger domains can only fold to the native 
structure in the presence of zinc. On the other hand, metal ions may bind to 
the nascent polypeptide chain as it emerges from the ribosome. In fact, heme 
binds to the unfolded state of cytochrome b562 [27-28] and copper remains 
bound after unfolding of azurin [29-30] and the CuA domain of cytochrome c 
oxidase [31]. 
Tightly binding metals can be permanently bound and be crucial for the 
acquisition of the native protein structure. Loosely bound metals can bind 
and rebind to proteins according to the metal concentration gradient. In this 
case, binding may be associated with conformational changes, dependent of 
the ligand bridging role of the metal. The concept of metal-induced folding or 
metal-induced conformational changes is associated with the mechanism of 
metal ion insertion into proteins. When they are synthesized in the ribosome, 
proteins emerge to the cytosol as unfolded or partially folded species. In 
some cases, in the absence of the metal ligand the newly-synthesized protein 
rests in a native-like fold (e. g. S100 proteins); metal ligation then determines 
conformational changes, being reversible in signaling-related proteins 
(Figure 6.5, blue pathway). In other situations metal ion incorporation is 
required for folding (e. g. Zinc fingers). It may occur either cotranslationally 
(Figure 6.5, green pathway) or posttranslationally (Figure 6.5, red pathway). 
Metal ion selection is determined either by the Irving-Williams binding 
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Figure 6.5 – Routes for the folding of metalloproteins. From [32]. 
stability series and metal ion concentration or by the action of 
metallochaperones. 
In the next sections we will address the issue of the interplay of metal ions 
in protein folding by focusing in the most relevant metal ions – iron, zinc, 
copper and calcium – and illustrating this subject with representative 
examples. 
6.2.1. Iron 
Iron is the most abundant transition metal ion in the human body. Iron is 
a very versatile element due to its two stable oxidation states (Fe2+/Fe3+) 
which allow it to mediate redox reactions in a broad potential range and its 
several spin states which catalyze reactions involving molecular oxygen [10]. 
Iron is incorporated in proteins in the form of a heme, iron-sulfur clusters, 
mixed metal centers, di-iron or mononuclear centers. One of the best studied 
models of the interplay between iron and protein folding is cytochrome c, an 
electron transfer protein operating in the mitochondrial respiratory chain. In 
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Figure 6.6 - Cytochrome c folding energy landscape. (A) Two dimensional cross-section of 
the folding energy profile for the cobalt, iron and zinc-substituted proteins. The folding 
reaction coordinate (R-RN) represents the size (R) difference to the native protein size (RN). 
Besides the native state, one can identify energy basins for expanded (E, E’) and collapsed (C, 
C’) intermediates. The metal substitution has a significant influence on the folding energy 
barrier. (B) Three-dimensional representation of the folding energy landscape for the native 
(iron-bound) protein. From [5, 34-35]. 
cytochrome c the iron is inserted in a heme group which is covalently bound 
to the polypeptide. The coordination is octahedral, the equatorial positions 
corresponding to the heme ligands and the two axial sites being filled by 
amino acid side chains. Cytochrome c is a highly stable protein, with a Tm 
close to 100°C [33]. The metal ion in the heme can be replaced in vitro with 
important consequences to protein folding (Figure 6.6). Substitution of Fe3+ 
by Zn2+ lowers the folding energy barrier but, of course, renders the protein 
redox inactive. Substitution by Co2+ raises the activation energy. 
Heme removal is associated to secondary and tertiary structure loss [36]. 
Hence, heme binding is thought be a prerequisite for cytochrome c folding. 
However, this conception has been challenged by the recent observation of 
spontaneous folding of the Aquifex aeolicus apo cytochrome c555 [37]. An 
intermediate situation occurs with apo cytochrome c551 from Pseudomonas 
aeruginosa. This protein unfolds reversibly and acquires a compact, though 
marginally stable, conformation [38]. 
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Figure 6.7 – Fe3+-dependent conformational changes in human transferrin. The apo form 
(1BP5, top) adopts an open conformation. When Fe2+ (shown as a sphere) binds, the two 
protein domains close around the inter-domain hinge enclosing the metal ion in the protein 
core (1A8F, bottom). 
The transport of iron in the blood is carried out by transferrin. Transferrin 
binds Fe3+ with an unusually high affinity (Kd = 10-22 M) [39]. Upon Fe3+ 
binding, the two transferrin domains undergo a conformational change 
which compacts the protein structure and buries the Fe3+ ion in the protein 
(Figure 6.7). Iron binding greatly stabilizes the protein and alters the 
unfolding pathway from an apparent three state (Tm,1 = 58°C, Tm,2 = 69°C) to 
a simple two state process (Tm = 87°C) [40]. Mutation of the Asp63 ligand 
decreases the Fe3+ binding affinity by approximately 5-6 orders of 
magnitude, with a concomitant destabilizing of ΔTm ~12°C for the holo 
protein and ~3°C for the apo protein [41]. 
6.2.2. Zinc 
Zinc is essential for life and the second most abundant transition metal 
ion in living organisms. Zinc is a redox-inactive metal ion due to its filled d 
Fe3+ Fe3+
90°
90°
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shell, 3d104s2, valence electronic configuration. However, it binds to proteins 
very tightly and fulfills structural roles in proteins. The most common 
coordination number for zinc is four. In proteins, three ligands are enough 
for ensuring tight binding, the fourth one being water. A recent survey has 
revealed that zinc-binding proteins are a significant part of all genomes (4-
10%) [42]. The percentage of zinc binding proteins correlates with growth 
temperature: organisms thriving at higher temperatures make more 
extensive use of zinc-binding proteins. Underlying this preference may be the 
stabilizing role of zinc. 
The most notable example of zinc-associated folding occurs in proteins 
containing zinc finger domains. Zinc fingers are the most abundant structural 
domain in the human proteome (present in 3% of all proteins) and the most 
abundant zinc binding motif [43-44]. [44] The classical zinc finger domain 
has a ββα fold, where the Zn2+ ion is coordinated by two cysteine ligands near 
the turn of the antiparallel β-sheet, and two histidine ligands in the C-
terminal part of the α-helix (Figure 6.8A). Although the domain contains a 
small hydrophobic core [45], the apo form is unstructured. The structure can 
only fold and be brought into close proximity upon zinc binding (Figure 
6.8B). Moreover, the zinc-bound domain is stabilized and becomes 
 
Figure 6.8 – Folding of a zinc finger domain. (A) Structure of a metallated Cys2His2 type zinc 
finger. (B) Far UC CD spectra of Xenopus transcription factor IIIA in the absence and presence 
of zinc, indicating the secondary structure occurring upon metal binding. From [46]. 
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competent in DNA binding [46]. The zinc binding affinity to zinc finger 
domains is high (Kd = 10-11 to 10-9 M) [47], rendering them sensitive to 
transient Zn2+ concentration rises. In this manner, zinc finger domains couple 
zinc concentration variation to transcriptional responses and interaction 
with multiple proteins [48]. 
Zinc is one of the cofactors of the cytosolic Cu,Zn-superoxide dismutase 
(SOD1), the main protection against the highly oxidant superoxide radical. It 
does not take part in catalysis but is determinant for the acquisition of the 
protein’s native β sheet-rich fold [49] and high thermostability. Yeast alcohol 
dehydrogenase is a tetrameric enzyme incorporating two Zn2+ ions in each 
subunit. One ion sits in the catalytic site; the other one has a structural role. 
Apart from activity, the incorporation of Zn2+ has been described as essential 
for proper folding, as it confers higher pH stability, higher stability towards 
chemical denaturation [50] and higher folding cooperativity [51-52]. The 
catalytical zinc ion is thought to have a more important effect in stability 
[50]. 
6.2.3. Copper 
Azurin contains a single copper ion, which can be substituted in vitro by 
zinc. The protein structure is identical in the apo and metallated (Cu/Zn) 
states [53-54]. However, metal ions have a significant effect in the protein’s 
thermodynamic stability. The stability of the apo protein is 6.9 kcal/mol. The 
binding of either Cu+ or Zn2+ raise the stability to ~9.5 kcal/mol, and Cu2+ to 
12.4 kcal/mol [55]. Both calcium and zinc bind the native as well as the 
unfolded state of azurin. This has important consequences in the folding 
kinetics: Cu2+ binding before folding greatly accelerates the kinetics 
(milliseconds) relatively to metal binding after apo protein folding (minutes 
to hours) [55]. This has been proposed as a mechanism to ensure fast folding 
and selective binding of copper over zinc (which binds ~17000 fold less 
tightly). 
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Ceruloplasmin is the major copper protein in the blood and an essential 
regulator of iron homeostasis. It binds six copper ions, three forming a 
trinuclear cluster and all others in mononuclear sites. Holo ceruloplasmin is 
more stable than the respective apo protein (ΔTm = 15 to 20°C). The metal 
load also influences the denaturation kinetics. In physiological-like 
conditions the apo protein unfolds is <2 days to a molten globule-like state 
[56], while the holo protein forms an intermediate state lacking one copper 
ion which is active and remains stable for more than two weeks, that was 
proposed to be relevant in vivo [57]. Ceruloplasmin also binds Ca2+ and Na+. 
Na+ is thought to restrict the mobility of surface loops creating an entry point 
for substrate to the active site [58]. 
6.2.4. Calcium 
Like magnesium, calcium is an inert and labile ligand. Evolution has 
exploited this property and rendered calcium an important second 
messenger, which is released from intracellular stores upon stimulation and 
binds reversibly to several proteins producing a transient signal. After 
release, calcium is rapidly sequestered by calcium-binding proteins or 
actively pumped outside the cell or to storage organelles. This is equivalent 
to say that calcium works as a trigger, activating the proteins it binds to. 
There are a variety of calcium binding motifs but the most abundant is the 
helix-loop-helix EF-hand (Figure 7.3), present in calmodulin, troponin C, the 
S100 proteins, among others [10]. Upon binding to EF-hands, calcium 
induces a large conformational change, shifting the position of one of the EF-
hand helices and exposing a hydrophobic surface for protein-protein 
interactions (Figure 6.9A). Moreover, the electrostatic neutralization at the 
binding site upon cation binding is frequently responsible for protein 
stabilization (Figure 6.9B). 
One of the most well studied EF-hand protein is calmodulin, a ubiquitous 
protein found in all eukaryotes which regulates enzyme activities, 
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Figure 6.9 – Calcium-dependent conformation and stability of EF-hands. (A) Overlay of 
the apo (1K9P, grey) and Ca2+-bound (1K9K, blue) S100A6 structures. The C-terminal EF-hand 
is highlighted to show the helix displacement occurring upon the binding of calcium (shown as 
yellow spheres). The inter-helical surface is hydrophobic and upon exposure becomes the 
docking site for downstream-acting proteins. (B) Thermal stability of S100A6 monitored by 
far UV CD in the apo and Ca2+-bound states (0.1 mg/ml protein, 5mM KPi pH 7, 98 µM Ca2+, 
λ=222 nm). Upon calcium binding the protein is significantly stabilized (ΔTm = 10°C) 
(unpublished observations). 
neurotransmitter release, cell proliferation and DNA repair. Most of these 
activities require interaction with other proteins in a calcium-dependent 
manner. Many of these proteins do not bind calcium themselves; they rely on 
calmodulin as a calcium sensor and signal transducer. Upon calcium binding 
calmodulin binds to nitric oxide synthase (NOS) and activates the electron 
transfer pathway necessary for catalysis [59], binds to microtubule-
associated proteins, favoring microtubule depolymerization [60], interacts 
with kinases responsible for neurite outgrowth [61]. 
The archetypical EF-hand is the one in parvalbumin [62], where it was 
identified. Calcium has important relevance in the folding of this protein [10]. 
In the calcium-bound state the protein rests in a compact globular state, with 
the EF-hand in the open state (e. g. Figure 6.9A). Calcium release induces a 
fast (~60 ps) conformational rearrangement resulting in a decrease in the 
native helical content (>20%, [63]) and enhanced residue solvent 
accessibility. The apo state has been described as natively disordered [64-
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Figure 6.10 – Bovine α-
lactalbumin thermal stability
as a function of metal
substitution. Thermal
denaturation curves from
intrinsic tryptophan
fluorescence. Binding of Ca2+ to
the apo protein brings about a
rise in the Tm of about 30°C. Na+
has no effect. K+ and Mg2+ have
intermediate effects. From [10]. 
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65]. A subsequent structural analysis revealed a calcium-induced 
hydrophobic core repacking [66]. Regarding the protein dynamics, the 
calcium-bound protein becomes highly resistant to trypsin proteolytic 
cleavage [67]. 
Bovine α-lactalbumin is another EF-hand protein. It regulates lactose 
synthesis though calcium-dependent conformational changes. Calcium 
increases its folding rate by three orders of magnitude [68-70] and couples 
refolding to the generation of the native disulfide bridge [71], which suggests 
a calcium regulation of lactose synthesis through controlling α-lactalbumin 
folding. A more careful examination of the process revealed that calcium 
accelerates the folding of α-lactalbumin by decreasing the energy barrier 
between the molten globule and the transition states, by decreasing the 
difference of entropy between the two states [70]. The metal binding 
properties of α-lactalbumin are promiscuous and it also binds other metal 
ions apart from Ca2+. Metal binding translates into specific protein stability 
(Figure 6.10). 
Unlike hen egg white lysozyme, equine lysozyme binds calcium [72-73]. 
At acidic pH and in the absence of calcium the α and β domains unfold at 
distinct temperatures. The calcium-binding β domain is stabilized by the 
metal ligand. [74]. At neutral pH the protein unfolds in one cooperative 
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transition in a calcium dependent melting temperature. 
6.3. Expanding the conformational space: amyloidogenesis 
Despite the solid evidence underlying it, Anfinsen’s thermodynamic 
hypothesis of protein folding has been shown not to be completely valid. 
Namely, the postulate that the native state is unique and represents the most 
thermodynamically stable conformation is challenged by amyloid-forming 
proteins. These structures were first identified depositing as β-sheet rich 
aggregates at specific organ locations in association with disease (Figure 
6.11A). These structures, could be selectively stained with a starch (amylose) 
selective dye, Congo Red (Figure 6.15), and were accordingly named as 
amyloid. Amyloid is a fibrillar conformation characterized by a cross-β 
structural motif emerging from X-ray fibril diffraction patterns [75-77]. Even 
though very distinct proteins are now known to form amyloid, they all 
exhibit a remarkably similar amyloid structure (e. g. Figure 6.11BC) wherein 
β-strands running nearly perpendicular to the fibril axis are stacked through 
hydrogen bond contacts. Structural polymorphism occurs at the detailed β-
strand alignment and the stacking stabilizing interactions [78]. 
The amyloid state represents an “alternative” protein conformation and 
can be considered an extreme case of protein conformational change. Indeed, 
for all amyloid-forming proteins a “classic” native state exists – even though 
for many proteins it is a natively disordered one – which, under determined 
conditions can interconvert to amyloid (Table 6.3). In the cellular context, 
amyloid fibrils form spontaneously, although as a “rare” event associated 
with ageing and diseases including Alzheimer’s, type 2 diabetes, prion 
diseases, Parkinson’s, systemic amyloidosis and Huntigton’s. Nevertheless, 
amyloid fibrils are remarkably stable, resisting proteolytic cleavage, 
chaperone-mediated disaggregation and, in some cases, even 
physicochemical denaturation. Thus, they must populate the bottom of the 
folding funnel. The “rare” amyloid formation in physiological context points 
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Figure 6.11 - Structure of Aβ amyloid structures. (A) Brain senile plaque stained with anti-
Aβ antibodies. (B) Transmission electron microscopy image of Aβ fibrils. (C) Structural model 
of Aβ fibril ultrastructure. The fibril is formed by β-turn-forming monomers stacked along the 
fibril axis. The slight lateral offset between adjacent monomers introduces a twist in the fibril. 
From [78-79]. 
to amyloidogenesis being represented by a folding funnel concurrent with 
the native one, from which it is separated by a large energy barrier [80] 
(Figure 6.12). In this framework, the native state must be considered a 
kinetically trapped state which can only convert to amyloid under specific 
conditions. 
Amyloid forming proteins were once viewed as a rare occurrence in biology, 
frequently associated with disease and not always reproduced in 
physiologically accessible conditions. Dobson and coworkers have shown 
otherwise. In fact, they have described amyloid formation by the SH3 domain 
of p85α subunit of bovine phosphatidylinositol 3-kinase, a artificial protein 
construct not involved in disease [82]. This discovery was the first evidence 
that, given the appropriate conditions, all proteins could, given adequate 
A
B
C
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Figure 6.12 – Expanded protein folding funnel, considering aggregation processes. The 
“classical” folding scenario consists in the acquisition of the native conformation from the 
unfolded state, through a series of intermediates (blue funnel). Partially folded intermediates 
may expose hydrophobic patches which, especially at high protein concentration like the 
crowded cellular milieu, may drive aggregation of these misfolded proteins. Growing evidence 
supports the proposal that these partially folded species may facilitate the structural 
conversion and polymerization of amyloid structures of the oligomeric or fibrillar type (purple 
funnel). From [81]. 
conditions, adopt the amyloid conformation [82-83]. Much data has 
strengthened this view, of which one of the strongest ones is that all 
amyloids display a set of common structural features independently of the 
protein identity, pointing that at least some amyloidogenesis factors should 
be associated with the protein backbone rather than with amino acid side 
chains. In this scenario, the initial association of amyloid with a few proteins 
involved in disease results from the fact that amyloidogenic conditions for 
these proteins are in the physiologically-accessible range. 
The infrequent amyloid formation in vivo as opposed to the postulate that 
the amyloid conformation should be accessible to all proteins suggests that 
evolution must have designed protein sequences for structure, fast folding 
kinetics, dynamics, stability, activity as well as for minimizing the amyloid-
formation propensity. The latter must be a strong driving force because, 
owing to their high temperature [84] and proteolysis [85] resistance, 
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Table 6.1 - Functional amyloids. From [87-88]. 
Amyloid protein Source Function
Chaplin Streptomyces coelicor Aerial hyphae formation 
Hydrophobin EAS Neurospora crassa Aerial hyphae formation 
Curlin Escherichia coli Biofilm formation, cell adhesion, invasion 
eRF3 Saccharomyces cerevisiae Polyamine regulation ([PSI+] phenotype) 
Rnq1 Saccharomyces cerevisiae Cytoprotection ([RNQ+] phenotype) 
HET-s Podospora anserina Heterokaryon formation 
Ure2p Saccharomyces cerevisiae Promote the uptake of poor nitrogen sources ([URE3+]) 
CPEB Aplysia californica Long-term memory 
Silk moth chorion protein Lepidoptera Protection 
Fish egg Austrofundulus limnaeus Resistance to dehydration 
Eggshell chorion proteins Bombyx mori Protection 
Pmel17 Mammals Regulation of melanin biosynthesis 
Fibrin Mammals Activation of haemostatic factors 
Spidroin Nephila edulis Spider web silk 
 
amyloids are not easily removed from biological systems and tend to 
accumulate. Insulin fibrils have strength and stiffness comparable to those of 
steel and silk, respectively. The amyloidogenic process is avoided by 
sequence design (i. e. by avoiding amyloid-prone sequence stretches), fast 
folding (minimizing aggregation), folding cooperativity (by disfavoring 
extensive conformational changes) and several cellular surveillance systems. 
Thorough investigations have further revealed that some amyloids do have 
physiological importance. Some organisms make use of their mechanical 
performance or conformational templating properties to fulfill specific 
requirements (Table 6.1). Remarkable examples of these functional amyloids 
are spider silk – whose strength is higher than steel – and the yeast prions 
eRF3 and Ure2p – whose amyloidogenesis is associated with alteration in 
their native nucleic acid processing properties and constitutes an epigenetic, 
protein-only phenotypic inheritance mechanism [86]. 
6.3.1. Mechanisms of amyloid formation 
Being a polymerization process, amyloid formation must be considered in 
the general framework of protein oligomerization and aggregation (Figure 
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6.13). Because of the gradual conformational changes occurring en route to 
the amyloid state, the intermediate oligomeric species also contain some 
amyloid features. One interesting aspect is that many of the proteins 
undergoing aggregation and deposition in amyloid diseases are globular and 
stable under physiological conditions. Nevertheless, the amyloid state in 
which they are found in disease situations is a highly stabilized state with a 
near universal structure, distinct from the native conformation, which is thus 
expected to occupy a disjoint space in the folding energy landscape. Then, the 
intriguing question is which conformational changes take place in this 
 
Figure 6.13 - Schematic representation of protein self-association processes. The same 
or distinct proteins can self-associate into oligomer structures with different structural 
features. Structured oligomers may actually constitute the native protein structure or be 
associated with signaling processes. The structural conversion from globular to amyloid 
conformations occurs through a series of intermediates. Once a nucleus is formed, 
fibrillization promptly proceeds by polymerization extending from these sites. Actual 
oligomerization processes are more complex and different structures and interconversions 
can occur. From [79, 97]. 
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extensive structural conversion and how can the energetic barrier between 
the native and amyloid funnels be overcome. Chiti and Dobson have 
suggested that partial protein unfolding as a result of mutations, pH 
fluctuations, metal binding or imbalancement in cell protein quality control 
systems are responsible for the appearance and/or not elimination of 
partially unfolded/misfolded intermediates which may be at the beginning of 
the amyloidogenesis pathway [89]. More importantly, this hypothesis does 
not require extensive, energy costly, global conformational changes, as the 
misfolded state is still native-like. Acidic organelles like the endosomes and 
the lysosome have been associated with pH-induced generation of amyloid-
like precursors of Aβ1-42 [90], the prion protein [91] and transthyretin [92] 
but the opposite, clearance effect was observed for α-synuclein [93]. In the 
case of natively unfolded proteins similar mechanisms may apply. The 
structures of such intermediates have been pursued by theoretical and 
experimental methods [94-96]. 
The mechanisms of amyloid formation have been extensively studied in 
vitro for a variety of proteins, with the main focus on those involved in 
pathology. Five different types of mechanisms have been proposed 
(reviewed in [98]): 
1. Subsequent monomer addition mechanism, where fibril elongation 
occurs by successive addition of monomers to a preformed fibril; 
2. Reversible association mechanism, which considers the interaction 
between all kinds of species (instead of just the monomer and fibril) 
and aggregation reversibility; 
3. Prion aggregation mechanisms, which explain prion infectivity by 
considering that the conformational transition of the native to the 
amyloid-prone conformational is thermodynamically unfavorable but 
aggregation is highly favorable and drives amyloid polymerization; 
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4. “Occam's razor”/minimalistic model (or Finke–Watzky 2-step model), 
which simplifies the analysis by considering separate contributions 
from nucleation and polymerization and representing all aggregation 
steps as simple kinetic steps; 
5. Quantitative structure activity relationship models, which rationalize 
amyloid aggregation rates as a function of the physico-chemical 
properties of the aggregating protein. 
Being an aggregation process, amyloid formation is based on three 
fundamental physical processes: 
1. A critical concentration below which the frequency of molecular 
collisions is not enough for promoting aggregation; 
2. A critical nucleus, which forms at the beginning of amyloid formation 
and seeds further fibril elongation; 
3. Lag phase, which corresponds to a delay in apparent polymerization 
due to conformational changes and nucleus formation time. 
The critical nucleus is defined as the least thermodynamically stable 
species in solution, which is the oligomer of minimal size capable of initiating 
further growth [99]. Fragmentation of existing aggregates also supplied 
nucleus-like structures [100-101]. The addition of preformed amyloid 
structures enhances the polymerization rate of the native protein. This is 
called amyloid seeding. The analysis of amyloidogenesis kinetics with 
mechanistic models allows extracting quantitative data which describe the 
fibrillization process: thermodynamic parameters, rate constants, 
cooperativity and nucleus size, among others [98].  
For Aβ, a model was proposed according to which fibrils elongate by 
addition of monomeric Aβ at the edges following a “dock-and-lock” 
mechanism [96]. According to this mechanism, monomers are added to the 
growing fibril in several steps: first the monomer interacts with the fibril tip 
in a readily reversible manner; next conformational changes convert the 
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Figure 6.14 - Dock and lock mechanism of amyloid fibril growth. A: preformed amyloid; S: 
soluble precursor. According to this model, amyloid propagation from a preformed nucleus 
involves an initial fast step where the soluble precursor exchanges between the free state and 
a docked state where it is associated to the nucleus in a native-like conformation. The docked 
precursor then undergoes a conformational transition to an amyloid-like state which is prone 
to converting to the amyloid state by nucleus templating. From [96]. 
peptide to the amyloid conformation and the monomer is integrated into the 
fibril (Figure 6.14). 
6.3.2. Detecting amyloids 
Amyloid formation is a structural modification accompanied by changes in 
spectroscopic and other physical properties. The process can be probed and 
amyloid species detected using the same methodologies used for any type of 
protein aggregation (Table 6.2). The classical methods for unambiguously 
determining if a protein aggregate is of the amyloid type are the 
characteristic apple-green birefringence under a polarized light microscope 
after staining with Congo red – the standard method in 
 
Figure 6.15 – Structure of thioflavin T and Congo red. 
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Table 6.2 - Physical methods to analyze protein aggregation. “Concentration dependent” 
techniques are those which can provide in situ analysis if aggregation conditions are within 
detection limits. [98]. 
Method Information In situ/ex situ Kinetics? 
Absorbance Direct Concentration dependent Yes
Atomic force microscopy Direct In situ Yes
Calorimetry Direct In situ Yes
Circular dichroism Direct Concentration dependent Yes
Dyes Indirect Concentration dependent Yes
Electron microscopy Direct Ex situ No
EPR Indirect Concentration dependent Yes
Flow birefringence Direct In situ Yes
Fluorescence spectroscopy / intrinsic fluorophore Direct Concentration dependent Yes
Fluorescence spectroscopy / extrinsic fluorophore Indirect Concentration dependent Yes
FT-IR Direct Concentration dependent Yes
Light scattering Direct In situ Yes
Mass spectrometry Direct Ex situ No
NMR Direct Concentration dependent Yes
Quartz crystal oscillation Direct Concentration dependent Yes
Turbidity Direct In situ Yes
Viscosity Direct In situ Yes
X-ray diffraction Direct Concentration dependent No
 
immunohistochemistry – the characteristic thioflavin T fluorescence 
enhancement at 182 nm (Figure 6.15) or the cross-β fibril diffraction pattern. 
The insoluble, heterogeneous, high molecular weight nature of amyloid 
fibrils poses great challenges to conventional structural characterization by 
X-ray fibril diffraction or NMR [102]. However, recent breakthroughs in fibril 
X-ray diffraction [102-104], solid-state NMR, neutron diffraction, microscopy 
and structural modeling have provided some evidence for the structure of 
amyloid fibrils. Still, only limited information is available about the structural 
conversion of natively folded proteins to amyloid structures. This is because 
despite the similarity of the amyloid fibrils formed by different proteins, the 
formation mechanism seems to be unique for each protein and the identity 
and structure of the intermediate conformational states is inherently 
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heterogeneous, transient and masked by the multimolecular polymerization 
mechanism. To tackle these problems, Kayed and co-workers have raised 
conformation-dependent antibodies (reviewed in [105]), which detect the 
universal structure features of amyloid-like structures [106-107]: fibril 
structures (OC antibody) or amyloid oligomeric structures (A11 antibody) 
(Figure 6.16). These antibodies have revealed that the same structural 
features are observed on oligomeric or amyloid structures formed by very 
distinct proteins. Conformation-sensitive antibodies are privileged tools for 
identifying specific conformations in mixtures, the role of each type of 
structure in disease and for structural characterization of conformers in the 
amyloidogenesis pathway. 
6.4. Metal ions and amyloid formation in disease 
Protein aggregation in general and amyloid fibrillization in particular are 
very specific processes, involving orchestrated conformational transitions. 
Consequently, proteinaceous deposits associated with disease are found at 
specific organism locations and involving well defined proteins. Protein 
aggregation increases with aging and this can change the proteostasis 
network and enhance further aggregation [108] resulting in diseases (Table 
6.3). 
Protein fibrillization can be induced in vitro by mild destabilizing 
A11
OC
Figure 6.16 – Conformation-
sensitive antibodies. Dot blot
analysis of Aβ1-42 and and a 36-mer
polyglutamine peptide in the fibrillar
or oligomeric forms detected with the
fibril-specific OC antibody or the
amyloid oligomer-specific A11
antibody. From [106]. 
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Table 6.3 – Representative human amyloid diseases. Including the information about the 
disease related polypeptide. From [109]. 
Disease Protein/Peptide Native structure
Neurodegenerative diseases
Alzheimer’s disease Aβ peptide Natively unfolded 
Spongiform encephelopathies Prion protein Natively unfolded & α-helical
Parkinson’s disease α-synuclein Natively unfolded 
Dementia with Lewy bodies α-synuclein Natively unfolded 
Frontoremporal dementia with 
Parkinsonism 
Tau Natively unfolded 
Amyotrophic lateral sclerosis Superoxide dismutase 1 Immunoglobulin-like 
Huntington’s disease Huntingtin, polyQ expansion Mostly natively unfolded
Spinocerebellar ataxias Ataxins with polyQ expansion All β 
Nonneuropathic systemic amyloidosis
AL amyloidosis Ig light chain or fragments Immunoglobulin-like 
AA amyloidosis Serum amyloid protein A All α 
Senile systemic amyloidosis Wt transthyretin All β 
Familial amyloidotic polyneuropathy Transthyretin mutants All β 
Hemodialysis-related amyloidosis β2-microglobulin Immunoglobulin-like 
Apolipoprotein amyloidosis Apolipoprotein fragments Natively unfolded/unknown
Lysozyme amyloidosis Lysozyme mutants α+β 
Nonneuropathic localized diseases
Type II diabetes Islet amyloid polypeptide Natively unfolded 
Atrial amyloidosis Atrial natriuretic factor Natively unfolded 
Injection-localized amyloidosis Insulin All α 
Corneal amyloidosis Lactoferrin α+β 
Cataract γ-crystallins All- β 
 
conditions like low pH, detergents or elevated temperature. However, the 
complex conformational changes involved and the concomitant protein fold 
perturbation have challenged our understanding of the mechanism 
responsible for in vivo amyloid formation. For some proteins, mechanisms 
for the amyloid conversion from the native conformation have been put 
forward [110]: intrinsic propensity for acquiring the amyloid conformation, 
which increases with age (e. g. α-synuclein in Parkinson’s disease [111] or 
transthyretin in familial amyloid polyneuropathy [112]), increased protein 
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expression (e. g. α-synuclein gene locus triplication [113-114], hemodialysis-
associated β2-microglobulin accumulation [115], reduced insulin clearance 
from injection sites [116]), amyloid-favoring point mutations (including 
glutamine extension in polyQ amyloidosis), abnormal post-translational 
protein processing (e. g. tau hyperphosphorylation in Alzheimer’s disease), 
altered proteolytic processing of the precursor protein (e. g. Aβ peptides in 
Alzheimer’s disease) and environmental hazards capable of inducing 
conformational changes in the precursor protein (e. g. oxidative agents, 
heavy metals, pesticides). However, for the majority of amyloid diseases the 
causative reasons for amyloid aggregation are not known and most cases are 
sporadic. 
In amyloid diseases protein misfolding is coupled to cellular degeneration, 
revealing that amyloid species are toxic. Several toxicity mechanisms have 
been uncovered: tissue integrity and function destruction by bulk invasion 
[110, 117], membrane destruction [118-119], induction of apoptosis by 
interacting with specific receptors [120], inhibition of neuronal calcium 
currents [121], impaired autophagosome maturation [122], autophagy 
dysfunction [123], oxidative stress induced by metal ion coordination by 
amyloid fibrils [124-128], exhaustion of cellular chaperoning capacity [129-
130] and proteasome inhibition [131]. Systems biology approaches analyze 
the multiple perturbations associated with amyloid diseases as an 
imbalancement in the cellular proteostasis network [123]. In this sense, the 
accumulation of the toxic amyloid species can be understood as perturbing 
complex cellular systems and originating the several unexpected toxicity 
mechanisms associated with disease. 
Metal ions are central players in amyloid formation. High affinity metal 
binding sites have been described in many amyloid-forming proteins, 
including β2-microglobulin [132-134], Aβ [135-138], α-synuclein [139-141], 
superoxide dismutase [49] and mammalian prion protein [142]. Metal ion 
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Figure 6.17 - Aβ plaques and tau
neurofibrillary tangles. From [147]. 
coordination may influence the conformational conversion of the native to 
the amyloid state or promote toxic reactivity. Iron and copper catalyze the 
generation of reactive oxygen species by cycling between their two 
accessible oxidation states. This can happen either in the free state or when 
bound to proteins. In either case, oxidative modifications can destabilize the 
native protein fold and contribute to amyloid formation. Even in the absence 
of any reactivity, metal ions can induce conformational changes which can 
determine the amyloid conversion. In the following sections we will illustrate 
the relevant role of metal ions in physiological amyloidogenic processes 
involved in disease focusing on neurodegenerative amyloid diseases. 
6.4.1. Metal ions and Alzheimer’s disease 
Alzheimer’s disease (AD) is the most common form of dementia. The 
major neuropathological lesions in AD patients are two kinds of amyloid 
deposits in the brain: amyloid-β (Aβ) peptide-containing neuritic plaques 
[143] outside neurons in limbic structures and association neocortex [144] 
and intracellular neurofibrillary tangles composed of hyperphosphorylated, 
polyubiquitinated tau protein [145] 
(Figure 6.17). Aβ and tau deposition seem 
to be driven by independent mechanisms 
as tau deposits occur in several other 
neurodegenerative diseases where no Aβ 
neuritic plaques are observed. This 
suggests that tau deposition is 
downstream from Aβ plaque formation 
but is an essential process in degeneration 
[146]. 
Aβ is produced by the proteolytic 
processing of Amyloid Precursor Protein 
(APP, Figure 6.18), an integral membrane 
Plaques
(Aβ) Tangles
(Tau)
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Figure 6.18 - In vivo generation of the Aβ peptide
from Amyloid Precursor Protein (APP). Cleavage of
APP by β-secretase forms the C-terminal membrane-
bound APP fragment which is then cleaved by γ-
secretase to yield the soluble Aβ peptide. γ-secretase
cleavage is unspecific and can produce 39 to 43 amino
acid long Aβ peptides. 
protein mostly expressed in 
the synapses of neurons 
involved in synapse 
formation [148], neural 
plasticity [149] and copper 
metabolism [150]. Unspecific 
APP processing produces 
distinct Aβ peptides. The 
major forms are the peptides 
with 40 (Aβ1-40) and 42 (Aβ1-
42) amino acid residues [143, 
151-153]. Aβ1-42 is 
significantly more 
amyloidogenic than Aβ1-40, 
initiating amyloid formation at lower concentrations, with higher rates [154], 
resulting in different structures [155] and whose metabolism imbalancement 
is closely related to disease [156]. 
The most accepted hypothesis for the origin of the disease is the amyloid 
cascade hypothesis, which postulates that the disease is primarily the 
outcome of the toxicity and physiological imbalancement originating from 
amyloid formation and deposition: oxidative stress, calcium homeostasis 
imbalancement [157], apoptosis [158], mitochondrial enzyme dysfunction 
[159], inflammation [160], neurovascular dysfunction and cell cycle 
abnormalities. Even though insoluble Aβ amyloid plaques are the most 
characteristic pathological hallmark of the disease, accumulating evidence 
suggests that the disease-causing agent are not Aβ fibrils but rather 
oligomers formed during the amyloidogenesis pathway [107, 161]. Aβ 
oligomers trigger specific neuronal dysfunction [162-164], disrupt long-term 
potentiation [165] and impair memory [166]. The highest toxicity is 
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associated with Aβ oligomers formed by 2-50 monomers [157].The relevance 
of Aβ1-42 has been consistently associated with its propensity of forming a 
diverse range of oligomeric structures which are stable, unlike those forming 
from Aβ1-40 [167-171]. Nevertheless, both peptides eventually polymerize 
into structurally indistinguishable fibrils [172-173]. 
Aβ coordination chemistry is rich and it can bind different metal ions 
which influence its structure and amyloidogenic properties (Figure 6.19). 
Copper and zinc – two metal ions released during neuronal activity – bind Aβ 
plaques directly [128, 174]. Iron accumulates in the vicinity, in plaque-
associated neuritic processes containing ferritin [175-176]. Overall, in the 
brain regions where amyloid deposition occurs Alzheimer’s and Parkinson’s 
disease (cortex in Alzheimer’s and substantia nigra in Parkinson’s, 
respectively) iron and zinc levels are found increased [177-178] while 
 
 
Figure 6.19 – Metal-dependent Aβ1-42 conformational changes. Apo Aβ1-42 is 
predominantly fibrillar. Incubation with iron, copper or zinc produces different types of 
amorphous oligomeric-like structures. Aluminum stabilizes small oligomeric forms, known to 
be the toxic species associated with Alzheimer’s disease. From [23]. 
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copper levels are decreased [179]. Copper-derived oxidative stress 
contributes significantly to disease onset [180]. Iron-related reactive oxygen 
species generation has been reported in vitro [181]. This may involve 
modifications of Aβ itself at methionine [182], histidine [183], glutamate 
[184] and tyrosine [185] residues. In the case of tyrosines, a frequent 
modification involves the formation of protease-resistant dityrosine cross-
links, which favor further oligomerization [186]. Zinc binding inhibits redox 
reactions but induces Aβ aggregation [14]. 
The zinc-associated Aβ aggregates are especially relevant in the 
physiological context of Aβ deposition. Glutamatergic synapses – one of the 
sites of Aβ accumulation – release up to micromolar zinc transients 
(millisecond timescale) in response to upstream neurotransmission-
associated stimuli, the so-called “zinc bursts”. In vitro, these concentrations 
conditions induce fast Aβ aggregation in the form of prefibrillar oligomers – 
the putative toxic species in Alzheimer’s disease – precluding proper fibril 
formation (Figure 6.20). Accordingly, it has been proposed that zinc 
homeostasis imbalancement contributes to disease onset by triggering an 
“amyloid cascade” of perpetuating self-seeding toxic oligomers [135]. Disease 
progression correlates with an increase in overall zinc levels which suggests 
enhanced metal-induced amyloid formation [178]. 
The chemical biology of glutamatergic synapse features the simultaneous 
availability of free zinc and copper, a unique coincidence at least in humans 
[179] which may explain the initial aggregation of Aβ at this site in 
Alzheimer’s disease (Figure 6.21). The zinc in the cytoplasm of glutamatergic 
neurons is pumped by the ZnT3 zinc transporter to intracellular vesicles 
which also store glutamate. Upon stimulation, the secretory vesicles fuse 
with the pre-synaptic membrane and release its content into the synaptic 
space [187]. Zinc seems to prevent excess stimulation by glutamate by 
inhibiting the post-synaptic glutamate NMDA receptor (NMDAR). NMDAR 
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Figure 6.20 - Zn2+-induced fast Aβ oligomerization. (A) Aβ aggregation kinetics as 
determined by stopped-flow light scattering measurements in the presence of different Zn2+ 
concentrations. Even sub maximal zinc bursts (which reach hundreds µM in vivo) promote fast 
Aβ aggregation. 25 µM Aβ. (B) Aβ aggregate morphology time course from transmission 
electron microscopy imaging. The fast Zn2+-induced aggregation is associated to oligomeric 
structure assembly, dissimilarly from the fibrils forming with apo Aβ. From [135]. 
activation triggers post-synaptic copper secretion involving the Menkes 
ATPase [188]. In the synapse, copper can function as an electron acceptor 
promoting the reaction of nitric oxide with thiols, thus controlling NMDAR 
nitrosylation, a mechanism modulating NMDAR function [188]. 
Metallothionein-3 (MT3) released by astrocytes removes the metals from the 
synapse [189]. 
Metal ions like zinc copper and iron fulfill neurotransmission roles in 
neurobiological processes. In addition, neurodegenerative diseases like 
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Alzheimer’s and Parkinson’s are characterized by perturbations in metal 
homeostasis: iron levels are increased and copper and zinc are sequestered 
in amyloid deposits. The copper and zinc flux in the glutamatergic in the 
cortex and hippocampus is especially relevant because this is the site of long-
term potentiation – the physiological basis of memory – and also the first 
amyloid deposition site in Alzheimer’s disease. In neurotransmission events, 
free ionic or weakly protein bound (thus exchangeable) zinc and copper are 
released into the synaptic cleft. Labile intracellular iron modulates the 
expression of amyloid precursor protein [190]. In mouse models of ALS, 
knock-out of the metallochaperone donating copper to SOD1, CCS, has no 
effect on pathology. However, overexpression accelerates disease 
progression, pointing to a complex relationship of copper with the disease 
[191]. 
Metal mis-homeostasis has been suggested to trigger amyloid formation, 
as assessed by the significant reduction in amyloid plaques in mice deficient 
for zinc transporter ZnT3 [192]. Metal homeostatic mechanisms are affected 
by age. In animals, copper levels decrease from middle age onwards, affecting 
 
Figure 6.21 - Zinc, copper and Aβ in the glutamatergic synapse. From [179]. 
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metal incorporation in copper-dependent proteins like cytochrome c oxidase, 
superoxide dismutase 1 – an important oxidative defense protein – and 
ceruloplasmin. Similarly, all animal species show increased iron levels in 
older ages, which affect proteins like ferritin and frataxin, whose 
misregulation is associated with neurodegeneration [179]. 
Although Aβ does not bind calcium, calcium-associated toxicity is one of 
the characteristics of Alzheimer’s disease (Figure 6.22). Calcium homeostasis 
is essential for several signaling processes which are disrupted by Aβ. Aβ 
modulates the conductance of several membrane calcium channels [157, 
193] including voltage-gated calcium channels, nicotinic acetylcholine 
channels and glutamate, dopamine, serotonin and intracellular inositol 
trisphosphate receptors through mechanisms mostly unknown. The calcium 
signaling perturbation induces excitotoxicity, neurotransmission 
perturbation, downstream signaling inhibition or aberrant stimulation. Aβ 
can also interact with membranes, partially disrupting their integrity and 
permeabilizing them to small molecules [194] or by forming integral 
membrane pores [195]. Sub-physiological calcium concentrations can favor 
 
Figure 6.22 - Association of Aβ aggregation and calcium-associated cellular toxicity. 
From [157]. 
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further Aβ generation [157] or bind Aβ and induce oligomerization and 
fibrillization processes [196-197]. 
6.4.2. Metal ions and Parkinson’s disease 
Parkinson’s disease is characterized by the loss of dopaminergic neurons 
in the substantia nigra of the brain where intracellular amyloid deposits 
named Lewy bodies composed mainly of α-synuclein form in the surviving 
neurons. α-synuclein is a natively unstructured protein [198-200] involved 
in presynaptic vesicle homeostasis which can bind di- and trivalent metal 
ions. The affinity for Cu2+ and Fe3+ binding is relatively high. Protein function, 
including membrane association and interaction with cytoskeletal proteins is 
regulated by Ca2+ [201-202]. Most data on the roles of metal ions in α-
synuclein amyloid formation come from in vitro experiments rather than 
from direct examination of living specimens. Although the mechanisms 
underlying α-synuclein fibrillization in vivo are not known, high temperature 
[203], low pH [203], polyamines [204] and metal ions can induce amyloid 
formation in vitro. Like in Alzheimer’s, Parkinson’s disease is characterized 
by altered metal homeostasis. The substantia nigra has increased iron and 
zinc levels and decreased copper levels [205-206]. Specifically in Lewy 
bodies, iron and aluminum are accumulated [207]. Iron accumulation 
perturbs its homeostatic mechanisms [208] and has been related to oxidative 
stress-related neurodegenerative damage in the disease [209], which is 
additionally relevant because of the decreased concentration of oxidative 
defense systems such as glutathione [206], as well as increased toxicity of α-
synuclein amyloid oligomers [210]. 
Cu2+ and, to a less extent, Al3+ induce α-synuclein aggregation [211]. α-
synuclein fibrillization is significantly accelerated in the presence of metal 
ions, namely Al3+, Fe3+, Cu2+. Non-physiological metal ions like Co2+ and Cd2+ 
also have the same effect. To a small extent even Mn2+ also accelerates 
fibrillization and induces di-tyrosine cross-linking, pointing to a the capacity 
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of promoting oxidative modifications [139]. These effects should be based on 
the capacity of metal ions induce partial folding of natively unfolded α-
synuclein [139]. However, Al3+ but not Zn2+ and Cu2+ induce a fibrillar 
structure distinct from the one of apo α-synuclein with higher β-sheet 
content and which does not favor iron Fenton reactivity [212]. The interest 
in assessing the effects of aluminum comes from the correlation of 
environmental exposure to aluminum and the accumulation of iron as well as 
aluminum in Lewy bodies [207]. The Al3+-bound α-synuclein acquires a 
protease resistant conformation [213]. Upon fibrillization, aluminum is 
entrapped in a-synuclein amyloid fibrils [139]. Magnesium has a dual effect 
in α-synuclein fibrillization. Millimolar concentrations promptly trigger 
amyloid formation [214]. However, lower concentrations inhibit fibril 
formation, suggesting a conformational stabilizer role [215]. 
Despite the similar amyloid favoring properties, metal ions bind at 
distinct sites of α-synuclein. The C-terminus is the most common metal 
binding region because of the local residual structure. The site involving 
Asp119, Asp121, Glu126 and possibly phospho-Tyr125 binds Fe2+, Mn2+, Co2+ 
and Ni2+ with submillimolar affinity [216]. Copper binds at the N-terminus 
(Kd ~0.1 µM) [217] involving two binding site [218]. Methionine oxidation 
inhibits α-synuclein fibrillization, an effect which can be reverted by zinc 
binding [140]. 
Like Aβ, α-synuclein fibrillization pathways include a wide variety of 
oligomer structures [219-220], some of the molten globule type [203]. Metal 
ions induce distinct oligomeric structures [221]: Cu2+, Fe3+ and Ni2+ yield apo-
like 0.8-4 nm spherical oligomers; Mg2+, Cd2+ and Zn2+ yield larger 5-8 nm 
spherical structures; Co2+ yields 22-30 nm wide annular oligomers; Ca2+ 
yields larger 70-90 nm wide annular oligomers. All oligomer types are toxic 
[220]. The toxicity of annular oligomers is derived, at least in part, to pore 
formation in membranes. Calcium binding occurs in the C-terminus of α-
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synuclein with a Kd around 2-300 µM [202]. Ca2+ binding affects α-synuclein 
interaction with cytoskeletal proteins and favors oligomerization. α-
synuclein deposition affects calcium homeostasis, activating voltage-gated 
calcium channels [222] and calcium-dependent proteases and determining 
mitochondrial dysfunction [223]. Like in Alzheimer’s disease, the altered 
calcium homeostasis sets a feed-forward loop, unbalancing α-synuclein 
metabolism and favoring more aggregation [197]. 
6.4.3. Metal ions and prion diseases 
Prions (proteinaceous infectious particles) are protein infectious agents 
responsible for transmissible spongiform encephelopathies (TSEs), which 
are amyloid neurodegenerative diseases affecting sheep, goats (Scrapie), 
cows (bovine spongiform encephalopathy), humans (Creutzfeldt-Jakob 
disease, Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia) 
and other animals. The cellular prion protein (PrPC) is a normal constituent 
of the brain, being most expressed at synapses [224], where it binds 
membranes through a glycophosphatidylinositol anchor. The native PrPC 
conformation is monomeric, mostly unstructured and protease sensitive. It 
can spontaneously convert to an amyloidogenic – or scrapie [225] – 
conformation (PrPSC) which is β-sheet rich, amyloid-prone, has low solubility 
and is highly protease resistant which initiates the autocatalytic amyloid 
formation process [226]. 
The prion protein has ~210 amino acid residues, its accurate size 
depending on the species. The C-terminus contains two short β-strands and 
three α-helices but the N-terminus is unstructured [227] and includes 
several PHGGSWGN octarepeats which bind copper in a pH dependent 
stoichiometry: two Cu2+ ions at pH 6 and four at pH 7.4. The binding at lower 
pH has a Kd in the low micromolar range. At higher pH the binding 
cooperativity is high and binding of the last two ions has a Kd < 100 nM [228]. 
The dissociation constants approach the cerebrospinal fluid copper 
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concentrations [229] (0.3 to 500 µM) [230] and binding is observed in vivo 
[231]. It induces PrPC endocytosis. The octarepeat region can also 
accommodate Zn2+ in a competitive way. According to the Irving-Williams 
series, copper is the preferred ligand. It can be displaced by Zn2+ at 
nanomolar Cu2+ concentrations and high millimolar Zn2+ concentrations 
[232]. Other metal ligands are Fe2+, Ni2+ and Mn2+ [233-234]. Upon 
conversion to the PrPSC state, the octarepeat undergoes a conformational 
change where it becomes more compact [235]. 
Iron, copper and manganese levels are affected in the brains infected by 
PrPSC and this is associated with prion protein conformational changes or 
increased oxidative stress generation [236-237], which may also perturb 
protein folding (Figure 6.23). Brain copper levels are lower in PrPSC infected 
subjects [238]. Copper binding promptly and reversibly promotes a 
conformational change wherein prion protein becomes detergent insoluble 
and protease resistant without acquiring the scrapie amyloid conformation 
[239] and inhibiting fibrillization [240] and disease progression [241]. 
Copper chelation delays onset of disease [242]. Copper-bound PrPC has 
superoxide dismutase (SOD)-like activity [243-244]. Infection with PrPSC – 
with the concomitant conversion of PrPC – is associated with a decrease in 
superoxide dismutase activity and increased oxidative stress. On the other 
hand, once PrPSC is formed, copper greatly stabilizes it against proteinase K 
digestion [245]. Iron induces the formation of the protease-resistant state 
[246]. Zn2+ critical for PrP 106-126 aggregation and neurotoxicity [142]. 
Manganese is one of the most important modulators of PrPC aggregation 
because it greatly enhances aggregation [238, 247] into the protease-
resistant state [246, 248]. Like in other amyloid diseases, cytotoxicity is 
mostly associated with oligomeric structures [107]. 
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Figure 6.23 – Metal-induced conformational changes in the prion protein. PrPC and PrPSC 
may exist in equilibrium with each other. Most of the time PrPSC is degraded and remains 
undetectable. PrPSC levels can increase due to proteasome activity inhibition by metal ions like 
Mn2+, Cd2+ or Zn2+, by binding of amyloid-favoring Mn2+ to PrPSC or by conformational 
fluctuations of PrPC to β-sheet enriched conformations which can convert to PrPSC. Cu2+ 
binding stabilizes the non amyloidogenic state. Once a PrPSC nucleus is formed, recruitment of 
more prion protein to the amyloid deposits proceeds through conformational templating. 
From [233]. 
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Figure 7.1 – Sequence alignment of human S100 proteins. The sketch depicts the
consensus location of helices (cylinders) and random coil (line). Red letters indicate the
calcium ligands. 
7.1. Family description 
The S100 protein family represents the largest subgroup within the Ca2+-
binding EF-hand superfamily. They are only found in vertebrates. The name 
of the protein family has derived from the fact that the first identified S100 
proteins were obtained from the soluble (S) bovine brain fraction upon 
fractionation with saturated (100%) ammonium sulfate [1]. The genes 
encoding the large majority of human S100 proteins are organized in a gene 
cluster located in chromosomal region 1q21 [2-3]. This region harbors the 
genes of S100A1 to S100A16, which are the result of several gene duplication 
events. The genes of other S100 proteins like S100B, S100P or S100Z are 
located in humans in chromosomes 21, 4 and 5, respectively. 
In humans, 21 different S100 proteins are identified up to date (Figure 
7.1) and similar numbers have been found in other mammalia based on 
genomic analysis. Further diverse branches of S100 proteins were found in 
other vertebrates. The level of sequence identity among the S100 proteins 
within one species varies considerably, e. g. for human proteins the identity 
ranges between 22% and 57%. Noteworthy, many S100 proteins exhibit very 
distinctive expression patterns in different tissues and cell types, as well as 
specific subcellular localization, underlining the high degree of specialization 
among them. Corresponding to their diversity in primary structure and 
localization, the S100 proteins are involved in the regulation of a multitude of 
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cellular processes like cell cycle control, cell growth, differentiation and 
motility. Considering the diverse S100 protein functions, it is no surprise to 
find that these proteins are implicated in numerous human diseases, like 
different types of cancers characterized by altered expression levels of S100 
proteins [4], neurodegenerative disorders such as Alzheimer’s disease [5-6], 
inflammatory and autoimmune diseases [4]. 
The conformational properties and function of S100 proteins are 
modulated by metal ion binding. Most S100 proteins are Ca2+ signal 
transducers. The binding of Ca2+ to EF-hand type domains triggers 
conformational changes allowing interactions with other proteins. The 
exception is S100G, which acts as a Ca2+ buffer, sequestering free Ca2+ in the 
cytoplasm after a concentration raise without significant conformational 
changes [7]. In many S100 proteins, additional binding of Zn2+ fine tunes 
protein folding and function [8-9]. Intracellularly, S100 proteins act as Ca2+ 
sensors, translating intracellular Ca2+ level increase into a cellular response. 
An increasing number of S100 proteins is also reported to occur 
extracellularly binding to the Receptor for Advanced Glycation Endproducts 
(RAGE) [10-13] or Toll-like receptor 4 [14]. Recently, a new property among 
S100 proteins was unveiled: S100A8/A9 proteins can form amyloids in a 
metal ion mediated fibrillization process in the ageing prostate [15]. In the 
following sections these aspects and the possible functional and biological 
implications of physiological amyloid formation by S100 proteins will be 
addressed. 
7.2. Structural properties of S100 proteins 
Most S100 protein family members form homo- and heterodimers, but 
with largely different preferences. Recently, it was shown that some S100 
proteins might exist as monomers at very low concentrations in the cell, 
although the physiological function of the monomers is unclear [16]. It was 
proposed that equilibrium between monomers and homodimers might 
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facilitate the formation of heterodimers in the cell [16-17]. Several 
heterodimeric S100 proteins have been reported, but only the S100A8/A9 
heterodimer is well characterized [14, 18-21]. The list of S100 heterodimers 
is steadily growing: S100B forms heterodimers with S100A1 [22], S100A6 
[23-24] and S100A11 [24]; S100A1 with S100A4 [25] and S100P [26]; and 
S100A7 with S100A10 [27]. Non-covalent multimers were observed for 
S100A12 [28], S100A8/A9 [18, 29], S100B [12], S100A4 [30] and a Zn2+-
dependent tetramer for S100A2 [31]. Comparison of the structure of 
S100A8/A9 with those of the corresponding homodimers revealed that the 
solvent exposed area is reduced in the heterodimer, which might represent 
the driving force of heterodimer formation [18]. It is proposed that 
heterodimer formation apart from homodimeric assembly might lead to 
further diversification of S100 protein functions [17, 32].  
7.2.1. EF-hand Ca2+ binding 
To date there is ample 3D structural information available for individual 
S100 proteins in both the inactive Ca2+-free and active Ca2+-loaded states 
[33]. Despite the variation in amino acid sequence, the 3D structures of S100 
proteins exhibit key structural features common to all members of the family. 
Each S100 monomer is about 10-12 kDa in size and composed of two EF-
hand helix-loop-helix structural motifs, which are arranged in a back-to-back 
manner and connected by a flexible linker. The C-terminal EF-hand contains 
the classical Ca2+-binding motif, common to all EF-hand proteins. The loop 
has a typical sequence signature of 12 amino acids flanked by helices HIII and 
HIV (Figure 7.2B). Ca2+ is coordinated mainly by amino acid side chains. The 
N-terminal EF-hand exhibits a slightly different architecture and contains a 
specific 14 amino acid motif flanked by helices HI and HII (Figure 7.2A) where 
Ca2+ is mainly coordinated by backbone carbonyls (Figure 7.3) [33]. This 
motif is characteristic for S100 proteins and therefore it is often called 
“S100-specific” or “pseudo EF-hand”. In both EF-hands, Ca2+ is 
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heptacoordinated in a pentagonal bipyramidal geometry. In S100 proteins, 
the ligands are denoted by X, Y, Z, −Y and –Z (Figure 7.3) [33-34]. The 
position –X is occupied by a water molecule. The glutamate or aspartate 
residue at position –Z binds Ca2+ in a bidentate manner. It is the displacement 
of this amino acid residue that determines the EF-hand opening and 
Ca2+/Mg2+ selectivity [35]. The S100 protein dimer interface is formed by 
helices HI and HIV from both monomers, building a compact four helix bundle 
as core structure of the S100 protein dimer (Figure 7.2C-D). 
Typically, S100 proteins bind two Ca2+ ions per monomer (Kd = 20-500 
µM) with strong positive cooperativity [33]. In the absence of Ca2+, EF-hands 
 
Figure 7.2 - Structure of S100 Proteins. (A-B) Calcium-driven conformational changes at the 
EF-hands in S100 proteins. Structure of the N-terminal, S100-specific EF-hand (A) and the C-
terminal, canonical EF-hand (B) in the metal-free (lighter) and Ca2+-bound (darker) form of 
S100A6. The EF-hand flanking helices (HI-HIV) are identified. (C-D) Structure of the human 
S100B homodimer loaded with Ca2+ and Zn2+ (Ostendorp, T., Diez, J., Heizmann, C.W., Fritz, G., 
unpublished work, 3D10). (C) Side view; (D) Top view. The monomers are shown in blue and 
green respectively. The N-terminal S100 specific EF-hand (EF-hand 1) is shown in dark color, 
the C-terminal canonical EF-hand in brighter color (EF-hand 2). The hinges connecting both 
EF-hands are shown in magenta and orange. The four bound Ca2+ ions are shown as red 
spheres. The two Zn2+ bound at the dimer interface of S100B are shown as yellow spheres. (E-
G) Multimeric states of S100 proteins. S100B octamer, 2H61 (E), S100A12 hexamer, 1GQM (F) 
and S100A8/A9 tetramer, 1XK4 (G). Each dimer in S100B or S100A12 is shown in individual 
color. S100A8 is shown in red, S100A9 in blue. Bound Ca2+ ions are shown as spheres; 
intersubunit Ca2+ ions are shown as magenta spheres. 
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Figure 7.3 – Ca2+-bound EF-hands in S100A6. (A) N-terminal S100-specific EF-hand (B) C-
terminal canonical EF-hand. Ca2+-coordinating residues are shown as lines and bead. 
Coordination bonds are depicted as dashed lines. From [33]. 
are occupied by water [36-37], Na+ [38] or Mg2+. The much lower Mg2+ 
affinity (Kd = 1-125 mM) [39-40] does not interfere with Ca2+ binding at 
physiological Mg2+ concentrations (0.5 mM) [39, 41-43]. Due to amino acid 
substitutions in the critical Z position, the EF-hands in S100A16 are not able 
to bind Ca2+ [44]. 
7.2.2. Zn2+ binding sites 
Many S100 proteins are reported to bind Zn2+ with high affinity (Kd = 4 nM 
to 2 mM) [9]. The Zn2+-binding S100 proteins can be subdivided into two 
subgroups. One group involves Cys residues in Zn2+ coordination, whereas 
the second group binds Zn2+ exclusively via the side-chains of His, Glu and 
Asp residues. The first group has been characterized so far by spectroscopic 
analysis in combination with molecular modeling, showing e. g. for S100A2 
that Zn2+ is coordinated by residues from different monomers [31]. For the 
second group, encompassing S100A7, S100A8/A9, S100A12 and S100B, 
detailed structural information mainly by X-ray crystallography is available. 
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S100A7, S100A12 and S100B bind two Zn2+ ions per homodimer at the dimer 
interface. The Zn2+ ions are coordinated by residues originating from both 
subunits, thereby additionally stabilizing the dimer [45-47]. 
7.2.3. Cu2+ binding sites 
Some S100 proteins like S100A5 [48], S100A12 [49], S100A13 [50] and 
S100B [51] also bind Cu2+. This happens in the same binding sites as Zn2+ but 
with different affinity (Kd = 0.46 – 55 µM) [48, 51-52]. 
7.3. Metal ions as modulators of S100 conformation and stability 
The metal binding properties of S100 proteins have a pivotal influence as 
modulators of their conformation, folding, oligomerization state and 
ultimately, function. As outlined above, S100 proteins are able to bind 
different metal ions, among Ca2+, Zn2+ and Cu2+. Generally, the dimeric S100 
proteins bind four Ca2+ ions per dimer with micromolar to hundreds 
micromolar binding constants and strong cooperativity. In the Ca2+-free state 
the helices of both EF-hands in each monomer adopt an antiparallel 
conformation masking the target protein interaction site. Upon Ca2+ binding, 
the C-terminus undergoes a major conformational change involving motions 
of the two helices which flank the Ca2+ binding residues (Figure 7.2B). Helix 
HIII of the canonical EF-hand makes a 90° movement, opening the structure, 
whereas the N-terminal EF-hand exhibits only minor structural changes 
(Figure 7.2A-B). This Ca2+-induced structural change leads to the exposure of 
a wide hydrophobic cleft which mediates target recognition. This surface is 
formed by residues of the hinge region, helix HIII, and the C-terminus, the 
regions exhibiting the largest variation in amino acid sequence throughout 
the S100 family. The dimer interface is built by residues of helices HI and HIV 
and is well conserved across the different S100 proteins. Also, these helices 
barely move during Ca2+ binding, maintaining the dimeric state of the S100 
proteins during signaling. The invariability of the residues and the conserved 
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spatial arrangement of the helices at the dimer interface are the basis for the 
formation of the different observed heterodimers.  
Structural studies on apo S100A2 have shown that in the absence of Ca2+, 
a Na+ ion resides in the N-terminal S100-specific EF-hand [38]. In contrast to 
the classical EF-hand that coordinates Ca2+ through four acidic side chains 
originating from Asn, Asp or Glu residues, the N-terminal EF-hand provides 
only one strictly conserved Glu side chain for Ca2+ coordination. Therefore, 
the Na+ ion can compensate partially for the negative charge in the Ca2+-free 
state. Ca2+ binding to the N-terminal EF-hand causes a movement of this Glu 
residue towards the bound ion, pulling helix HII slightly towards the Ca2+ site. 
Similar to many other EF-hand proteins, S100 proteins bind also Mg2+ ions 
into their EF-hand sites but the reported affinities for Mg2+ ions are rather 
low having only a minor effect on Ca2+ binding. 
Next to Ca2+, many S100 proteins (S100B, S100A2, S100A3, S100A6, 
S100A7, S100A8/9, S100A12) bind Zn2+ in specific sites, whose metallation 
state also influences protein conformation, folding and presumably function. 
Binding of Zn2+ occurs invariably at interfaces, involving coordinating 
residues from different subunits that are close to the dimer interface. One of 
these proteins is S100A7, that is upregulated in the keratinocytes of patients 
suffering from the chronic skin disease psoriasis, and that has been 
hypothesized to account for the microbial resistance of skin [53]. The 
structure of this protein has elicited two identical high affinity Zn2+ binding 
sites formed by His/Asp residues from different monomers that “clip” 
together the two subunits. A substantial stabilization of the dimer is expected 
to arise from Zn2+ binding, as it promotes head-to-tail interactions between 
the two monomers, although in this particular case Zn2+ does not seem to be 
essential for protein stability [46]. 
There is evidence for an interesting cross talk between Ca2+ and Zn2+ 
binding to S100 proteins, illustrating how binding of different metal ions 
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results in conformational adjustments and modulation of protein folding and 
function. In S100B and S100A12 Zn2+ binding leads to an increase of the Ca2+ 
affinity [54-55], whereas in S100A2 the opposite effect was observed, i. e. 
Zn2+ decreased Ca2+ affinity pointing to interplay of the metal ions in the 
activation of S100 proteins [31]. For S100A12 and S100B, the molecular 
mechanism of increase of Ca2+ affinity by Zn2+ can be deduced from the 
structural information available (Ostendorp, T., Diez, J., Heizmann, C.W., Fritz, 
G., unpublished work) [45]. In both proteins there is one Zn2+-coordinating 
His residue located in the Ca2+-binding loop, which might help to stabilize the 
Ca2+bound conformation, thereby increasing Ca2+ affinity. The structure of 
S100A12 with only bound Zn2+ shows also that Zn2+ alone already can induce 
structural changes similar to those induced by Ca2+, which will also lead to an 
increase in Ca2+ affinity. Other Zn2+ coordinating residues are located in the 
C-terminus of the S100 proteins. Zn2+ coordination leads to a stabilization 
and extension of the of the C-terminal helix, changing the orientation of 
residues involved in target binding. As expected from these structural 
changes, Zn2+ binding modulates target binding properties of the different 
S100 proteins. e. g., Zn2+ prevents S100A8/A9 binding to arachidonic acid 
[56]. On the other hand, Zn2+ and Ca2+ binding to S100A9 are both required 
for interaction with receptors like RAGE or Toll-like receptor 4 [10, 14]. 
Similarly, Zn2+ increased the Ca2+ dependent interaction of S100A12 with 
RAGE [57]. In the case of S100B, Zn2+ alone already could trigger binding to 
tau [58-59], or IQGAP1 [60]. Moreover, Zn2+ binding enhanced Ca2+ 
dependent interaction with the AHNAK [61] or the target protein derived 
peptide TRTK-12 [62].  
Recent work on the S100A2 protein, a cell cycle regulator which binds and 
activates p53 in a Ca2+ dependent manner, has shown that metal ion binding 
influences the protein conformation and stability [8]. S100A2 binds two Ca2+ 
and two Zn2+ ions per subunit, known to be associated with activation (Ca2+) 
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or inhibition (Zn2+) of downstream signaling. Zn2+ binds at distinct sites 
which have different metal binding affinities, and physiologically relevant 
Zn2+ concentrations decrease the affinity for Ca2+ binding, resulting in a 
blockage of p53 activation. It has been recently elicited that the S100A2 
conformation is sensitive to the metallation state, although rearrangements 
resulting from metal binding preserve the overall fold of the protein: S100A2 
is destabilized by Zn2+ and stabilized by Ca2+, suggesting a synergistic effect 
between binding of the different metals. Thus, the decrease in Ca2+ affinity 
through Zn2+ is presumably a result of the general destabilization of the 
protein. Further contributions might come from the exposure of a 
hydrophobic surface on Zn2+ binding, making additional exposure of the 
hydrophobic surface induced by Ca2+ less favorable. The antagonistic effect of 
Zn2+ and Ca2+ in the control of S100A2 stability provides a molecular 
rationale for the action of both metal ions: hypothetically, in tissues 
expressing S100A2, the Zn2+ imbalance, which may arise in some types of 
cancers as a result of the upregulation of Zn2+ transporters [63-64], may 
contribute to enhanced cell proliferation through destabilization of S100A2. 
That would impair the interaction with p53 and disrupt subsequent 
downstream cell cycle regulation. This further illustrates how binding of 
different metal ions to S100 proteins has the potential to result in 
conformational adjustments and modulation of protein folding and functions. 
A number of S100 proteins also bind Cu2+ (S100B [51], S100A5 [48], 
S100A12 [49] and S100A13 [50]) and this frequently occurs at the same sites 
to which Zn2+ binds. That is for example the case of S100A12, an important 
protein in the inflammatory response and a factor in host/parasite defenses, 
which binds Cu2+ and Zn2+ at the same site and corresponds to the Zn2+ 
binding site in S100A7, evoking a possible similar structural and functional 
role. S100B, one of the most abundant proteins in the human brain also binds 
Cu2+, and in this case a putative neuroprotective role was suggested. 
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7.4. S100 functional oligomers  
Metal ions play also a crucial role in the formation of larger oligomeric 
species of S100 proteins, namely tetramers, hexamers and octamers. These 
are in many cases essential for biological function and signaling: tetrameric 
S100B [12] and hexameric S100A12 [65] bind RAGE with higher affinity than 
the dimeric counterparts, only multimeric S100A4 promotes neurite 
outgrowth [66], and microtubule formation is only promoted by the Ca2+ 
induced S100A8/A9 tetramer [18]. Ca2+-loaded S100A12 forms a functional 
hexamer whose quaternary structure is maintained by additional interdimer 
bridging Ca2+ ions, which are coordinated by residues from the C-terminal 
EF-hand and helix HIII from two adjacent dimers. This arrangement of ligands 
for the interdimer Ca2+ “crosslinker” is only possible when the C-terminal EF-
hand is in the Ca2+ bound state [49]. Similarly, two S100A8/A9 heterodimers 
can assemble into a heterotetramer in a strictly Ca2+-dependent manner [18]. 
However, the initial S100A8/A9 heterodimer can be formed in the presence 
or absence of Ca2+. By contrast, the formation of S100B tetramers is not 
dependent on Ca2+ and the tetramer remains stable in the absence of the 
metal ion [12]. This difference may result from the additional hydrophobic 
moieties found in interfaces of S100B, which are essentially polar in S100A12 
and S100A8/A9 [12]. Nevertheless, the presence of Ca2+ enhances the 
oligomerization of S100B into hexamers and octamers, and the octameric 
crystal structure reveals intersubunit Ca2+ ions. The oligomerization role is 
not restricted to Ca2+, as in S100A2 binding of Zn2+ to the low affinity site 
triggers formation of a tetramer via the assembly of two S100A2 dimers [31]. 
Altogether these results point to a very clear role of metal ions in the 
formation of functional S100 oligomers. However, novel roles for non-
functional S100 oligomers are emerging with the recent finding of metal-
dependent amyloid formation processes by S100A8/A9, which will be 
addressed further. 
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7.5. Functional diversity of S100 proteins 
To date a great number of distinct functions have been attributed to S100 
proteins in both the intra- and extracellular milieu. Though S100 proteins 
appear to lack enzymatic activity themselves, they play biological roles 
through binding to other proteins and changing the activity of their targets. 
As we discussed above, the conformation and even oligomerization state of 
S100s are responsive to Ca2+ and consequently they mediate Ca2+ signals by 
binding to other intracellular target proteins and modulating their 
conformation and activity in a Ca2+- and possibly also in a Zn2+- and Cu2+-
dependent manner. Indeed, the assembly into multiple complexes is 
considered in general as a significant generic mechanism of protein 
functional diversification via varying their conformational states and 
associated ligands [67]. Several S100 proteins exhibit Ca2+-dependent 
interactions with metabolic enzymes (S100A1 and S100B with aldolase C) 
[68], with kinases (S100B with Ndr or Src kinases) [69-70], with cytoskeletal 
proteins (S100A1 with tubulin, S100B with CapZ and S100P with ezrin) [71-
76] or with DNA binding proteins (S100A2, S100A4 and S100B interact with 
p53) [77-79]. As a result, intracellularly S100 proteins are involved in the 
regulation of cell cycle, cell growth and differentiation, apoptosis, migration, 
calcium homeostasis, protein phosphorylation, cellular motility and other 
important processes. 
Some S100 proteins including S100A4, S100A7, S100A8/A9, S100A11, 
S100A12, S100B and others can be secreted, exhibiting cytokine-like and 
chemotactic activity. When S100A7, S100A8, S100A9, S100A12 or S100B are 
secreted in response to cell damage or activation, they become danger 
signals, activating other immune and endothelial cells. Accordingly, they 
were defined as damage-associated molecular pattern (DAMP) molecules in 
innate immunity [80-81]. The S100A8/A9 complex accounts for up to 40% of 
total cytosolic proteins in neutrophils and secreted S100A8/A9 as well as 
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S100A12 are found at high concentrations in inflamed tissues, producing 
strong pro-inflammatory effects. 
S100B is highly expressed in the human brain and actively secreted by 
astrocytes, neurons, microglia, glioblastoma or Schwann cells [82]. Its 
extracellular concentration reaches micromolar levels after traumatic brain 
injury and in neurodegenerative disorders such as Alzheimer’s disease or 
Down’s syndrome. The action of S100B is strongly dependent on its 
concentration: at nanomolar levels it is neuroprotective, while at the 
micromolar concentration range it promotes apoptosis [83]. Both trophic 
and toxic effects of extracellular S100B are mediated by RAGE, the multi-
ligand Receptor for Advanced Glycation Endproducts [21]. 
A large number of S100 proteins have been shown to interact with RAGE, 
including S100A1, S100A2, S100A4, S100A5, S100A6, 100A7, S100A8/A9, 
S100A11, S100A12 and S100B [20]. For example, S100A8/A9 interacts with 
a subpopulation of RAGE carrying carboxylated glycans and triggers RAGE-
dependent NF-κB activation and cellular proliferation [84]. However the 
interaction with RAGE does not exclude that S100A8/A9 can act via different 
mechanisms. It was reported that S100A8/A9 proteins exert apoptosis-
inducing activity causing cell death via the mitochondrial pathway [85] as 
well as that the S100A8/A9-induced cell death occurs via apoptosis and 
autophagy-like mechanisms including ROS-mediated cross-talk between 
mitochondria and lysosomes: increasing ROS production by mitochondria is 
followed by mitochondrial damage and lysosomal activation [86]. In addition, 
Viemann et al. [87] have reported that S100A8/A9 induce cell death via 
caspase-dependent and caspase-independent programmes which have 
features of both apoptosis and necrosis.  
S100A8 and S100A9 were found to activate also Toll-like receptor 4, 
acting as innate amplifiers of inflammation and cancer [88-89]. Specifically, it 
was suggested that S100A8/A9, Toll-like receptor 4 and SAA3, an important 
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downstream target for S100A8/A9, represent a paracrine positive-feedback 
cascade, which is critical for inducing an inflammatory response in pre-
metastatic tissues and thus, rendering them susceptible for tumor cell 
immigration and metastasis formation [89]. Recently it was demonstrated in 
a mouse model that via activation of Toll-like receptor 4 S100A8 and S100A9 
induce the development of systemic autoimmunity [88]. 
Due to their deregulated expression, response to stress and association 
with neoplastic, degenerative and autoimmune disorders, S100 proteins gain 
significant interest as potential therapeutic targets. In a view of the large 
number of tertiary and quaternary structures adopted by S100s and the 
complex structure-functional relationship affecting their interactions with 
the target proteins, it is tempting to speculate that this variability may 
account for the promiscuity of S100 proteins. Therefore, systematic studies 
of the conformational changes and oligomerization of S100 proteins will be 
of critical importance in the development of potential therapeutics.  
7.6. Amyloid formation by S100A8/A9 proteins 
Recently we have found a new amyloidogenic property of S100A8/A9 
proteins, implicating them in another degenerative process in the ageing 
prostate, specifically, in amyloid formation [15]. The conversion of functional 
proteins and peptides into insoluble amyloid structures and their deposition 
in a variety of tissues and organs is a hallmark of a growing number of age-
related degenerative disorders, including Alzheimer's and Parkinson’s 
diseases, type II diabetes and systemic amyloidoses. Prostate amyloid 
deposits known as corpora amylacea belong to the type of localized 
amyloidoses. They are associated with age-related prostate tissue 
remodeling and occur frequently in middle-aged and elderly men. 
These inclusions can vary in size from sub-millimeter to a few millimeters 
diameter (Figure 7.4A) and can in some instances constitute up to a third of 
the prostate gland bulk weight. Despite of their high prevalence in later life 
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[90], their role in prostate benign and malignant changes is still disputed. 
The fact that pro-inflammatory S100 proteins contribute to corpora amylacea 
formation elevates their role as potential cancer risk factors. There is a 
growing body of evidence indicating that inflammation is a crucial 
prerequisite in prostate pathogenesis, as it is found to be associated with 
40−90% of benign prostatic hyperplasia and with 20% of all human cancers 
[91]. Prostate cancer is the most common non-cutaneous malignant 
neoplasm in men in Western countries, affecting several million men in the 
Western world, and its incidence is rising rapidly with population ageing. 
Therefore, cancer risk assessment is of critical significance in its preventing 
strategies. 
 
Figure 7.4 - Amyloid formation by S100A8/A9 proteins in the ageing prostate. (A) 
Corpora amylacea deposits extracted as result of prostatectomy (ruler is shown in 
centimeters). (B) Co-immunostaining of corpora amylacea with anti-S100A8 (shown in 
purple) and anti-S100A9 antibodies (shown in brown). (C) Immunostaining of corpora 
amylacea by antibodies towards amyloid fibrils (shown in purple). AFM images of (D) ex vivo 
amyloid oligomers; (E) ex vivo amyloid fibrillar network and (F) amyloid fibrils produced in 
vitro at pH 7.4, 37 °C with agitation. The fibril height analysis corresponds to the cross-section 
marked as a red line. Scale bars represent 250 nm. 
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By using mass-spectrometry, gel electrophoresis and Western blot 
analyses, we have found that proinflammatory S100A8/A9 proteins are 
persistently present in all specimens obtained as a result of prostatectomy in 
prostate cancer patients [15]. Immunohistochemical analysis of corpora 
amylacea revealed that they are stained positively with both anti-S100A8 
and anti-S100A9 antibodies (Figure 2B). Positive foci of S100A8 and S100A9, 
including glandular epithelial cells and tissue macrophages, were observed in 
the tissues adjacent to corpora amylacea inclusions, indicating that the latter 
infiltrate inflamed glands and ultimately lead to raising local concentrations 
of S100A8/A9. Proteinaceous compounds constitutes up to 30-40 % of 
corpora amylacea deposits as revealed by X-ray photoelectron spectroscopy 
and FTIR, while the rest corresponds to inorganic components consisting of 
hydroxylapatite (Ca5(PO4)3OH) and whitlockite (Ca2(PO4)3), containing high 
concentration of Zn2+ ions. The calcification of protein deposits leads 
effectively to their further stabilisation in the protease-rich prostate fluid. 
The mineral content of corpora amylacea is rather uniform in all seven 
studied patients, indicating that calcification can be a regulated process. A 
recently reported function of S100A9 is associated with promoting 
calcification [92], suggesting that dystrophic calcification of corpora 
amylacea deposits could be influenced by the activities of S100A8/A9. 
Remarkably, all corpora amylacea specimens were also stained with anti-
amyloid fibril antibodies [93] (Figure 7.4C) and Congo red dye, used as a 
marker for the presence of the amyloid form of proteins, demonstrating that 
the amyloid material constitutes a significant mass of these specimens. 
Indeed, atomic force and transmission electron microscopy analyses 
revealed a variety of highly heterogeneous aggregates in the corpora 
amylacea extracts (Figure 7.4D-E), ranging from oligomeric species to 
extensive networks of mature fibrils, which is typical for the amyloid 
assemblies [94], as well as larger scale supramolecular assemblies, reaching 
Chapter 7 
188 
a few microns in length. Similar amyloid forms of S100A8/A9 were produced 
in vitro, providing further insight into their amyloidogenic properties. The 
S100A8/A9 complexes, extracted from granulocytes and produced 
recombinantly from Escherichia coli, were each incubated under the native 
conditions of pH 7.4 and 37 °C with agitation and at pH 2.0 and 57 °C without 
agitation. Under both conditions the proteins were assembled into 
heterogeneous fibrillar species. At pH 7.4, species resembling ex vivo 
oligomers and short protofilaments were formed after 2 weeks and thick 
bundles of fibrils with heights of 15−20 nm and a few microns in length 
constituted the major population of fibrillar aggregates after 8 weeks of 
incubation (Figure 7.4F). In the S100A8/A9 samples incubated at pH 2.0, 
oligomeric species and protofilaments also emerged in 2 weeks and flexible 
fibrils with height of ca. 4−5 nm and microns in length together with straight 
and rigid fibrillar structures a few hundred nanometers in length after 4 
weeks, all closely resembling the ex vivo species.  
It is important to note that Ca2+ and Zn2+ play a critical role in promoting 
amyloid assembly of S100A8/A9 proteins. As ex vivo corpora amylacea 
deposits are calcified and contain zinc salts, these ions can play a critical role 
in S100A8/A9 amyloid formation in vivo. Indeed, after 2 weeks of incubation 
the S100A8/A9 amyloid protofilaments of ca. 2 nm height were assembled in 
the presence of 10 mM ZnCl2 and in a suspension of Ca3(PO4)2 [15], but not 
when EDTA was added in solution. These species were converted into the 
fibrillar assemblies after 4 weeks of incubation, and again no filamentous 
structures were developed in the presence of EDTA.  
The bundles of amyloid fibrils of S100A8/A9 proteins, formed both in vivo 
and in vitro (Figure 7.4F), are amongst the largest reported amyloid 
supramolecular species. The lateral association and thickening of the fibrils is 
likely to be a contributing factor to their stability in the prostate gland. It has 
been suggested that the various functions of the S100A8/A9 hetero- and 
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homo-oligomers may be regulated by their differential protease sensitivity 
[20]. The hetero-oligomeric complexes of S100A8/A9 are characterized by 
significant stability and protease resistance comparable to that of prions. In 
the protease rich environment of the prostate gland, and especially at sites of 
inflammation, where proteases are present at even higher levels, protease 
resistance of the S100A8/A9 proteins could favour their accumulation and 
conversion into amyloid structures. If so, the amyloid structures formed by 
the S100A8/A9 can be at the extreme end of the scale of resistance to 
proteolysis. 
As prostatic fluid is very rich in protein content, small quantities of other 
proteins were also found in the corpora amylacea inclusions, presumably 
being trapped in the aggregating and growing deposits. Among them, the 
finding of Escherichia coli DNA and Escherichia coli proteins indicates that 
corpora amylacea formation may be associated with bacterial infection, 
causing consequently inflammation in surrounding tissues during the course 
of corpora amylacea establishment and growth. The identification of the 
highly amyloidogenic bacterial co-chaperonin GroES can be related not only 
to the fact that bacterial infection is a contributory factor to inflammation, 
but also suggests the potential role of bacterial infection in the initiating of 
the amyloid depositions via seeding [95]. 
As a result, a self-perpetuating cycle can be triggered in the ageing 
prostate, leading ultimately to amyloid growth. The increasing concentration 
of aggregation-prone proteins in the sites of inflammation would favor their 
amyloid assembly and deposition, as amyloid formation is a concentration-
dependent process. This can be further promoted by the presence of calcium 
and zinc salts abundant in corpora amylacea and S100A8/A9 in turn can 
themselves regulate their own calcification. In the course of corpora 
amylacea growth, neighboring acini are obstructed, exacerbating 
inflammation and enhancing the risk of neoplastic transformation. Thus, the 
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direct involvement of pro-inflammatory S100A8/A9 proteins in corpora 
amylacea biogenesis emphasizes their role in the age-dependent prostate 
remodeling and accompanied ailments. 
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8.1. Summary 
The EF-hand protein S100A2 is a cell cycle regulator involved in 
tumorigenesis, acting through regulation of the p53 activation state. Metal 
ion free S100A2 is homodimeric and contains two Ca2+ binding sites and two 
Zn2+ binding sites per subunit, whereby the Zn2+ ion binding to one of the 
sites is coordinated by residues from two homodimers. The effect of selective 
binding of these metal ions was investigated using site specific mutants 
which lack one or both zinc sites. Circular dichroism analysis of secondary 
structure changes upon metallation have shown that Zn2+ binding is 
associated with a decrease in the secondary structure content, whereas Ca2+ 
has the opposite effect in two of the three S100A2 mutants studied. The 
energy of unfolding (ΔGU) of the apo wild type S100A2 was determined to be 
89.9 kJ/mol, and the apparent midpoint transition temperature (Tmapp) 
58.4°C. In addition, a detailed study of the urea and thermal unfolding of the 
S100A2 mutants in different metallation states (apo, Zn2+ and Ca2+) has been 
performed. Thermal denaturation experiments showed that Zn2+ acts as a 
destabilizer and Ca2+ as a stabilizer of the protein conformation. This 
suggests a synergistic effect between metal binding, protein stability and 
S100A2 biological activity, according to which Ca2+ activates and stabilizes 
the protein, the opposite being observed upon Zn2+ binding. 
8.2. Introduction 
S100A2 is a member of the S100 protein family, the largest subgroup 
within the superfamily of Ca2+-binding EF-hand proteins. Human S100A2 is a 
22 kDa homodimer, expressed mainly in the kidney, liver, heart and skeletal 
muscle [1]. Notably, the cellular localization of S100A2 is restricted to the 
nucleus [2-3]. S100A2 was found to be a tumor suppressor protein [4], which 
is down-regulated by promoter hypermethylation in breast and prostate 
cancers [5-6]. Its tumor suppressor activity is directly linked to p53, which is 
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Figure 8.1 - S100A2 subunit topology, including
the location of cysteines and other Zn2+-
coordinating residues [8, 12]. Boxes represent α-
helices and arrows represent β-strands. 
activated by binding of S100A2, in a Ca2+-dependent manner [7] (Kd(Ca2+) ~ 
100 μM). Each S100A2 protomer is composed of two tandem Ca2+-binding 
helix-loop-helix EF-hands [8], of which the N-terminal one has a consensus 
sequence that is specific to S100 proteins (Figure 8.1). Like in other cases, 
the binding of Ca2+ to S100 proteins is known to induce structural changes: 
helix III rotates approximately 90º, exposing an inter-helical hydrophobic 
protein interaction site [9-11]. Zn2+ ions bind in two surface sites [12]. Site 1 
has higher affinity and is composed of Cys21 and very likely His17, Gln22 and 
a solvent molecule. Site 2 comprises Cys2 and involves two S100A2 dimers. 
Both Ca2+ and Zn2+ are able to bind simultaneously to S100A2 as two Ca2+ 
binding events are detected when titrating the Zn2+ saturated protein [12]. 
Within the S100 family, Zn2+ has unique roles in S100A2 whose molecular 
basis remains to be established: i. Zn2+ binding is not common to family 
members and S100A2 exhibits the second highest Zn2+ affinity (Kd = 25 nM, 
close to S100A3, with Kd = 4 nM [13]), making S100A2 a more sensitive 
sensor for Zn2+, rather than for Ca2+ ; ii. Zn2+ binding to the low affinity Cys2 
site triggers dimerization of dimers, which is exclusive to S100A2; iii. 
physiologically relevant Zn2+ concentrations decrease the Ca2+ affinity, upon 
binding to the same Cys2 site 
[12]. The latter regulatory 
mechanism suggests that Zn2+-
loaded S100A2 (Kd,1(Ca2+) = 832 
μM Kd,2(Ca2+) = 17 mM [12]) 
cannot activate p53, as 
physiological free Ca2+ 
concentrations do not exceed 
100-300 μM [14-16]. This 
indicates that down-regulation 
of S100A2 takes place also at the 
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post-translational level. 
In order to further explore the interplay between Zn2+ and Ca2+ binding to 
S100A2 and to address how metallation affects the protein conformation and 
stability we have investigated the effects of metal ions on the wild type 
protein and on mutants lacking one or both Zn2+-binding sites. A detailed 
knowledge on how Zn2+ ions modulate the conformation and stability of 
S100A2 by will contribute to a better understanding of the regulation of 
protein function by metal ions, in particular as a putative Zn2+ sensor. 
8.3. Materials and methods 
8.3.1. Proteins 
Wild type human S100A2 and mutants C2S and ΔCys (C2S-C21S-C86S-
C93S) were expressed in E. coli and purified to homogeneity, as described 
elsewhere [12]. 2 mM Tris/HCl pH 7.0 was used throughout. All solutions 
were prepared in Chelex (Sigma, Steinheim, Germany) treated water and 
buffers were oxygen-free. Noteworthy, previous studies have determined 
that the cysteine to serine substitutions do not compromise the overall fold 
[12, 17].  
8.3.2. Preparation of apo and metal loaded mutants 
The proteins containing cysteines were reduced prior to all experiments 
as described elsewhere [12] and quantified spectrophotometrically (ε275, wt = 
3050 M-1.cm-1; ε280, C2S = 3105 M-1.cm-1 and ε280, ΔCys = 2980 M-1.cm-1). Zn2+ was 
added as 1 or 2 molar equivalents to the S100A2 monomer in order to fill 
only the high affinity or both sites. Ca2+ was added as 10 molar equivalents. 
Metal chloride salts were used (Fluka, Steinheim, Germany). For CD and 
fluorescence measurements in the presence of metals, the protein samples 
were equilibrated 1 h at 4°C, after the addition of the metal. 
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8.3.3. Circular dichroism spectroscopy 
CD measurements were recorded in a Jasco J-815 spectropolarimeter 
equipped with a Peltier-controlled thermostated cell support. Thermal 
denaturation experiments were carried out increasing the temperature from 
25 to 95°C at a heating rate of 1°C/min. Changes of the CD signal at 222 nm 
were plotted as a function of temperature and the Tmapp was determined from 
fitting to single or the sum of two sigmoidal curves. Protein concentration 
was 0.1 mg/ml. Thermal denaturation was irreversible. However, no 
kinetically controlled steps affected protein unfolding as the Tmapp was 
independent of the heating rate for S100A2-ΔCys (not shown), like observed 
in a system undergoing reversible unfolding. Therefore, the determined Tmapp 
are those of a pseudo-equilibrium and are suited for comparative purposes 
between the mutants studied. 
The thermal denaturation kinetics (25-65°C temperature jumps) of the 
single Zn2+ site mutant S100A2-C2S was investigated in the apo and Zn2+-
loaded (1:1) state, following the decay of the CD signal at 225 nm. This 
mutant preserves Zn2+ site 1, present in all S100A2 mutants, and does not 
tetramerize because it lacks site 2. Protein concentration was 0.2 mg/ml.  
8.3.4. Fluorescence spectroscopy 
Intrinsic tyrosine fluorescence measurements were performed on a 
Varian Cary Eclipse instrument. Temperature was kept at 25°C by a Peltier-
controlled cell support. Emission spectra upon 275 nm excitation were 
recorded using 10 nm excitation and emission slits. 
8.3.5. ATR FT-IR spectroscopy 
ATR FT-IR measurements were performed in a Bruker IFS 66/S 
spectrometer equipped with a nitrogen-cooled MCT detector using the 
thermostatized Harrick BioATRcell II. Spectra were acquired at a 4 cm-1 
resolution. Difference spectra were calculated after vector normalization of 
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the absorbance in the amide I – amide II region. Different metallated forms of 
S100A2 mutants were prepared by in situ dialysis using the manufacturer’s 
accessory. Apo protein samples (~10 mg/ml) were dialysed at 20°C against 5 
mM Tris/HCl pH 7 23 mM NaCl. 10 molar equivalents of Ca2+ were added in 
the same buffer with NaCl concentration adjusted to equalize the ionic 
strength. 
Thermal denaturation experiments consisted of increasing the cell 
temperature from 20 to 94°C. The heating rate was discontinuous (average 
~1.3°C/min) as a result of stepwise spectrum acquisition (every 2°C, 
acquisition time: 1 min). Denaturation curves were obtained by plotting 
spectra 2nd derivative values at local maxima or minima as a function of 
temperature. 
8.3.6. Chemical denaturation 
Protein unfolding was studied by monitoring the variation of CD at 222 
nm or fluorescence intensity at 305 nm, at 25°C, as a function of urea 
concentration. Fresh urea (Riedel-de Haën, Seelze, Germany) solutions were 
used for every assay and the rigorous concentration was determined using 
refractive index measurements [18]. Apo or metallated protein samples (0.1 
mg/ml) were incubated 2 h at room temperature for complete chemical 
denaturation. The influence of protein concentration on the Cm was assessed 
in the 0.08-0.25 mg/ml range. Denaturation was reversible for all cases as 
urea dilution of the completely denatured protein yielded protein with native 
state spectra. 
8.3.7. Dynamic light scattering 
The molecular diameter of S100A2 mutants in different metallation 
conditions (0.1 mg/ml) was assessed using a Malvern Instruments Zetasizer 
Nano ZS instrument equipped with a 633 nm laser. Temperature was kept at 
25°C using a Peltier-controlled thermostatized cell support. Before each 
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measurement, samples were filtered through a 0.22 μM membrane. For each 
time measurement, the backscattered light (173°) from fourteen 10 s 
accumulations was averaged. Results were analyzed with Malvern 
Instruments DTS software using a multimodal fit with quadratic weighting 
and 0.01 regulariser. Size results are from the Mie theory derived volume 
distribution of sizes. When available, error bars are the standard deviations 
from at least 3 replicate measurements. 
8.4. Results and discussion 
8.4.1. Structural changes upon Ca2+ and Zn2+ binding 
In order to investigate the effect of Ca2+ and Zn2+ ions on the structure of 
S100A2, two previously characterized mutants [12] were studied together 
with the wild type protein. Cysteine residues, which are part of the two 
S100A2 Zn2+ sites (Figure 8.1), have been replaced by serines in mutants C2S 
and ΔCys (all 4 cysteines in each subunit are replaced by serines). Each 
mutant has therefore a different number of available Zn2+ sites: whereas 
S100A2-wt has two sites, S100A2-C2S only preserves one high affinity site 
and S100A2-ΔCys is devoid of specific Zn2+ sites. These mutations do not 
affect the Ca2+ affinity [12], thus allowing analyzing the Zn2+ role upon 
binding to the available sites. 
These S100A2 mutants were investigated in the apo and in holo forms 
corresponding to different metallated states at 25°C using far-UV circular 
dichroism (CD) (Figure 8.2). The CD spectra of all protein preparations are 
typical of α-helix proteins, with local minima at 208 and 222 nm and local 
maxima at 195 and 215 nm, in agreement with the ΔCys-S100A2 crystal 
structure [8] and other structural data [12, 17, 19-21]. This observation also 
corroborates the previous observation that the cysteine replacements do not 
affect the overall protein fold [12]. 
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Figure 8.2 - CD spectra of S100A2 wt (A), C2S (B) and ΔCys (C) in several metal load 
conditions: apo (thick solid line), 1 Eq Zn2+ (dot), 2 Eq Zn2+ (dash), 10 Eq Ca2+ (thin solid line), 
1 Eq Zn2+ plus 10 Eq Ca2+ (dash dot) and 2 Eq Zn2+ plus 10 Eq Ca2+ (dash dot dot). 
Binding of Zn2+ to S100A2-wt and S100A2-ΔCys does not elicit significant 
secondary structure changes (Figure 8.2AC). In the latter case, this is justified 
by the absence of Zn2+ sites, although the far-UV CD spectrum is sensitive to 
unspecific Zn2+ binding to this mutant (data not shown). On the other hand, 
Zn2+ binding to the S100A2-C2S mutant produced a concentration-dependent 
decrease of secondary structure (Figure 8.2B) upon addition of 1 and 2 Zn2+ 
equivalents, respectively. Binding of Ca2+ to S100A2-wt and S100A2-ΔCys 
results in an increase in the α-helical content (Figure 8.2AC). An opposite 
effect is observed in the S100A2-C2S mutant (Figure 8.2B). The highest 
increase in secondary structure occurs when both Ca2+ and Zn2+ are added to 
the wild type protein (Figure 8.2A). 
In order to investigate the possibility that the observed variations in 
secondary structure resulting from metallation with Ca2+ and Zn2+ are due to 
a change in the oligomeric state of the proteins or aggregation, we carried 
out dynamic light scattering (DLS) studies. We have detected average 
molecular diameters around 5-5.5 nm, irrespectively of mutation or metal 
load (Figure 8.3), consistent with the structure of apo S100A2 [8]. The 
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Figure 8.3 - Molecular 
diameter of the apo and 
metallated S100A2 variants as 
assessed by DLS. When 
available, results are average ± 
standard deviation of at least 3 
replicate measurements. Sizes 
are derived from the volume-
averaged distribution of sizes. 
There is no measurement of 
S100A2-ΔCys +2 Eq Zn2+
because the protein aggregates. 
diameter of S100A2-wt +2 Eq Zn2+ is slightly higher (6.4 nm), reflecting 
partial tetramerization. 
8.4.2. Chemical stability of holo and apo S100A2 proteins 
The conformational stability of S100A2-wt and mutants, in the apo and 
distinct metallated states was investigated by performing urea denaturation 
experiments. For all proteins, the far-UV CD spectra obtained at increasing 
urea concentrations denoted a transition from α-helix to random 
conformations, apparently via intermediate β-sheet structures (Figure 8.4A). 
To extract thermodynamic information from protein denaturation curves 
the unfolding mechanism has to be known. For single domain dimeric 
proteins like S100A2, this process may be hypothesized to comprise two 
steps: the dissociation of the native dimer into folded monomers which in 
turn undergoes denaturation. However, the chemical denaturation of S100A2 
could be rationalized using a simple two state unfolding mechanism, where 
the unfolding of the folded dimer (F2) yields denatured monomer (U) 
directly: 
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Figure 8.4 - Circular dichroism-monitored urea chemical denaturation curves of
S100A2. Representative spectra of Ca2+-loaded S100A2-wt at increasing urea concentration
(0 - 7.5 M), as indicated by the arrow (A). Displacement: 0.1 M-1.cm-1. Denaturation curves of
wt (B), C2S (C) and S100A2-ΔCys (D) in several metal load conditions: apo (?), 1 Eq Zn2+ (?)
and 10 Eq Ca2+ (?). 
This mechanism is supported by several criteria: i. No intermediate 
species were detected in none of the denaturation curves (Figure 8.4); ii. The 
Cm of apo wt and S100A2-ΔCys increased with protein concentration (not 
shown), and; iii. Denaturation curves of the latter mutant obtained by CD and 
intrinsic tyrosine fluorescence were superimposable (not shown) [22]. 
Accordingly, the mechanism in equation 1 was used to derive the 
thermodynamic parameters, using the formalism established by Grant et al. 
[23] (Figure 8.4B-D, Table 8.1, Table 8.2). 
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Table 8.1 - Thermodynamic stability parameters for the apo S100A2 variants 
 [Urea]1/2(M) 
ΔGU 
(kJ/mol) 
m  
(kJ.mol-1 M-1)
ΔΔGUa 
(kJ/mol) 
Wt 4.7 89.9 13.0 - 
C2S 4.5 78.9 11.2 -2.3 
ΔCys 4.2 71.8 10.3 -5.8 
aΔΔGU = Δ[Urea]1/2 × maverage [18] 
 
Table 8.2 - Thermodynamic stability parameters for the S100A2 variants in the apo, 
Zn2+ (1:1) and Ca2+ (10:1) metallated states. 
 S100A2-wt S100A2-C2S S100A2- ΔCys 
 [Urea]½ (M) 
ΔGU 
(kJ/mol) 
m  
(kJ.mol-1.M-1)
ΔΔGUa
(kJ/mol)
[Urea]½
(M) 
ΔGU 
(kJ/mol)
m  
(kJ.mol-1.M-1)
ΔΔGUa
(kJ/mol)
[Urea]½ 
(M) 
ΔGU 
(kJ/mol) 
m  
(kJ.mol-1.M-1) 
ΔΔGUa
(kJmol)
Apo 4.7 89.9 13.0 - 4.5 78.9 11.2 - 4.2 71.8 10.3 - 
Zn2+ 2.5 35.1 3.5 -14.2 4.0 50.1 5.3 -3.9 4.1 68.2 9.7 -0.8 
Ca2+ 3.9 40.3 2.9 -5.2 4.8 62.4 7.0 +2.4 4.3 51.8 5.3 +0.8 
aΔΔGU = Δ[Urea]1/2 × maverage [18]   
 
A two state unfolding mechanism has also been reported for human 
S100B [24] and porcine S100A12 [25]. All stability parameters extracted 
from denaturation curves (Figure 8.4B-D, Table 8.1, Table 8.2) were found to 
be within the typical range for small dimeric proteins [26] and, in particular, 
in accordance to thermodynamic data reported on human S100B [24] and 
porcine S100A12 [25]. 
The ΔGU of the apo S100A2-wt was 89.9 kJ/mol and S100A2-C2S and ΔCys 
were destabilized by -2.3 and -5.8 kJ/mol in respect to the wild type (Table 
8.1). The data suggest identical unfolding mechanisms for all three apo 
proteins as neither the transition cooperativity (m index) nor the shape of 
the far-UV CD spectra at different urea concentrations (not shown) were 
significantly affected. Thus, meaningful information on the thermodynamic 
stability of the Ca2+- or Zn2+- loaded mutants can be retrieved from analyzing 
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metallation effects within the background of the same mutation (Table 8.2). 
With the exception of Zn2+-loaded S100A2-ΔCys, which is devoid of Zn2+ sites, 
the metallated states exhibit a decreased cooperativity of the unfolding 
transition. This suggests that in such cases the amount of surface area being 
exposed during urea unfolding is lower than in the apo state and/or that 
metal binding increases the subpopulations of native protein with slightly 
different conformations.  
However, occupation of the metal sites by Zn2+ or Ca2+ ions has a distinct 
effect on the protein stability. Metallation of the high affinity Zn2+ site of 
S100A2-C2S has a destabilizing effect of -3.9 kJ/mol, while the same 
stoichiometric Zn2+ amount destabilizes the wild type protein by -14.2 
kJ/mol. This large destabilization probably arises from residual binding of 
Zn2+ to the low affinity site, which is known to promote exposure of 
hydrophobic surfaces [12]. In contrast, binding of Ca2+ stabilizes the mutants 
by +0.8 or +2.4 kJ/mol, while destabilizing the wild type protein by -5.2 
kJ/mol. Some point mutations are known to exert long range effects in S100 
proteins because of their effect in hydrogen bond networks [27]. It is 
reasonable to hypothesize that the same applies to the S100A2 mutants 
under study. The lower unfolding cooperativity of the Ca2+-loaded samples 
suggests a concurrent opening of the EF-hands, resulting in a decreased 
exposure of the surface area during unfolding.  
8.4.3. Thermal stability of holo and apo S100A2 proteins 
We have complemented the chemical denaturation study by performing 
analogous temperature-induced unfolding assays. For all proteins, increasing 
the temperature results in a progressive α-helix to random coil transition 
(Figure 8.5A). No notorious protein precipitation was observed, suggesting 
that other non-reversible modification may occur at high temperatures. This 
differed from the urea unfolding, precluding a detailed thermodynamic 
analysis, and is suggestive of distinct pathways for chemical and thermal 
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unfolding. Nevertheless, a comparison of the apparent midpoint transition 
temperature (Tmapp) obtained for the different metallated states is very 
informative in respect to the effect of each metal in the stability of each 
protein mutant (Table 8.3). 
Apo S100A2-wt and S100A2-ΔCys have a very similar Tmapp of 58.4°C and 
59.5°C, respectively, which are lower than the Tmapp value of 66.6°C of 
S100A2-C2S. The outlying behavior of apo S100A2-C2S may result from long 
 
Figure 8.5 - Circular dichroism-monitored thermal denaturation of S100A2. Representative 
spectra of apo S100A2-wt at increasing temperatures (25-85°C), as indicated by the arrow (A). 
Displacement: 1.2 M-1.cm-1. The native and denatured form spectra are representative for all 
thermal denaturations. Thermal denaturation curves of wt (B), C2S (C) and S100A2-ΔCys (D) 
in several metal load conditions: apo (?), 1 Eq Zn2+ (+), 2 Eq Zn2+ (×), 10 Eq Ca2+ (?) and 1 Eq 
Zn2+ plus 10 Eq Ca2+ (?). 
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Table 8.3 - Apparent Tm values determined from CD-monitored thermal denaturation curves 
of S100A2 variants. The aggregation of S100A2-ΔCys incubated with 2 Eq Zn2+ occurs during 
the temperature ramp. 
 Tmapp (°C) 
 Apo +Zn
2+  
(1:1) 
+Zn2+ 
(2:1) 
+Ca2+ 
(10:1) 
+Zn2+
+Ca2+ 
(1:10:1)
+Zn2+
+Ca2+ 
(2:10:1)
wt 58.4 56.6 56.6 68.1 65.0 n. d. 
C2S 66.6 53.9 50.6 ~42> 80 n. d. 76.8 
ΔCys 59.5 58.1 Aggregates ~75> 85 
~65
> 81 Aggregates
 
range mutation effects [27], which are not observed in the other mutants. 
Considering these aspects, the relevant comparisons will relate with 
differences observed upon selective metallation, within the same mutant. 
Interestingly, Ca2+ and Zn2+ metallation showed antagonistic effects in 
thermal stability (Figure 8.5B-D). Zn2+ ions had a destabilizing effect, which 
was concentration dependent in S100A2-C2S, in agreement with the 
observed decrease in secondary structure content. The destabilization arose 
from the metal-induced conformational change because no kinetic 
distortions affected the Zn2+-induced conformational destabilization. Binding 
of Zn2+ to the unfolded state could have caused cause a shift in the 
equilibrium, but this effect is only significant at a large excess of Zn2+ [28], 
which is not the case in our experiments (a maximum of 1 or 2 Zn2+ 
equivalents were used). Also, the kinetics of thermal denaturation did not 
vary significantly between apo, and Zn2+-loaded S100A2-C2S (see methods). 
The Ca2+-loaded proteins exhibit an increased Tmapp, although the mutants 
have at least one unfolding intermediate in the denaturation curves. The 
increased stability of Ca2+-loaded proteins likely resides in the electrostatic 
compensation at the negatively charged Ca2+-binding sites. 
The opposite effect of both metals on the thermal stability prompted us to 
study Ca2+ and Zn2+ ions in combination. In S100A2-wt, where all binding 
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sites are available, metal ion effects are dominated by the Ca2+ contribution. 
In fact, an intermediate stability in respect to the Zn2+ destabilization 
(ΔTmapp= -1.8°C) and Ca2+ stabilization (ΔTmapp= +9.7°C) is determined when 
Zn2+ and Ca2+ are combined (ΔTmapp= +6.6°C) (Figure 8.5B). 
It can be hypothesized that the two thermal transitions of Ca2+-loaded 
S100A2-C2S correspond to unfolding of different structural regions, the 
transition at ~ 42°C (Figure 8.5C) corresponding to unfolding at the N-
terminal EF-hand, as it is stabilized by Zn2+ binding at the adjacent site 1 
(Figure 8.1). Such stabilization is not observed in S100A2-ΔCys (Figure 8.5D), 
which has no specific Zn2+ sites. In this case, unspecific Zn2+ binding is likely 
to result in destabilization without changing the shape of the denaturation 
curve. 
Complementarily to the CD experiments, the thermal denaturation of 
S100A2-ΔCys was followed by FT-IR. The absorbance change at the amide I 
(1600-1700 cm-1) and amide II (1500-1600 cm-1) bands was used to probe 
the unfolding, monitoring secondary structure elements. As shown above, 
this mutant does not bind Zn2+, so we have carried out a study of the apo and 
Ca2+-loaded forms of ΔCys-S100A. In both conditions, denaturation consisted 
of transition from α-helical (~1650 and 1550 cm-1) to random (1525 cm-1) 
and β structures (~1622 cm-1) (Figure 8.6AC). The latter vibration is 
associated with intermolecular β-sheets and aggregation. The formation of 
insoluble β-sheet containing aggregates is most certainly an important 
contributor to the irreversibility of the thermal denaturation. The 
denaturation curves of the above-mentioned structural elements are 
compatible with the CD results, and further corroborate a two-state 
unfolding process. All secondary structure elements of apo S100A2-ΔCys 
exhibit similar profiles, with Tmapp ranging from 67-71°C. The unfolding of the 
secondary structure elements of Ca2+-loaded S100A2-ΔCys also occurs 
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Figure 8.6 - ATR FT-IR-monitored thermal denaturation of S100A2-ΔCys in the apo (A,B) and 
Ca2+-loaded forms (C,D). Representative difference spectra at increasing temperature (20-
94°C), as indicated by the arrows (A and C). Thermal denaturation curves for the apo (B) and 
Ca2+-loaded protein (D) are derived from the 2nd derivative trend with temperature. 
simultaneously, and at a Tmapp > 80°C. Again, a very good agreement with the 
far-UV CD data is observed. 
8.5. Conclusions 
In this work we have characterized how the conformation and stability of 
S100A2 is influenced by specific metal ions, Zn2+ and Ca2+. In particular, 
considering the unique role of Zn2+ in S100A2, we have dissected the 
contribution arising from Zn2+ binding using two mutants, which selectively 
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disrupt the low and the high affinity Zn2+-binding sites, as models. We have 
observed that the S100A2 conformation is sensitive to the metallation state, 
although it retains essentially an α-helical structure. Chemical denaturation 
suggests that both Zn2+ and Ca2+-associated conformational changes facilitate 
the accessibility of urea to the protein core, leading to destabilization. 
Thermal denaturation suggest that Zn2+ and Ca2+ regulate protein thermal 
stability antagonistically, being Zn2+ a destabilizer and Ca2+ a stabilizer. 
Similarly, Ca2+ stabilizes and Cu2+ destabilizes S100A13 towards thermal 
perturbation [29]. Other studies highlight distinct regulatory mechanisms of 
S100 proteins by metals ions. For example, Ca2+ was shown to stabilize 
human S100B towards denaturation by guanidinium hydrochloride [23] and 
porcine S100A12 was shown to be stabilized by Ca2+ and Zn2+ towards 
thermal denaturation [25]. The behavior of Zn2+-Ca2+-loaded S100A2 in the 
thermal unfolding experiments indicates that Ca2+ can at least partially revert 
the conformational destabilization triggered by Zn2+ binding to the high 
affinity site. 
These effects of metal ions on S100A2 folding and stability contribute to a 
better understanding to the Ca2+ and Zn2+ dependent regulation of the 
protein. In the Ca2+-loaded state S100A2 binds and activates p53 [7]. 
However, Zn2+ negatively regulates the affinity of S100A2 for Ca2+ binding 
[12], which might disable the Ca2+ signal, resulting in a blockage of p53 
activation. The mechanism of how Zn2+ may decrease the Ca2+ affinity 
remained unresolved in our previous study [12]. The results of the present 
work reveal that the decrease in Ca2+ affinity through Zn2+ is presumably a 
result of the general destabilization of the protein. Further contributions 
might come from the exposure of a hydrophobic surface on Zn2+ binding [12], 
making additional exposure of the hydrophobic surface induced by Ca2+ less 
favourable. 
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Zn2+ binding to close homologues of S100A2, such as S100A3 [13] and 
S100A4 (G. Fritz and M. Koch, unpublished data), also occurs mainly via 
cysteine residues. It remains to be shown whether Zn2+ binding to S100A3 
and S100A4 also results in a decrease in protein stability. In S100A3, Zn2+ 
binding causes the loss of approximately 40% of the a-helical structure [13], 
supporting destabilization of the protein. In contrast with S100A2, other 
S100 proteins, such as S100A12 and S100B, display an increased Ca2+ affinity 
on Zn2+ binding [30-31]. Future investigations might show whether, in these 
S100 proteins, Zn2+ increases the conformational stability, thereby 
facilitating the Ca2+ conformational change. 
Together, the data presented here provide new insights into the 
mechanism of Zn2+- and Ca2+- dependent activation of S100 proteins. The 
antagonistic effect of Zn2+ and Ca2+ in the control of S100A2 stability provides 
a molecular rationale for the action of both metal ions. Our results allow the 
formulation of the following hypothesis: in tissues expressing S100A2, the 
Zn2+ imbalance which arises in some cancers may contribute to enhanced cell 
proliferation through destabilization of S100A2. This mechanism would 
impair the interaction with p53, and disrupt subsequent downstream cell 
cycle regulation. Indeed, Zn2+ transporters are upregulated in breast 
carcinoma and pancreatic tumours [32-33] leading to elevated Zn2+ levels 
[34-36], which may impair Ca2+ binding to S100A2 [12]. Current work in our 
laboratories will allow the testing of this hypothesis. 
8.6. Acknowledgements 
This work was supported by grants POCTI/QUI/45758 and 
PTDC/QUI/70101 (to CMG) from the Fundação para a Ciência e a Tecnologia 
(FCT/MCTES, Portugal), DAAD D/07/13610 PPP (to GF and MK). CMG and 
GF are recipients of a CRUP/DAAD collaborative grant A-15/08. HMB is a 
recipient of a Ph. D. fellowship (SFRH/BD/31126/2006) from Fundação para 
a Ciência e a Tecnologia (FCT/MCTES, Portugal). 
Chapter 8 
214 
8.7. References 
1. Glenney JR, Jr., Kindy MS & Zokas L (1989) Isolation of a new member of the S100 protein family: 
amino acid sequence, tissue, and subcellular distribution. J Cell Biol 108, 569-578 
2. Mueller A, Bachi T, Höchli M, Schäfer BW & Heizmann CW (1999) Subcellular distribution of S100 
proteins in tumor cells and their relocation in response to calcium activation. Histochem Cell Biol 111, 
453-459 
3. Mandinova A, Atar D, Schäfer BW, Spiess M, Aebi U & Heizmann CW (1998) Distinct subcellular 
localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in 
response to rises in intracellular calcium. J Cell Sci 111 ( Pt 14), 2043-2054 
4. Lee SW, Tomasetto C & Sager R (1991) Positive selection of candidate tumor-suppressor genes by 
subtractive hybridization. Proc Natl Acad Sci U S A 88, 2825-2829 
5. Pedrocchi M, Schäfer BW, Mueller H, Eppenberger U & Heizmann CW (1994) Expression of Ca(2+)-
binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. 
Int J Cancer 57, 684-690 
6. Rehman I, Cross SS, Catto JW, Leiblich A, Mukherjee A, Azzouzi AR, Leung HY & Hamdy FC (2005) 
Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate 
cancer. Prostate 65, 322-330 
7. Mueller A, Schäfer BW, Ferrari S, Weibel M, Makek M, Höchli M & Heizmann CW (2005) The calcium-
binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 
280, 29186-29193 
8. Koch M, Diez J & Fritz G (2008) Crystal structure of Ca2+ -free S100A2 at 1.6-Å resolution. J Mol Biol 
378, 931-940 
9. Fritz G & Heizmann CW (2004) 3D structures of the calcium and zinc binding S100 proteins. In 
Handbook of metalloproteins (Messerschmidt A, Huber R, Poulos T & Wieghardt K, eds). John Wiley & 
Sons. 
10. Heizmann CW & Cox JA (1998) New perspectives on S100 proteins: a multi-functional Ca(2+)-, 
Zn(2+)- and Cu(2+)-binding protein family. Biometals 11, 383-397 
11. Lewit-Bentley A & Rety S (2000) EF-hand calcium-binding proteins. Curr Opin Struct Biol 10, 637-643 
12. Koch M, Bhattacharya S, Kehl T, Gimona M, Vasak M, Chazin W, Heizmann CW, Kroneck PM & Fritz G 
(2007) Implications on zinc binding to S100A2. Biochim Biophys Acta 1773, 457-470 
13. Fritz G, Mittl PR, Vasak M, Grutter MG & Heizmann CW (2002) The crystal structure of metal-free 
human EF-hand protein S100A3 at 1.7-A resolution. J Biol Chem 277, 33092-33098 
14. Alonso MT, Villalobos C, Chamero P, Alvarez J & Garcia-Sancho J (2006) Calcium microdomains in 
mitochondria and nucleus. Cell Calcium 40, 513-525 
15. Jones HE, Holland IB, Baker HL & Campbell AK (1999) Slow changes in cytosolic free Ca2+ in 
Escherichia coli highlight two putative influx mechanisms in response to changes in extracellular 
calcium. Cell Calcium 25, 265-274 
16. Knight MR, Campbell AK, Smith SM & Trewavas AJ (1991) Recombinant aequorin as a probe for 
cytosolic free Ca2+ in Escherichia coli. FEBS Lett 282, 405-408 
17. Koch M, Diez J & Fritz G (2006) Purification and crystallization of the human EF-hand tumour 
suppressor protein S100A2. Acta Crystallogr Sect F Struct Biol Cryst Commun 62, 1120-1123 
18. Pace CN, Shirley BA & Thomson JA (1990) Measuring the conformational stability of a protein. In 
Protein structure - a practical approach (Creighton TE, ed, pp. 311-330. IRL Press, Oxford. 
19. Franz C, Durussel I, Cox JA, Schafer BW & Heizmann CW (1998) Binding of Ca2+ and Zn2+ to human 
nuclear S100A2 and mutant proteins. J Biol Chem 273, 18826-18834 
20. Randazzo A, Acklin C, Schäfer BW, Heizmann CW & Chazin WJ (2001) Structural insight into human 
Zn(2+)-bound S100A2 from NMR and homology modeling. Biochem Biophys Res Commun 288, 462-
467 
21. Stradal TB, Troxler H, Heizmann CW & Gimona M (2000) Mapping the zinc ligands of S100A2 by site-
directed mutagenesis. J Biol Chem 275, 13219-13227 
22. Bosshard H, R., (2005) Concurrent Association and Folding of Small Oligomeric Proteins. In Protein 
Folding Handbook (Buchner J & Kiefhaber T, eds), pp. 965-997. Wiley-VCH Verlag GmbH, Weinheim. 
23. Grant SK, Deckman IC, Culp JS, Minnich MD, Brooks IS, Hensley P, Debouck C & Meek TD (1992) Use 
of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV 
proteases. Biochemistry 31, 9491-9501 
Conformation and stability of S100A2 
215 
24. Ferguson PL & Shaw GS (2002) Role of the N-terminal helix I for dimerization and stability of the 
calcium-binding protein S100B. Biochemistry 41, 3637-3646 
25. Garcia AF, Garcia W, Nonato MC & Araujo AP (2008) Structural stability and reversible unfolding of 
recombinant porcine S100A12. Biophys Chem 134, 246-253 
26. Mei G, Di Venere A, Rosato N & Finazzi-Agro A (2005) The importance of being dimeric. Febs J 272, 
16-27 
27. Nelson MR, Thulin E, Fagan PA, Forsen S & Chazin WJ (2002) The EF-hand domain: a globally 
cooperative structural unit. Protein Sci 11, 198-205 
28. Conejero-Lara F, Mateo PL, Aviles FX & Sanchez-Ruiz JM (1991) Effect of Zn2+ on the thermal 
denaturation of carboxypeptidase B. Biochemistry 30, 2067-2072 
29. Sivaraja V, Kumar TK, Rajalingam D, Graziani I, Prudovsky I & Yu C (2006) Copper binding affinity of 
S100A13, a key component of the FGF-1 nonclassical copper-dependent release complex. Biophys J 
91, 1832-1843 
30. Baudier J, Glasser N & Gerard D (1986) Ions binding to S100 proteins. I. Calcium- and zinc-binding 
properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ 
regulates Ca2+ binding on S100b protein. J Biol Chem 261, 8192-8203 
31. Dell'Angelica EC, Schleicher CH & Santome JA (1994) Primary structure and binding properties of 
calgranulin C, a novel S100-like calcium-binding protein from pig granulocytes. J Biol Chem 269, 
28929-28936 
32. Li M, Zhang Y, Liu Z, Bharadwaj U, Wang H, Wang X, Zhang S, Liuzzi JP, Chang SM, Cousins RJ, et al. 
(2007) Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human 
pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A 104, 18636-18641 
33. Taylor KM, Morgan HE, Smart K, Zahari NM, Pumford S, Ellis IO, Robertson JF & Nicholson RI (2007) 
The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Mol Med 13, 396-406 
34. Cui Y, Vogt S, Olson N, Glass AG & Rohan TE (2007) Levels of zinc, selenium, calcium, and iron in 
benign breast tissue and risk of subsequent breast cancer. Cancer Epidemiol Biomarkers Prev 16, 
1682-1685 
35. Geraki K, Farquharson MJ & Bradley DA (2002) Concentrations of Fe, Cu and Zn in breast tissue: a 
synchrotron XRF study. Phys Med Biol 47, 2327-2339 
36. Ionescu JG, Novotny J, Stejskal V, Latsch A, Blaurock-Busch E & Eisenmann-Klein M (2006) Increased 
levels of transition metals in breast cancer tissue. Neuro Endocrinol Lett 27 Suppl 1, 36-39 
 
  
Chapter 8 
216 
 
 
 217 
9. S100: A family of proteins with new amyloid-forming 
properties with potential implications in human disease 
 
9.1. Summary ...................................................................................................................... 219 
9.2. Introduction ............................................................................................................... 219 
9.3. Materials and methods .......................................................................................... 222 
9.3.1. Chemicals and proteins ................................................................................ 222 
9.3.2. Amyloid propensity assessment ............................................................... 222 
9.3.3. Amyloid formation assays ........................................................................... 222 
9.3.4. Thioflavin T fluorescence ............................................................................ 223 
9.3.5. Circular dichroism spectroscopy ............................................................. 223 
9.3.6. Atomic force microscopy ............................................................................. 224 
9.3.7. Dynamic light scattering .............................................................................. 224 
9.3.8. ATR FT-IR spectroscopy .............................................................................. 224 
9.4. Results .......................................................................................................................... 225 
9.4.1. Amyloidogenic potential of S100 proteins ........................................... 225 
9.4.2. S100 proteins form amyloid-like species in vitro ............................. 227 
9.4.3. Morphology of S100 amyloids ................................................................... 229 
9.4.4. Structural characterization of S100B amyloidogenesis .................. 230 
9.4.5. Folding and stability of S100A6 ................................................................ 233 
9.5. Discussion ................................................................................................................... 235 
9.6. Conclusions ................................................................................................................. 238 
9.7. References ................................................................................................................... 239 
 
 
Chapter 9 
218 
Part of this chapter was published in 
Fritz G, Botelho HM, Morozova-Roche LA, Gomes CM (2010) Natural and 
amyloid self-assembly of S100 proteins: structural basis of functional 
diversity. FEBS J, 277(22) 4578-4590 
 
Proteins were purified by Günter Fritz (Freiburg University, DE). AFM 
analysis was performed by Kiran Yanamandra and Ludmilla A. Morozova-
Roche (Umeå University, SE) 
Amyloidogenesis in the S100 family 
219 
9.1. Summary 
S100 proteins constitute a protein family with structurally homologous 
elements exhibiting a high degree of conformational plasticity. They are 
signaling proteins coupling calcium binding to conformational changes and 
interaction with other proteins, sometimes requiring functional 
oligomerization. In this respect, the recently identified amyloid forming 
properties of S100A8/A9 raised the possibility of a new level of 
conformational regulation in these proteins. We have assessed the 
amyloidogenic potential of selected human S100 proteins using thioflavin T 
fluorescence enhancement and FT-IR spectroscopy and found that apo 
S100A2, S100A3, S100A4, S100A6 and S100B promptly form amyloid 
structures under acidic conditions. Atomic force microscopy imaging has 
revealed distinct amyloid structures for each protein: oligomeric (S100A6, 
S100B), protofibrilllar (S100A2) and fibrillar (S100A3). S100A12, which did 
not form ThT-reactive species, nevertheless formed aggregates. Here, we 
dissect the amyloidogenic processes of S100A6 and S100B using FT-IR, 
thioflavin T fluorescence and circular dichroism. These results are framed in 
respect to the phylogeny of S100 proteins and in the computed 
amyloidogenic potential. We propose that members of the S100 family are 
intrinsically amyloidogenic, a phenomenon with possible implications in 
human pathology. 
9.2. Introduction 
The S100 protein family is a remarkable example of conformational 
plasticity, wherein the binding of metal ions, most frequently calcium, 
triggers conformational transitions rendering the protein capable of binding 
other signaling polypeptides and fulfill distinct functions depending of the 
partner. Subtler effects occur when metal binding at specific sites influences 
binding properties elsewhere (e. g. positive calcium binding cooperativity or 
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the influence of zinc on calcium binding affinity). Within specific S100 
proteins, dimerization may be promiscuous, with S100A1, S100A4, S100A6, 
S100A7, S100A8, S100A9, S100A10, S100A11, S100B and S100P 
accommodating heterodimerization partners. Moreover, the dimeric S100 
building block may also form higher order assemblies, namely tetramers, 
hexamers and octamers. Recently, novel conformational properties of S100 
proteins were uncovered as S100A8/A9 were implicated in amyloidogenic 
processes in the prostate [1]. Calcium and zinc-rich amyloid deposits named 
corpora amylacea were shown to be mainly composed of S100A8 and 
S100A9 in the amyloid form. The co-deposition of bacterial proteins and 
macrophage recruitment suggested that S100 amyloidogenesis could be 
associated with inflammatory processes, associated with prostate cancer 
onset. The importance of metal ions in the amyloidogenic conversion was 
established as pathological-like protein fibrils could be assembled in vitro in 
the obligatory presence of calcium or zinc. Importantly, corpora amylacea 
exist in the normal brain and are mainly composed of S100 proteins, raising 
the possibility of S100 fibrillization being a general process with possible 
implication in other pathologies. 
The S100 protein family is composed of more than 20 members in 
humans. Despite remarkable sequence and structural similarities [2], S100 
proteins exhibit a high degree of functional specialization, including specific 
cell and tissue expression patterns. Due to their altered expression level 
changes, they are frequently used as clinical markers for cancer, although 
mis-regulation is also common in cardiomyopathy, inflammation and 
neurodegeneration [3]. In accordance, if the amyloidogenic properties of 
S100A8/A9 were shared by other family members, there would be putative 
implications in these diseases. 
Fibrillization in amyloid structures has been suggested to be a general 
feature of all proteins [4]. The distinct amyloid-permissive conditions for 
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each protein are then responsible for the different amyloid propensities 
among different proteins. Structural studies have revealed a staggering 
similarity of fibrils built by different proteins at the microscopic as well as at 
the molecular level. These observations have allowed understanding the 
ubiquitous fibrillization accessibility as the outcome of being the backbone 
and not the amino acid side chains the responsible for the interactions 
polymerizing individual polypeptides in the fibril. Nevertheless, like all 
biophysical properties of proteins, the amyloidogenic propensity depends on 
the overall protein chemistry, set up by its sequence. No single 
physicochemical property can account for the amyloidogenic propensity of a 
protein [5]. Currently, the best assessments of amyloidogenic potential are 
based either on the physicochemical amino acid properties (e. g. TANGO [6]), 
the combination of amyloid-prone pattern recognition with physicochemical 
properties and homology modeling (e. g. WALTZ) or the correlation of 
aggregation rate changes upon mutation and polypeptide physicochemical 
properties (e. g. Zyggregator [7]). For the characterization of amyloid 
processes, numerous biochemical, biophysical and spectroscopic 
methodologies can be used to probe the varying properties of proteins 
during the amyloid assembly process. 
Based on published data on the biology of S100 proteins and the recently 
described amyloidogenic properties of S100A8/A9 we have analyzed the 
amyloid formation propensity of the human S100 proteins, finding 
widespread amyloid-prone regions in several family members. From this 
initial result, we have screened several S100 family members with distinct 
biochemical and functional properties for their amyloidogenic potential at 
acidic pH. We have observed that several S100 proteins promptly form 
amyloid structures with very distinct morphologies. We report a structural 
characterization of the tested S100 amyloids. We discuss the putative 
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widespread amyloidogenic nature of the S100 family and its implications in 
disease. 
9.3. Materials and methods 
9.3.1. Chemicals and proteins 
All reagents were of the highest grade commercially available. Thioflavin 
T was obtained from Sigma. Trace metals were removed from all solutions by 
solution treatment with a chelex resin. S100 proteins (S100A2, S100A3, 
S100A4, S100A6, S100A12 and S100B) were expressed in E. coli and purified 
to homogeneity as described previously [8]. Molar protein concentrations 
refer to the S100 subunit. Hen egg white lysozyme was obtained from Fluka. 
9.3.2. Amyloid propensity assessment 
Amyloid formation propensities of human S100 proteins at pH 7 were 
assessed using the Zyggregator (http://www-
vendruscolo.ch.cam.ac.uk/zyggregator_test.php) [7, 9] and Waltz 
(http://waltz.vub.ac.be/) online servers. In Zyggregator, both the intrinsic 
amyloid aggregation propensity (Zagg) and the oligomerization tendency 
(Ztox) were retrieved. In Waltz, best overall performance settings were 
selected. For data comparing, S100 sequences were aligned in ClustalX [10] 
and GeneDoc [11]. 
9.3.3. Amyloid formation assays 
S100 proteins were placed in 50 mM Glycine buffer pH 2.5 by repeated 
dilution and re-concentration. Sample temperature was kept at 4°C at all 
times before amyloid formation assays. Protein concentration was set at 3 
mg/ml using Bradford’s method [12]. Due to spontaneous and extensive 
aggregation in aerobic conditions, S100A3 (4 mg/ml) was previously 
reduced with 25 mM TCEP overnight. Any pre-existing aggregates were 
pelleted and removed by centrifuging at 12000 g for 10 minutes. Amyloid 
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formation was promoted by quiescent incubation at 57°C. The positive 
control for amyloid formation was hen egg white lysozyme, at 10 mg/ml in 
the same buffer and incubated at 57°C, a previously validated assay [13]. The 
structural characterization of S100B amyloid formation was carried out at 
10mg/ml protein concentration.  
9.3.4. Thioflavin T fluorescence 
ThT binding assays were performed according to [13]. Briefly, 5 µl of 
protein sample were mixed with 65 µM ThT in 10 mM potassium phosphate 
(KPi), 150 mM NaCl, pH 7.0 at room temperature to a final volume of 1 ml. 
Samples were incubated under stirring for 2 min and ThT fluorescence at 
482 nm was recorded with a Cary Varian Eclipse instrument with 
temperature set at 25°C using a peltier-thermostated cell support. Excitation 
wavelength was 440 nm, PMT voltage 600 V, and excitation and emission 
slits 10 nm.  
9.3.5. Circular dichroism spectroscopy 
The folding and stability of S100A6 (0.1 mg/ml) at pH 7 (50 mM KPi) and 
pH 2.5 (50 mM glycine) were compared through far UV CD spectroscopy. 
Measurements were recorded in a Jasco J-815 spectropolarimeter equipped 
with a Peltier-controlled thermostated cell support. Thermal denaturation 
experiments were carried out increasing the temperature from 20 to 95°C at 
a heating rate of 1°C/min. The normalized Changes of the CD signal at 222 
nm was plotted as a function of temperature and the Tmapp was determined 
from a sigmoidal fit. Denaturation was irreversible. Spectra in the 180-260 
nm wavelength range were acquired at 25°C before and after heating, as well 
as at 95°C. Spectra were deconvoluted with CDNN. 
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9.3.6. Atomic force microscopy 
After reaching the plateau phase in amyloid formation kinetics, S100 
samples were stored at 4°C and morphology was analyzed by AFM on a PICO 
PLUS 5500 microscope (Agilent) as previously described [14]. 
9.3.7. Dynamic light scattering 
For monitoring molecular size variations during amyloid formation at 
57°C, S100 proteins (3 mg/ml in 50 mM glycine pH 2.5) were filtered 
through a 0.22 μM membrane and analyzed with a Malvern Instruments 
Zetasizer Nano ZS instrument equipped with a 633 nm laser. Temperature 
was kept using a Peltier-controlled thermostatized cell support. Kinetic data 
was obtained from continuously repeated measurements. In each 
measurement, the backscattered light (173°) from fifteen 10 s accumulations 
was averaged. Amyloid formation was assessed from light scattering 
intensity and the average particle size obtained from the intensity 
distribution. Results were analyzed with Malvern Instruments DTS software 
using a multimodal fit with quadratic weighting and 0.01 regulariser. 
9.3.8. ATR FT-IR spectroscopy 
Secondary structural changes occurring during S100B amyloid formation 
were monitored by ATR FT-IR measurements performed in a Bruker IFS 
66/S spectrometer equipped with a nitrogen-cooled MCT detector using the 
thermostatized Harrick BioATR II cell. 10 mg/ml S100B in 50 mM glycine pH 
2.5 were incubated at 57°C while spectra were continuously acquired (1 min 
accumulation time, 12 mm aperture, 20 kHz scanner velocity). Spectral 
resolution was 4 cm-1. Amyloid formation was assessed by the absorption 
ratio between the intermolecular β-sheet characteristic band at 1618 cm-1 
and the amide I absorption maximum, occurring between 1642 and 1652 cm-
1. Secondary structure quantification was based in the spectral deconvolution 
of the amide I band with lorentzian curves centered at second derivative 
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maxima of the self-deconvoluted spectra. Assignment of each lorentzian to 
secondary structure features took into consideration typical absorption 
regions [15]. Curve integration yielded the secondary structure estimations. 
9.4. Results 
9.4.1. Amyloidogenic potential of S100 proteins 
The amyloidogenic potential of a protein can be estimated at the amino 
acid residue level using different algorithms. We have used the WALTZ [16] 
and Zyggregator [7, 9] algorithms to calculate the intrinsic aggregation 
propensity of human S100 proteins. WALTZ computes the amyloid formation 
probability (as a percentage). Zyggregator can compute the fibrillization 
potential (Zagg score) as well as the propensity to form toxic β-rich oligomers 
(Ztox score). If the difference between the amyloidogenic potential of the 
query sequence and the one of a random sequence is expressed and the 
standard deviation, its value is the Zyggregator score. Accordingly, significant 
scores are the ones larger than the unity. In addition, Zyggregator scores can 
be averaged to yield an overall propensity. We have set up our calculations at 
pH 7.0 to assess the amyloidogenic at near physiological conditions (Figure 
9.1). 
 
 
Figure 9.1 – Overall amyloid formation propensity of S100 proteins. Sequence-averaged 
scores, computed at pH 7.0. (A) Intrinsic aggregation propensity (Zagg). (B) Oligomeric 
assembly formation propensity (Ztox). Bars represent the score error. 
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Figure 9.2 – Position-specific amyloidogenic potential of S100 proteins. Alignment of
human S100 protein sequences, showing the intrinsic aggregation propensity (Zagg) (A), the
oligomeric assembly formation propensity (Ztox) (B) or the WALTZ high score regions (C) at
pH 7.0. Zyggregator results (A-B) are color coded: values above the significance threshold (>1)
are in shades of green. WALTZ scores (C) either equal zero or are above 92% (red shaded
sequences). Shades of grey highlight sequence consensus. Cartoons represent the canonical
location of secondary structure elements in S100 proteins. Cylinders represent helices and
spheres represent the position of EF-hand calcium binding loops. 
Interestingly, for most S100 family members the fibrillization propensity 
(Zagg) is comparable with the one of Aβ peptides, forming amyloid deposits in 
Alzheimer’s disease: the overall aggregation scores for Aβ1–40 and Aβ1–42 at 
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pH 7.0 are 0.97 and 0.94, respectively [9]. These results thus evidence a 
rather high fibrillization propensity in the S100 family. The overall Ztox scores 
are low. To determine which protein sequences are contributing to this 
amyloidogenic propensity, we determined the position-specific Zyggregator 
and WALTZ scores (Figure 9.2). 
The position-specific Zyggregator scores (Figure 9.2AΒ) reveal that 
amyloidogenic regions are segregated at helices HI and HIV, which form the 
hydrophobic core of S100 proteins. Every family member displays a distinct 
location of amyloidogenic regions, not all of them being located at HI and HIV 
sites, but all family members display highly amyloidogenic regions. 
Interestingly, in contrast with the low overall values, almost all S100 proteins 
display regions with highly significant oligomerization propensities (Ztox >> 
1). Exceptions are S100A8 and S100G. The overall low Ztox values are thus the 
consequence of the highly clustered oligomerization-prone regions in a 
mostly non-amyloidogenic context. The WALTZ score in S100 sequences was 
found to be either 0% or above 92%. Accordingly, we have defined WALTZ 
amyloidogenic and non-amyloidogenic sequences (red zones in Figure 9.2C), 
which are found in most S100 proteins: S100A1, S100A2, S100A3, S100A6, 
S100A8, S10A9, S100A10, S100A11, S100A12, S100A13, S100A16. More 
importantly, the Waltz amyloidogenic sequences also cluster around helix HI 
and HIV, in accordance with the Zyggregator analysis. 
9.4.2. S100 proteins form amyloid-like species in vitro 
Building on these initial observations and considering the fact that S100 
proteins share a rather high chemical and structural identity, we have further 
addressed the hypothesis that amyloid formation could be a generalized 
property among the members of the S100 protein family. For this purpose, 
we have carried out a series of preliminary experiments in conditions 
identical to those assayed for S100A8/A9 (pH 2.5 and 57°C) to test if other 
S100 proteins (S100A2, S100A3, S100A4, S100A6, S100A12 and S100B) 
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Figure 9.3 – Amyloid formation kinetics by S100 proteins.
would form thioflavin-T (ThT)-reactive amyloid species (Figure 9.3). These 
proteins are representative of the overall biological roles of S100 proteins: 
cell proliferation control /cancer (S100A2, S100A4, S100A6, S100B) [17], 
inflammation (S100A12, S100B) [18], cell motility (S100A4, S100B) [2], 
chemotaxis (S100A2, S100A12, S100B) [19-21] and RAGE activation 
(S100A2, S100A4, S100A6, S100A12, S100B) [22]. Lysozyme, a well studied 
amyloid-forming protein [13] was used as a positive control. 
After prolonged incubation (≥50 h) all tested S100 proteins – with the 
exception of S100A12 – promptly formed ThT-binding amyloid structures 
that resulted in increase of fluorescence intensity of ThT, comparable to that 
observed upon dye interaction with the lysozyme amyloids used as a positive 
control. The kinetics of amyloidogenesis was similar in all amyloid-forming 
S100 proteins. Near endpoint fluorescence values were reached within the 
first hours of incubation. Three kinds of behavior are observed: the ThT 
negative S100A12; the proteins forming amyloid from a ThT negative state, 
putatively native-like (S100A4, S100A6, S100B); and proteins exhibiting a 
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ThT positive signal even before thermal treatment (S100A2, S100A3). The 
latter case suggests that S100A2 and S100A3 are highly amyloidogenic, being 
particularly susceptible to pH acidification which can induce amyloid 
formation by itself. No lag phase was detected in any of the amyloid-forming 
samples, an indication of the highly amyloidogenic nature of these proteins. 
9.4.3. Morphology of S100 amyloids 
The characterization of amyloid structures requires a morphological 
description which complements the ThT information on enhanced β-sheet 
content. After reaching the plateau phase in the amyloid formation assays 
(Figure 9.3), S100 samples were adhered to mica and analyzed by atomic 
force microscopy (AFM), which allowed the detection of amyloid and other 
precursor structures (fibrils, protofibrils and disordered aggregates) (Figure 
9.4). 
 
Figure 9.4 – Atomic Force Microscopy analysis of S100 amyloid morphology. 
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Surprisingly, despite the similar amyloid formation kinetics, all S100 
proteins form quite distinct amyloid structures. S100A2 and S100A3, which 
had a high initial ThT fluorescence exhibit dissimilar structures: S100A2 
presents an oligomeric/protofibrillar morphology and S100A3 is highly 
amyloidogenic, forming proper amyloid fibrils. S100A6 and S100B, which 
exhibit similar amyloid formation kinetics, rather than forming fibrillar 
structures, assemble in β-sheet rich oligomeric structures. Most striking is 
the morphology of S100A12. This protein did not bind ThT even after 
prolonged incubation at amyloid formation prone conditions but assembled 
in thin protofilaments. This indicates that despite the microscopic 
morphological resemblance to amyloid species, the ultrastructural details are 
distinct, with lower β-sheet content. This morphological analysis indicates 
that the conformational plasticity of S100 proteins is further evidenced by 
their amyloidogenic properties, leading to the formation of remarkably 
different structures despite sequence similarity within the same protein 
family. 
9.4.4. Structural characterization of S100B amyloidogenesis 
To gain further structural knowledge of S100 amyloidogenesis we have 
selected S100B, one of the most abundant proteins in the brain and thus 
naturally present in high concentration, which is one of the prerequisites for 
amyloidogenesis. Further, this protein is secreted at micromolar 
concentrations under particular conditions [23]. To this purpose, we have 
monitored S100B amyloid formation by Attenuated Total Reflectance Fourier 
Transform-Infra Red spectroscopy (ATR FT-IR), a particularly adequate 
technique for describing amyloidogenic processes due to its high intrinsic 
sensitivity to β structures (Figure 9.5). Due to sensitivity requirements, for 
this study we have increased the protein concentration to 10 mg/ml (versus 
3 mg/ml in the ThT-derived amyloidogenesis kinetics), keeping all remaining 
experimental parameters unchanged. 
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Figure 9.5 – Structural characterization of S100B amyloid formation. (A) FT-IR spectra in 
the amide I and amide II regions obtained throughout S100B amyloidogenesis. Deconvoluted 
FT-IR spectra obtained before (B) and after a 6 min incubation (D) at 57°C. Component band 
assignment is shown in the plots: α-helices (α), β-sheets (β), β-turns (T), random coil (R) and 
intermolecular aggregation β-sheets (Agg). The FT-IR spectrum is shown as black dashes. The 
sum of the component bands is shown as a continuous grey line. (C) S100B amyloid formation 
kinetics monitored through the ThT fluorescence assay and absorption enhancement at FT-IR 
intermolecular β-sheet characteristic 1618 cm-1 wavenumber normalized by the amide I 
absorption maximum. Experimental points are fitted to a monoexponential decay equation. 
Protein concentration was 10 mg/ml in 50 mM glycine pH 2.5 and amyloid formation was 
promoted by incubating at 57°C. 
The spectral maximum around 1650 cm-1 is characteristic of S100 
proteins [24] for their high helical content. The spectra obtained before 
incubation at the amyloidogenic temperature (57°C) also exhibits a local 
maximum at 1618 cm-1 (Figure 9.5A), which is characteristic of 
intermolecular β-sheets, occurring in aggregation processes. This indicates 
that acidic pH alone can induce some S100B aggregation. During incubation 
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at the amyloidogenic temperature, the relative contribution of the 1618 cm-1 
band to the overall absorption increases rapidly, revealing amyloid 
formation, which is well described as a monoexponential decay with a rate 
constant of 3.51 min-1 (Figure 9.5C). Probing the same process by the ThT 
fluorescence assay yields similar results. We have taken advantage of the 
quantitative absorption of specific secondary structure types in the amide I 
spectral region (1600-1700 cm-1) to deconvolute the FT-IR spectra before 
thermal incubation and at the beginning of the kinetic’s plateau phase into 
individual component bands (Figure 9.5BD). We have assigned each band to 
the secondary structure element absorbing at each specific wavenumber and 
quantified structural content by curve integration (Table 9.1). 
By comparing the content of each type of secondary structure at the two 
time points one can assess the conformational changes occurring (Table 9.2). 
The low helical content is a consequence of solution acidification, which is 
used to facilitate amyloid generation by enhancing the intrinsic protein 
aggregation propensity. Throughout amyloid generation 11% of the α-helical 
and coil content is converted to β-sheets and β-turns, a conformational 
change typical of amyloidogenic processes. The end state is thus β-sheet rich, 
as the ThT fluorescence assays also indicate. 
 
Table 9.1 – Assignment of component bands from FT-IR spectra deconvolution. 
 0 min 6 min 
Structure Type 
Wavenumber 
(cm-1) % Structure 
Wavenumber 
(cm-1) % Structure 
α-helix 1654 17 1652 11 1661 11 1658 7 
β-sheet 
1626 9 1622 11 
1637 15 1637 19 
1675 6 1678 9 
1684 8 1691 4 
Β-turns 1668 7 1667 10 
Random 1646 15 1645 16 
Aggregation sheets 1617 11 1615 12 
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Table 9.2 – Secondary structure changes occurring during S100B amyloidogenesis. 
From FT-IR spectra decomvolution. 
 % Structure  
 0 min 6 min Variation (%)
α-helices 28 18 -10
β-sheets 38 44 +6
β-turns 7 10 +3
Random coil 15 16 -1
Intermolecular β-sheets 11 12 +1
 
9.4.5. Folding and stability of S100A6 
Our amyloid formation screening is based on the observation that the 
amyloid state is accessible to multiple protein folds [25] and may be attained 
via a destabilized, slightly misfolded native-like state [26]. This observation 
is crucial to the understanding of pathology-related amyloidogenic 
properties, since the extensive conformational rearrangement occurring in 
the proteins involved are thus more likely to happen in the mild 
physiological milieu. To assess the structural and stability changes occurring 
in S100 proteins upon lowering the pH we have selected S100A6 as a model. 
From all the S100 proteins included in our screening, this is the only one 
whose folding properties were not yet addressed in the literature, so this 
approach further contributes to the biophysical characterization of S100 
protein folding. We have performed thermal denaturation assays on S100A6 
placed either on 50 mM KPi pH 7 or 50 mM glycine pH 2.5 while monitoring 
the far UV CD spectral signal (Figure 9.6). 
Like other S100 proteins, the thermal unfolding of S100A6 is irreversible. 
At pH 7 (Figure 9.6A) S100A6 is rather stable but the high Tmapp precludes 
the detection of the unfolding post-transition. From the accessible 
temperature range, the Tmapp was estimated at 81.4°C. Upon acidification the 
characteristic α-helical spectra is kept (Figure 9.6B), though with lower 
intensity, revealing a partially misfolded state of S100A6. We have quantified 
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Figure 9.6 – Thermal unfolding of S100A6. Denaturation curves correspond to the 
normalized CD variation at 222 nm of the apo protein in 50 mM KPi pH 7 (A) or 50 mM glycine 
pH 2.5 (B). Insets are the far UV CD spectra recorded at 25°C before the temperature ramp, at 
95°C and after recooling the sample to 25°C. The sigmoidal fit yields a Tmapp = 81.4°C. 
this conformational change by deconvoluting the spectra (Table 9.3), 
estimating the amount of each secondary structural element in this protein. 
This further indicates that at pH 2.5 there is a minor conversion of helical 
and turn elements to β-sheets and random coil. 
However, acidification has significant effects in the stability of S100A6. 
Unfolding proceeds through a multistate mechanism, with two clearly 
distinguishable transitions, the first being uncooperative and occurring 
around 30°C and the second occurring around 95°C in a highly cooperative 
manner. The Tmapp of this second transition could not be determined 
Table 9.3 - Deconvolution of the far UV CD spectra of S100A6 at pH 7 and 2.5 before 
thermal perturbation. 
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accurately due to the lack of the post-transition zone. According to these 
measurements, the incubation at 57°C in the amyloid screening assay yielded 
a misfolded state, though with residual structure. The fast amyloid formation 
kinetics could be then attributed to the helical-to-sheet transition brought 
about by acidification alone, raising the possibility that amyloid formation 
may be readily accessible at higher pH values. 
9.5. Discussion 
Even before of the association of S100 proteins with amyloidogenic 
processes in the prostate it was known that that several S100 proteins 
accumulate in the brain in benign corpora amylacea [27], the etiology of 
which is unknown and the possible implications in brain inflammatory or 
other pathologies still unaddressed. On the other hand, the control of S100 
amyloid deposition is related to the development of prostate 
adenocarcinoma wherein prostate corpora amylacea abundance is lower 
than in the healthy population [28]. A correlation between prostate 
S100A8/A9 corpora amylacea and cancer onset through inflammation has 
been suggested on the basis of co-deposition of bacterial proteins and 
macrophage activation in situ [1]. Following these observations and taking 
into consideration the sequence homology among S100 proteins, the high 
expression level of some S100 proteins, their frequent extracellular 
localization and expression mis-regulation in many pathologies we screened 
several S100 proteins for amyloid formation in acidic conditions and found 
widespread amyloidogenic propensity associated with morphological 
polymorphism. We have deliberately chosen acidic pH conditions for our 
amyloid formation screening because these are known to facilitate the 
amyloidogenic conversion of native proteins [13], which would otherwise be 
seldom reached at more physiological conditions through thermal 
fluctuations [26]. The “rare” formation of amyloids in vivo is partially based 
in this phenomenon. In this sense, low pH enhances the intrinsic 
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amyloidogenic potential of proteins and is a useful tool in the 
characterization of amyloidogenesis. 
The high amyloid formation propensity assigned to the hydrophobic core-
forming helices (HI and HIV) suggests that S100 dimerization can work as a 
mechanism to prevent or minimize amyloidogenesis. All members of the 
S100 family are homo or heterodimers (with the notable exception of S100G, 
a smaller family member which functions as a calcium buffer rather than as a 
calcium signal transducer). Unlike helix HIII, which undergoes the EH-hand 
calcium-induced conformational change, helices HI and HIV maintain their 
relative position during calcium binding and keep the dimeric state 
throughout signaling events. The importance of dimerization as a 
amyloidogenic protection mechanism has been highlighted in the 
S100A8/A9 heterodimer [1], where the overall aggregation propensity of the 
individual subunits decreases upon heterodimer formation. Remodeling of 
the hydrophobic core in the all helical S100 proteins may thus be an 
important step in the amyloidogenic conversion of S100 proteins.  
The first step in amyloid fibril assembly is the formation of a nucleus – the 
least stable identifiable species on the aggregation pathway – which is 
elongated through the polymerization of monomeric or oligomeric soluble 
proteins. Frequently, the nucleation step is rate-limiting in the 
amyloidogenesis pathway and gives rise to a lag phase preceding amyloid 
formation. Still, some proteins do not present such delay and promptly form 
amyloid when placed in permissive conditions. This is the case of Aβ peptide 
mutants [29-30]. Contrary to the wild type form, D23N-Aβ1-40 fibrillization 
shows no obvious lag period at 100 µM peptide concentration, with a rate 
constant of 3.77 x 10-3 min-1. For wt-Aβ1-40 the rate constant is 1.07 x 10-4 
min-1 [29]. Despite the experimental conditions in our survey (57°C pH 2.5) 
are outside the physiological range, they nevertheless reveal an intrinsic 
amyloid propensity widespread in the S100 protein family. These 
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experimental conditions have allowed establishing a proof-of-concept for 
amyloid formation in this protein family, an approach which has been used 
previously in the literature for distinct proteins (e. g. [13]). Further 
investigations will address amyloid formation under physiological conditions 
(pH ~7.0, 37°C) and the effects of molecular crowding, which is known to 
promote nucleation in amyloid formation [31]. 
From an evolutionary point of view, the proteins included in our amyloid 
formation screening represent distinct branches of the S100 family (Figure 
9.7) which are thought to have evolved through multiple gene duplication 
events from a common ancestor protein [3].This suggests that, instead of 
being a peculiarity of a subgroup of S100 proteins, amyloidogenic behavior 
may be shared by other family members. Such generality is further based in 
the S100 family sequence analysis, where amyloid propensity was predicted 
by distinct algorithms. 
Concerning corpora amylacea, the protein content is in fact only around 
4% (w/w) [32-33]. The major component in these inclusions are hexoses 
(~88% w/w) in a glycogen-like form [34]. The presence of the abundant 
 
Figure 9.7 – Phylogenetic tree of human S100 proteins. Computed from S100 protein 
sequences. From [3]. 
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glycan portion may be relevant in the amyloidogenic processes as it is 
established that macromolecular crowding accelerates the nucleation step of 
amyloidogenesis and promotes fibrillization of distinct proteins [31]. Further 
investigations will address the possibility of S100 proteins forming amyloid 
at physiological-like conditions and the identification of other factors 
modulating amyloidogenesis. A priori candidates are metal ions, 
macromolecular crowding, oxidant species, amyloid seeds and point 
mutations, all of which have been associated either with S100 folding or 
amyloid deposition in general. Also, the correlation of the conditions where 
amyloid formation is accessible with a more thorough characterization of the 
structure of amyloid species (oligomers, protofibrils, fibrils) will provide 
insight on the feasibility of S100 amyloid formation in physiological 
conditions. Last, the association of S100 amyloids with putative pathologies 
will require the in vivo detection of such species. 
By including a comprehensive spectroscopic description of amyloid 
formation by S100A6 and S100B in our experimental approach, combined 
with AFM imaging of S100 amyloids as a function of the metallation status, 
we have indirectly excluded the possibility that the metal-influenced amyloid 
formation kinetics could be due to the Hoffmeister effect alone: distinct 
morphologies were observed as a function of metallation. 
9.6. Conclusions 
Altogether, the above described findings suggest that amyloid-like 
conformations (β-rich oligomers, protofibrils and fibrils) might be accessible 
to S100 proteins under particular conditions. The involvement of S100 
proteins in several pathologies (including inflammatory processes in the 
prostate associated to S100A8/A9 amyloids), their deposition in corpora 
amylacea in the healthy brain and the here reported amyloidogenic 
propensity of several family members points to a new and relevant 
biomedical research field wherein S100 proteins are hypothesized to form 
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amyloid deposits associated to several pathologies. The extensively reported 
overexpression of several S100 proteins in multiple pathologies like cancer, 
cardiomyopathies, inflammatory conditions and neurodegeneration [3] 
provides the candidates for putative disorders where S100 fibrillization can 
be involved. Future research on this field will determine the exact conditions 
where S100 fibrillization is accessible and if it has pathological relevance 
apart from the already reported one [1]. 
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10.1. Summary 
Amyloid deposition constitutes the cytological hallmark of several 
diseases, where metal ions are important players, either because they favor 
fibrillization or act as toxic agents. We have assessed the role of metal ions as 
modulators of the amyloidogenesis pathways of representative members of 
the S100 protein family (S1002, S100A3, S100A4, S100A6, S100A12 and 
S100B). We have observed that S100 amyloid structure is highly sensitive to 
metallation. Further, in most cases S100 amyloid species are oligomeric. In 
S100A6 Ca2+ binding induces a non-amyloid and non-toxic off-pathway 
conformation which nevertheless has an increased β-sheet content. The 
oligomeric nature of most S100 amyloids is associated with cytotoxicity of 
S100A6 oligomers, S100B mature amyloids and S100A12 oligomers and 
mature fibrils. These proteins are overexpressed in ALS and Alzheimer’s 
disease and cytotoxicity may be relevant in the understanding of the 
associated neurodegenerations if S100 fibrillization has physiological 
relevance. 
10.2. Introduction 
S100 proteins constitute a family of metal signaling buffers or 
transducers. At the protein level, metal ions regulate protein conformation 
and/or oligomerization, therefore determining function. Ca2+ binding triggers 
the characteristic EF-hand conformational change whereby helix HIII moves 
around 90° [1], exposing a hydrophobic patch responsible where 
downstream signaling partners bind to [2]. Zn2+ and Cu2+ are usually 
associated to subtle conformational changes. On the other hand, metal-bound 
S100 proteins frequently exhibit differential stability. Both Ca2+ and Zn2+ are 
S100 oligomerization modulators. Ca2+ functions as a dimer cross-linker in 
the assembly of the S100A8/A9 heterodimer [3], S100A12 hexamer [4] and 
S100B octamers [5]. Zn2+ drives the assembly of the S100A2 tetramer [6]. 
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Moreover, S100A8/A9 oligomerization into amyloid fibrils is dependent of 
Ca2+ or Zn2+ in vitro [7]. At the cellular level, metal homeostasis and S100 
metallation are responsible for determining protein compartmentalization. 
This exposes S100 proteins to distinct interacting partners and medium 
compositions. S100B is secreted from astrocytes upon elevation of cytosolic 
Ca2+ concentration or decrease in intracellular Zn2+ concentration [8]. In 
smooth muscle cells S100A1, S100A4 and S100A6 relocate from the 
sarcoplasmic reticulum to perinuclear vesicles [9]. 
Our analysis of S100 amyloid-forming propensity revealed that helices HI 
and HIV, forming the S100 hydrophobic core, are highly amyloidogenic 
(Figure 9.1). From our demonstration that S100 proteins form amyloid 
species (Chapter 9) and the knowledge of the α-helical S100 fold, one may 
hypothesize that hydrophobic core remodeling yielding enhanced β-sheet 
content is an early step in S100 amyloidogenesis. In this sense, metal ions can 
be hypothesized to be important modulators of S100 amyloidogenesis. The 
calcium-induced conformational change which enhances the solvent 
exposure of the hydrophobic core could then facilitate S100 amyloidogenesis. 
Similarly, other metal ions could fulfill similar roles. 
Here we have screened for the effect of calcium and zinc in the 
amyloidogenesis kinetics and amyloid oligomeric structure of S100A2, 
S100A3, S100A4, S100A6, S100A12 and S100B. We have found a strong 
influence of metallation on the kinetics and endpoint morphology. 
Remarkably, S100A6 amyloidogenesis was completely inhibited by Ca2+. A 
detailed analysis of amyloid formation kinetics by S1006 revealed that Ca2+-
S100A6 formed oligomeric structures with increased β-sheet content which 
nevertheless lacked the amyloid-specific cross-beta core, as shown by the 
absence of ThT fluorescence. The potential cytotoxicity of S100 oligomers 
was assessed the quantification of SHSY-5Y neuroblastoma cell viability. 
S100A6 oligomers, S100A12 oligomers and mature amyloids and S100B 
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mature amyloids were found to be cytotoxic. Apart from the structural 
importance, Ca2+ is also relevant in modulating the cytotoxic potential of 
S100 amyloids as it reverts the cytotoxicity of S100A6 and S100B structures, 
as well as of S100A12 mature amyloids. This is particularly relevant 
considering that S100 proteins are overexpressed in Amyotrophic Lateral 
Sclerosis, Alzheimer’s and Parkinson’s diseases [10-13]. 
10.3. Materials and methods 
10.3.1. Chemicals and proteins 
All reagents were of the highest grade commercially available. Thioflavin 
T was obtained from Sigma. Trace metals were removed from all solutions by 
solution treatment with a chelex resin. Metal ion solutions were prepared in 
chelex-treated water. S100 proteins (S100A2, S100A3, S100A4, S100A6, 
S100A12 and S100B) were expressed in E. coli and purified to homogeneity 
as described previously [6]. Molar protein concentrations refer to the S100 
subunit. Hen egg white lysozyme was obtained from Fluka. 
10.3.2. S100 fibrillization 
S100 proteins were placed in 50 mM Glycine buffer pH 2.5 by repeated 
dilution and re-concentration. Sample temperature was kept at 4°C at all 
times before amyloid formation assays. Protein concentration was set at 3 
mg/ml using Bradford’s method [14]. Due to spontaneous and extensive 
aggregation in aerobic conditions, S100A3 (4 mg/ml) was previously 
reduced with 25 mM TCEP overnight. S100 proteins were prepared in the 
apo state or in the presence of 10 fold molar excess over the S100 monomer 
(~2.6-2.8 mM) of known metal ion ligands, as the ZnCl2, CaCl2 or CuSO4 
forms. Binding was promoted by incubating from 15 min to 2 h at 4°C. Any 
pre-existing aggregates were pelleted and removed by centrifuging at 12000 
g for 10 minutes. Amyloid formation was promoted by quiescent incubation 
at 57°C. For S100A6 samples containing EDTA, an excess amount was added 
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at before incubation (apo-S100A6) or at a selected time point (Ca2+-S100A6). 
The positive control for amyloid formation was hen egg white lysozyme, at 
10 mg/ml in the same buffer and incubated at 57°C, a previously validated 
assay [15].  
10.3.3. Thioflavin T fluorescence 
ThT binding assays were performed according to [15]. Briefly, 5 µl of 
protein sample (15 µg) was mixed with 65 µM ThT in 10 mM potassium 
phosphate (KPi), 150 mM NaCl, pH 7.0 at room temperature to a final volume 
of 1 ml. Samples were incubated under stirring for 1-2 min and ThT 
fluorescence at 482 nm was recorded with a Cary Varian Eclipse instrument 
with temperature set at 25°C using a peltier-thermostated cell support. 
Excitation wavelength was 440 nm, PMT voltage 600 V, and excitation and 
emission slits 10 nm. 
10.3.4. ATR FT-IR spectroscopy 
Secondary structural changes occurring during S100A6 amyloid 
formation were monitored by ATR FT-IR measurements performed in a 
Bruker IFS 66/S spectrometer equipped with a nitrogen-cooled MCT 
detector using the thermostatized Harrick BioATR II cell. 3 mg/ml S100A6 in 
50 mM glycine pH 2.5 were prepared in the apo state, in the apo state with 
excess EDTA and in the presence of mM Ca2+ (i. e. 10 molar equivalents). 
Samples were incubated at 57°C while spectra were continuously acquired (3 
min accumulation time, 12 mm aperture, 20 kHz scanner velocity). Spectral 
resolution was 4 cm-1. Amyloid formation was assessed by the absorption 
ratio between the intramolecular β-sheet characteristic band at 1626 cm-1 
and the amide I absorption maximum, 1655 cm-1. 
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10.3.5. Atomic force microscopy 
After reaching the plateau phase in amyloid formation kinetics, S100 
samples were stored at 4°C and morphology was analyzed by AFM on a PICO 
PLUS 5500 microscope (Agilent) as previously described [16]. 
10.3.6. Dynamic light scattering 
For monitoring molecular size variations during amyloid formation of 
S100A6, 3 mg/ml protein solutions were prepared in the apo state or in the 
presence of 10 molar equivalents (2.9 mM) of Ca2+ or Zn2+ in the form of 
chloride metal salts in 50 mM glycine pH 2.5. Samples were then filtered 
through a 0.22 μM membrane and analyzed with a Malvern Instruments 
Zetasizer Nano ZS instrument equipped with a 633 nm laser while the 
temperature was kept at 57°C by a Peltier-controlled thermostatized cell 
support. Kinetic data was obtained from continuously repeated 
measurements. In each measurement, the backscattered light (173°) from 
fifteen 10 s accumulations was averaged. Amyloid formation was assessed 
from light scattering intensity and the average particle size (diameter) 
obtained from the intensity distribution. Results were analyzed with Malvern 
Instruments DTS software using a multimodal fit with quadratic weighting 
and 0.01 regulariser. 
10.3.7. Amyloid cytotoxicity 
For cytotoxicity measurements S100A6, S100A12 and S100B samples 
were prepared at 3 mg/ml in 50 mM glycine pH 2.5 and incubated at 57°C. 
Distinct samples were prepared in the presence of 10 molar equivalents 
relatively to the S100 subunit. Several species in the amyloid formation 
pathway could be obtained by varying the incubation time: native protein 
(no incubation), oligomeric structures (0.5 or 1 h incubation for S100A6; 2 h 
for S100A12 and S100B) or endpoint structures (~3 days incubation). S100 
cytotoxicity towards the human neuroblastoma SH-SY5Y cell line was 
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assessed using the WST-1 assay. In viable cells, WST-1 is reduced by 
mitochondrial reductases, forming formazan dyes, which serves as an 
indicator of the amount of metabolically active cells. The amount of WST-1 
can be quantified by its characteristic absorption around 450 nm [17]. Cells 
were cultured in Dulbecco's modified Eagle's medium supplemented with 
10% (v/v) fetal bovine serum and antibiotics in a 5% CO2 humidified 
atmosphere at 37 °C. Measurements were performed on cells seeded 
overnight in 96 well plates (104 cells/well). Before starting the measurement, 
culture medium was replaced by 100 µl fresh medium without fetal bovine 
serum and S100 samples were added. Cytotoxicity was determined 24 and 
48 h after placing S100 samples by adding 10 μl WST-1 reagent solution 
(Roche) at each well. Cells were further incubated for 4 h and absorbance 
was measured with an ELISA plate reader (Labsystem Multiscan RC) at 450 
nm after cell shaking. Cell viability was expressed as the absorption 
percentage relatively to control cells which were incubated with buffer alone 
(50 mM glycine pH 2.5). Statistical differences were assessed with double-
tailed, two sample unequal variance Student’s t-test. For metallated S100 
samples, additional control wells were prepared which did not contain 
protein but metal ions alone at the same concentration. 
10.4. Results 
10.4.1. Metal ions modulate S100 amyloidogenesis 
To determine the effect of metallation in S100 amyloid formation kinetics, 
we have built on our observation of amyloid formation by several S100 
proteins at acidic pH (Chapter 9). We have prepared S100 samples (S100A2, 
S100A3, S100A4, S100A6, S100A12 and S100B) as in the previous assay (3 
mg/ml, 50 mM glycine pH 2.5) and included 10 molar equivalents of known 
metal ion ligands. Samples were incubated quiescently at 57°C and time 
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Figure 10.1 – Metal ions and S100 amyloidogenesis. (Left) Amyloid formation kinetics of 
S100A2, S100A3, S100A4, S100A6, S100A12 and S100B at 57°C as assessed by the thioflavin T 
fluorescence assay. S100 proteins were prepared in 50 mM glycine pH 2.5 in the apo state or 
in the presence of 10 fold molar excess of Ca2+, Zn2+ or Cu2+. Lysozyme is the positive control 
for amyloid formation. (Left) AFM images of protein samples after the kinetic assay. Scale bar: 
1 µm. 
resolved amyloid formation was quantified using the Thioflavin T (ThT) 
fluorescence assay. In amyloidogenesis kinetics after a plateau was reached, 
the morphology of endpoint structures was analyzed by atomic force 
microscopy (AFM) (Figure 10.1). This complementary approach provides 
information about the overall secondary (ThT) and quaternary structure 
(AFM) of S100 oligomers. However, AFM is not a quantitative technique, 
precluding such kind of image analysis. Data from apoprotein preparations 
was used as reference. 
S100A2 amyloid formation kinetics are unaffected by metal load. All 
S100A2 preparations show enhanced fluorescence before incubation, an 
indication that low pH alone can induce an amyloid-like state and reach near 
final signal values after ~1 h, an indication that low pH alone is able to induce 
a β-sheet rich conformation in S100A2, suggesting an amyloidogenic 
potential of this protein, in line with theoretical calculations (Figure 9.2). 
Whereas apo-S100A2 amyloid species are protofibrilllar, the presence of Ca2+ 
or Zn2+ results in the formation of large oligomeric assemblies, which are 
irregularly shaped in the presence of Ca2+ or spherical in the presence of Zn2+. 
Specifically for S100A2, the starting point for the Zn2+ sample should be the 
homotetramer [6] because of the metal ion concentration (2.7 mM, 10 fold 
excess. However, this must not be the only factor determining the distinct 
morphology of Ca2+- and Zn2+-S100A2 as the binding sites for each metal are 
distinct [6]. 
Like S100A2, S100A3 seems to rest in a β-sheet enriched state at low pH, 
as seen by the high ThT fluorescence before the amyloid formation assay. 
ThT-derived amyloidogenesis kinetics is similar for the three metallated 
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states. Fluorescence intensity at the plateau phase is higher than the 
standard lysozyme curve, which was obtained with a higher protein 
concentration (10 mg/ml lysozyme versus 3 mg/ml S100A2). The reason for 
this is that S100A3 is highly amyloidogenic, forming long amyloid fibrils in all 
metallated states. 
S100A4 forms ThT-reactive species independently of the presence of Ca2+ 
and with a similar kinetics. Nevertheless, structures of apo- and Ca2+-S100A4 
amyloid species are distinct, as assessed by the higher ThT fluorescence 
emission in the latter. The morphological analysis of Ca2+-S100A4 endpoint 
structures revealed small oligomers. 
S100A6 exhibited an extreme case of metal-modulated amyloidogenesis. 
Apo-S100A6 promptly formed ThT-reactive species, the process not being 
affected by the presence of Zn2+. Notably, Ca2+ completely inhibited the 
process. However, after extensive incubation, all S100A6 species are of the 
oligomeric type, irrespectively of metal load. Both Ca2+ and Zn2+ induced 
S100A6 aggregation into large structures, unlike the small oligomers seen in 
the apo protein preparation. The amyloid formation kinetics and the 
ultrastructural details of the different metallated forms of S100A6 were 
addressed more thoroughly in Section 10.4.2. 
In S100A12, metal ions also exerted a significant influence in the 
amyloidogenic process. Neither apo-, Ca2+- nor Zn2+-S100A12 formed 
amyloid species. However, Cu2+-S100A12 promptly assembled in amyloid 
species, which nevertheless exhibited lower ThT fluorescence than other 
S100 ThT-reactive preparations. The AFM analysis revealed that all 
metallated S100A12 forms formed oligomeric species. In the Zn2+-S100A12 
sample some protofibrils were also visible. 
Regarding S100B, amyloid species were formed from the apo and all 
metallated forms. Cu2+-S100B exhibited a lower fluorescence intensity, which 
suggests lower amyloid formation efficiency or an alternative conformation. 
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In the presence of Ca2+ S100B forms oligomeric and protofibrilllar 
assemblies, unlike the small oligomers originating in the apo protein 
preparation. 
10.4.2. Reversible control of S100A6 amyloidogenesis by Ca2+ 
The distinct roles of metal ions in S100A6 amyloidogenesis – Zn2+ 
affecting morphology without modifying the formation kinetics and Ca2+ 
inhibiting amyloid formation – have prompted us to investigate this aspect in 
more detail. To determine the reversibility of the inhibition of S100A6 
amyloidogenesis by Ca2+ we placed a Ca2+-S100A6 sample in amyloidogenic 
conditions for 3 h, at which time an excess of EDTA was added (Figure 
10.2A). Promptly, ThT-positive species built up, with a plateau ThT 
fluorescence similar to the one of S100A6 incubated with EDTA alone. 
Moreover, at the end of incubation the AFM-assessed morphology of EDTA-
S100A6 and Ca2+-EDTA-S100A6 was of the oligomeric type, similar to the one 
of apo-S100A6 but unlike the ones obtained in the presence of Ca2+ alone, 
which were much larger. These results indicate that amyloid formation by 
S100A6 can be controlled – even at low pH and moderate temperature – by 
the availability of Ca2+. 
Because amyloid formation is a process wherein β-sheet content 
increases, Fourier transform infrared spectroscopy (FT-IR) is one of the best 
suited technique to study it, due to its high sensitivity to such structural 
features [18]. FT-IR absorption at the amide I band (1600-1700 cm-1) arises 
from distinct secondary structure elements in a quantitative manner, 
implying that absorbance changes can be assigned to specific conformational 
changes. Of particular interest to fibrillization processes is the fact that 
characteristic absorption peaks for α-helices (~1654 cm-1), intramolecular β-
sheets (~1684 and 1633 cm-1) and intermolecular β-sheets (~1620 cm-1) are 
well established [18]. In particular, intermolecular β-sheets are characteristic 
of amyloid species. To dissect the mechanism of Ca2+-induced inhibition of 
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Figure 10.1 – Modulation of S100A6 amyloidogenesis kinetics by Ca2+. (Left) S100A6 
amyloid formation kinetics at 57°C assessed by the thioflavin T fluorescence assay as [15]. For 
analyzing the amyloidogenesis suppression by Ca2+, excess EDTA was added to apo-S100A6 
before incubation (?) or to Ca2+-S100A6 after 3 h incubation (?). (Right) AFM pictures of the 
EDTA-S100A6 and Ca2+-EDTA-S100A6 obtained after the kinetic’s plateau phase. Scale bar: 1 
µm. 
S100A6 fibrillization, we have prepared apo-S100A6, EDTA-S100A6 and 
Ca2+-S100A6 samples as before and followed amyloidogenesis by FT-IR 
(Figure 10.3). 
We observed that amyloid formation was accompanied by the 
development of a new spectral band at 1626 cm-1 which, by its intermediate 
position, we have assigned to a mixture of intra and intermolecular β-sheets. 
The amide I absorption maximum occurs at 1655 cm-1, a typical value for 
S100 proteins [19] due to the α-helical fold. We have expressed the 
amyloidogenesis kinetics by the absorbance ratio between these two 
wavenumbers (Figure 10.3D). FT-IR data are adequately described as single 
or double exponential decays. In accordance, we computed kinetic rate 
constants which describe the amyloidogenic processes (Table 10.1). Apo- 
and EDTA-S100A6 traces were virtually superimposable in the first 1.5 h. 
Apo-S100A6 amyloidogenesis kinetics was double exponential, with rate 
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Figure 10.3 – ATR FT-IR monitored amyloid formation by S100A6. Spectral changes in the 
amide I/II bands during incubation of 3 mg/ml S100A6 in 50 mM glycine pH 2.5 in the apo 
state (A), in the apo state with excess EDTA (B) and in the presence of 2.9 mM Ca2+ (C). (D) 
Kinetic traces correspond to the absorbance variation at 1626 cm-1 (associated with 
intramolecular β-sheets) normalized by the absorbance at 1655 cm-1 (spectral maximum). 
constants 0.51 and 1.71 h-1. The fastest rate constant is similar to the one 
obtained for the single decay of EDTA-S100A6 (0.36 h-1), suggesting that the 
slowest process could be due to a small amount of contaminant metal ions. 
For Ca2+-S100A6, the FT-IR derived kinetics was overall faster. 
The other characteristic biophysical feature of amyloid formation apart 
from β-sheet accumulation is protein particle size increase. We have 
assessed size variation of apo- and Ca2+-S100A6 in real time by dynamic light 
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scattering (Figure 10.4). Apart from the increasing light scattering intensity 
due to aggregation processes, we have also analyzed the particle size 
obtained through autocorrelation analysis of Brownian light scattering 
intensity fluctuations, which complements AFM measurements with time-
resolved size information. 
The kinetic information extracted from all techniques is similar, reporting 
full amyloid conversion around 10 h of incubation in amyloidogenic 
conditions. Light scattering intensity yields slower kinetics. This occurs 
because light scattering is proportional to the inverse square of particle size. 
Consequently, light scattering intensity is biased to higher particle sizes like 
the ones of endpoint S100A6 structures. We observed that amyloidogenesis 
rate constants obtained through different techniques (Table 10.1) are similar 
for apo- and Ca2+-S100A6. This means that Ca2+ does not inhibit amyloid 
formation by S100A6 by locking it in a native-like conformation but by 
inducing an alternate aggregated, β-sheet rich conformation off the 
amyloidogenic pathway. The different morphology can be appreciated by the 
different oligomer size for apo-S100A6 (~14.5 nm) and Ca2+-S100A6 (15.5 
nm). 
 
Figure 10.4 - S100A6 amyloidogenesis kinetics. Kinetic traces obtained through ThT 
fluorescence at 482 nm, FT-IR absorbance change at 1626 cm-1, light scattering intensity and 
particle size variation. Data points were fitted to mono or double exponential decay equations. 
(A) Apo-S100A6. (B) Ca2+-S100A6. 
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Table 10.1 - Rate constants for S100A6 amyloidogenesis. n/a: not applicable, Ca2+-S100A6 
does not form ThT-reactive species. n.d.: not determined. *Values for ThT fluorescence-derived 
kinetics are estimations due to the low data point number. 
 Rate constants (h-1)
 Apo-S100A6 Ca2+-S100A6 EDTA-S100A6
ThT fluorescence* 0.70 n/a n.d.
FT-IR 0.51 1.71 
0.50
17.29 0.36 
Light scattering intensity 2.55 2.24 n.d.
Particle size 0.69 0.56 n.d.
 
10.4.3. Cytotoxicity of S100 amyloid structures 
Noteworthy, most S100 amyloid structures are of the oligomeric type. 
Oligomers have been proposed as a general cytotoxic species [20]. 
Specifically, in Alzheimer’s disease, cognitive impairment is associated with 
oligomeric Aβ buildup than with senile plaque formation. Accordingly, it is 
relevant to examine the toxicity of S100 amyloid oligomers. Due to the 
specific cell expression pattern of S100 proteins, we have selected a 
subgroup composed of S100A6, S100A12 and S100B to examine their 
cytotoxic effects. All these proteins are expressed in the brain, some of them 
at high levels (S100B represents 0.5% of total brain protein and S100A12 
constitutes about 5% of total cytosolic protein in resting neutrophils [21]) 
and are involved in amyloid neurodegenerative diseases: S100A6 is 
overexpressed in Amyotrophic Lateral Sclerosis (ALS) [11] and Alzheimer’s 
disease [10]; S100A12 and S100B are overexpressed in Alzheimer’s disease 
[12-13]. To assess cytotoxic effects we have selected the human 
neuroblastoma SHSY-5Y cell line, a well established model for these studies. 
We have quantified cell viability in the presence of S100 native and amyloid 
species – oligomers obtained at early stages of the amyloid formation 
pathway and endpoint structures – by measuring the reduction of the 
artificial chromogenic electron acceptor WST-1. To examine the role of metal 
ions in modulating S100 cytotoxicity, we have analyzed S100 species in the 
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Figure 10.5 – Cytotoxicity of native and amyloid S100 species. S100 proteins at distinct 
points in the amyloid formation pathway (57°C, pH 2.5) in the apo or Ca2+-bound states were 
added to SHSY-5Y cell cultures and cellular viability relatively to unperturbed controls was 
assessed by the WST-1 reduction assay. (A) Cytotoxicity of 5 µM S100A6 species after 48 h 
incubation. (B) Cytotoxicity of 5 µM S100B species after 24 h incubation. (C-D) Cytotoxicity of 
S100A12 species after 24 h incubation at 5 µM (C) or 25 µM (D) protein concentration. Error 
bars represent the standard deviation (n=3).*: p<0.05. **: p<0.1. 
apo and calcium-bound states (Figure 10.5). Zinc and copper were excluded 
from our screening because of their inherent toxicity at the concentration 
range for this assay. Protein concentration and incubation time were selected 
so that the native protein was not toxic itself. In the sole presence of buffer or 
calcium at the maximal tested concentration, cell viability was identical to 
unchallenged controls after 24 and 48 h (not shown). 
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Apo-S100A6 oligomers were found to be cytotoxic but toxicity decreased 
as higher order oligomeric structures formed at the expense of these (Figure 
10.5A). Apart from inhibiting amyloid formation, Ca2+ also induced a non-
toxic conformation, effectively reverting toxicity. S100B mature amyloid 
species exhibited low cytotoxicity (~80% cell viability versus control, Figure 
10.5B), but the remaining species were not significantly toxic irrespectively 
of metal load. The cytotoxicity profile of S100A12 (Figure 10.5C) was 
concentration dependent. At 5 µM, the oligomeric and endpoint structures 
were equally toxic (50-60% cell viability), independently of metal load. At 25 
µM, oligomeric and mature apo-S100A12 species were cytotoxic. Ca2+-
S100A12 oligomers exhibited enhanced toxicity, which is fully abolished in 
as mature species form. Interestingly, no ThT binding was observed for apo- 
of Ca2+-S100A12. Differential toxicity then reveals that incubation at amyloid 
prone conditions is responsible for a conformational transition distinct from 
amyloid β-sheet buildup. The protofibrilllar structures of the mature apo-
S100A12 misfolded conformation compared to the oligomers formed by 
Ca2+-S100A12 (Figure 10.1) is probably the molecular basis for the 
differential toxicity. 
10.5. Discussion 
The results presented herein constitute novel evidence bridging S100 
conformational control, misfolding and molecular neurobiology. For this 
study we have chosen S100 proteins representative of different family 
evolutionary branches to reveal the potential for metal ion modulation of 
S100 amyloidogenic processes. Our results show that despite the 
amyloidogenic potential being shared by all proteins, the actual structure is 
frequently oligomeric rather than fibrillar. S100A3 is an exception in the 
sense that it forms archetypal amyloid fibrils. In almost all proteins analyzed 
Ca2+ promotes the formation of ticker aggregate structures. 
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Amyloid oligomers, i. e. oligomeric structures with enhanced β-sheet 
content, are intermediates in the amyloid formation pathways where they 
precede fibril formation and disappear after fibrils have formed. Despite 
sharing the β-sheet component which is responsible for ThT intercalation 
and fluorescence, they are most unlike short fibrils. In fact, amyloid 
oligomers from different proteins share morphological features which can be 
identified using conformation-sensitive antibodies [22]. They are relevant in 
neurodegenerative processes like Alzheimer’s disease, where disease 
severity correlates better with the amount of oligomeric Aβ than with the 
amount of fibrillar deposits [23-24]. 
Our cytotoxicity assessment was focused in brain proteins overexpressed 
in neurodegenerative diseases because toxicity has already been described in 
such cases the origin of which is not yet fully established. Moreover, S100 
proteins are present in corpora amylacea in the normal brain [25] and these 
structures have been associated with S100 amyloidogenic conversion in the 
prostate, involving locally abundant calcium, iron and copper [7]. In 
Alzheimer’s disease (AD), Aβ hexamers or tetramers are thought to insert in 
membranes [26] forming pores [27-29] which disturb calcium homeostasis 
[30]. Larger species are less toxic because inter-subunit contacts outcompete 
peptide-membrane interactions [26]. It is not clear at the moment if a similar 
mechanism may apply to S100 amyloids. Such determination will require a 
thorough analysis of the structure of S100 oligomers’ structure as well as the 
consideration of other cytotoxicity mechanisms (e. g. via RAGE activation). 
Nevertheless, in the presence of calcium, the S100A12 homodimer may 
spontaneously form hexamers and S100B is known to assemble into 
octameric structures. As our results further support, amyloid-associated 
toxicity is strongly associated to oligomeric-type structures [20]. Indeed, 
even after prolonged incubation in amyloidogenic conditions, most S100 
protein preparations exhibit an oligomer-like morphology. It is possible that 
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toxicity is detected in some endpoint preparations because of residual 
amounts of more toxic oligomeric-like species. However, the amounts of such 
oligomers should be low as all endpoint preparations were collected at the 
plateau phase of the ThT fluorescence-monitored amyloid formation kinetics 
trace. 
Toxicity induced by S100 proteins is established in the literature. S100B is 
known for its concentration-dependent cellular effects in the central nervous 
system, being neurotrophic at nanomolar levels [31] and inducing apoptosis 
in a RAGE-dependent manner [32] and exacerbating Aβ neurotoxicity [33] at 
micromolar concentrations. The novelty in our results is the description of 
increased toxicity associated solely with the amyloid conversion of S100 
proteins.  
Metal ion binding affects the protein folding energy landscape. Regarding 
amyloid formation, metal ions may facilitate the conformational change 
resulting in the amyloid state, stabilize partially unfolded and amyloid-prone 
states or stabilize the amyloid conformation. This cross-linking effect is akin 
to a covalent modification. An artificial cross-linking between Asp23 and 
Lys28 side chains, stabilizing the β-turn in the amyloid conformation of the 
Aβ1-40 peptide eliminated the lag phase present in the wild type peptide and 
increased the formation rate constant 1000 fold [34], suggesting that local 
conformational constraining accelerates fibril nucleation or fibril growth. On 
the other hand, zinc promptly induces Aβ fibrillization and stabilizes toxic 
oligomeric forms [35]. Regarding S100B, Zn2+ and Cu2+, which bind to the 
same site, have quite distinct effects in the amyloid formation by this protein 
(Figure 10.1): Zn2+ has no influence but Cu2+ greatly decreases ThT reactivity, 
implying a structure with lower β-sheet content. It is known that Cu2+ drives 
the oxidation of the two cysteines in the S10B sequence to the disulfide form 
[36]. This modification is found in vivo and is a prerequisite for S100B’s 
neurite extension function [31]. We can hypothesize that the conformational 
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restriction coupled to disulfide formation partially/completely inhibits the 
amyloidogenic conversion or induces an alternative conformation. Similar 
effects may apply to S100A6. Ca2+ induced a β-sheet rich aggregated 
conformation which was not productive for amyloid species and reversed 
apo-S100A6 cytotoxicity. In the framework of putative S100 cytotoxicity in 
vivo, this finding represents a possibility for the modulation of S100 
cytotoxicity by metal ions or other ligands. Apart from metal ions, other 
relevant modulators of S100 amyloidogenic processes can be interaction 
with other proteins, some of which occurring even in the absence of calcium 
and frequently involving the amyloidogenic helices HI and HIV, or S100 
heterodimerization [2]. The reported amyloid formation by S100A8/A9 has 
been connected with heterodimerization, as the homodimeric counterparts 
exhibited lower amyloidogenic propensity [7]. 
In future studies, a systematic and comprehensive description of amyloid 
formation by S100 proteins will combine the spectroscopic description of 
amyloidogenesis kinetics (FT-IR, dynamic light scattering, circular dichroism, 
intrinsic fluorescence) and secondary structure changes (FT-IR and far UV 
CD spectra deconvolution) to the immunological description of the native-
oligomer-fibril transition. 
10.6. Conclusions 
Here we have described the modulation of amyloidogenesis and amyloid 
structure of S100A2, S100A3, S100A4, S100A6, S100A12 and S100B by metal 
ions. All proteins exhibited metal-dependent amyloid endpoint 
morphologies, even though the formation kinetics is not affected in such a 
sensitive manner. Amyloid formation by S100A6 was analyzed in more 
detail, revealing that inhibition of amyloidogenesis by Ca2+ was associated to 
a distinct off-pathway conformation which nevertheless had increased β-
sheet content. We quantified the cytotoxicity of native, oligomeric and 
endpoint amyloid structures of s100A6, S100A12 and S100B, proteins 
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overexpressed in ALS and Alzheimer’s disease [10-13], finding that Ca2+ can 
also revert the cytotoxicity apo-S100A6 oligomers and S100A12 amyloid 
endpoint structures. From our results, a precise structure-toxicity 
relationship cannot still be established. This will require future studies 
which, on the one hand, determine the detailed, molecular level structure of 
S100 amyloids and, on the other hand, pinpoint the interaction potential of 
these structures with diverse cell components and the cell signaling 
pathways being triggered. 
It is established that Ca2+, Zn2+ and Cu2+ promote conformational changes 
within the S100 fold which have an impact in protein stability (as in S100A2 
[19]), in the formation of functional oligomers (as in S100B [5]) and in the 
formation of amyloid fibrils (as in S100A8/A9 [7]). Considering the latent 
propensity encoded in the primary sequence of S100 proteins to form β-rich 
oligomers and fibrils, it is reasonable to envisage that factors like an 
imbalance in metal homeostasis and anomalous protein-metal interactions, 
inflammation, oxidative stress or/and genetic mutations may provide 
conditions in the cellular milieu that affect any of the functional states of 
S100 proteins (Figure 10.6) and result in the formation of amyloid structures 
or of its precursor oligomers in a physiological context. 
One interesting aspect, which remains to be addressed and may even 
suggest a toxic gain of function characteristic to amyloid oligomers in general 
[37], is if S100 amyloids would exacerbate the apoptoptic activity of the 
S100A8/A9 complex [38-40] or interact with the RAGE receptors further 
contributing or abrogating the toxic effects. The latter are already known to 
be involved in Aβ peptide amyloid transport and recognition processes in the 
context of Alzheimer’s disease. A contrasting perspective can also be 
hypothesized: considering that most of the S100 proteins have upregulated 
expression patterns in inflammatory, neurodegenerative and malignant 
proliferation processes, could amyloid formation serve as a sink for 
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dangerous or somehow harmful proteins promoting inflammation or 
involved in cancer? Now that even Aβ plaques are viewed from a positive 
side [41], is it possible that the amyloid formation of S100 proteins may 
potentially play some "positive" role? Future research in the coming years 
will certainly contribute to clarify some of these and other questions and will 
ultimately bring us to higher level of understanding the biology of tumor and 
degeneration and enable to use our acquired knowledge of S100 structure 
and functions in developing strategies to modulate their activity for 
therapeutic purposes. 
 
 
Figure 10.6 - Native states and oligomerization pathways in S100 proteins. Scheme 
outlining interconversion pathways of S100 proteins, evidencing Ca2+ and other metal (M2+) 
binding sites, and possible routes for oligomerization pathways. 
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11.1. Summary 
The recently identified amyloidogenic properties of S100 proteins related 
to corpora amylacea formation combined with the presence of numerous 
S100 proteins in corpora amylacea in the brain raises the possibility of the 
involvement of other S100 proteins in pathological processes. In particular, 
the association of S100B with Alzheimer’s disease and accumulation in the 
synaptic cleft support the hypothesis that amyloid cross-seeding between 
oligomers of these proteins may be relevant in disease. Here we carry out 
S100B and Aβ1-40 cross-seeding experiments to address this possibility. Our 
results show that Aβ1-40 fibrils – but not oligomers or other amyloid fibrils – 
seed S100B amyloidogenesis. Conversely, S100B amyloids specifically seed 
Aβ1-40 fibrillization. Overall, our data supports the hypothesis of correlation 
between Aβ and S100B amyloid formation including seeding effects 
facilitating cytotoxicity onset and neurodegeneration. 
11.2. Introduction 
Protein deposition as amyloid oligomers in the brain is the cytological 
hallmark of several neurodegenerative diseases including Alzheimer’s (AD), 
Parkinson’s (PD) and Amyotrophic Lateral Sclerosis (ALS). The identification 
of cellular modulators of protein deposition, either proteinaceous or not, 
remains a challenging issue. In this respect, the recently identified amyloid 
forming properties of S100 proteins opens new possibilities in regard to the 
involvement of these proteins in neurodegenerative processes [1]. Due to 
their cell- and tissue-specific expression patterns, S100 proteins are 
frequently used as disease markers. This includes the above mentioned 
neurodegenerative conditions: S100A6 [2], S100A12 [3] and S100B [4] are 
overexpressed in the brains of Alzheimer’s disease patients; S100A6 is found 
overexpressed in astrocytes located near impaired axons of motor neurons 
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of ALS patients [5]; and the serum levels of S100B correlate with PD severity 
[6-7]. 
S100B is highly abundant in the brain, constituting about 0.5% of all brain 
protein [8]. It is abundantly expressed in astrocytes and released 
constitutively [9], although other cell types also express S100B [10]. 
Schwann cells release S100B following RAGE activation [11-12]. Astrocytes 
release S100B via activation of metabotropic glutamate receptor 3 in a 
neural- and synaptic-activity-dependent manner [13]. Numerous modulators 
of astrocytic S100B secretion are known. Stimulation by Ca2+ [14], 
antioxidants [15], branched-chain α-keto acids [16], 5-HT1A [17], 
lysophosphatidic acid [18], glutamate [19] and TNF-α [20], and during 
metabolic stress [21] enhance S100B release. High glucose [22] or glutamate 
[23] concentrations, inhibition of Src kinase [24] or cell confluency [9, 14] 
inhibit S100B secretion. Extracellular S100B concentration determines 
protein function in vivo. At the physiological nanomolar level, S100B is a 
neurotrophic agent promoting neuronal survival and differentiation [25]. 
Micromolar concentrations are pro-apoptotic [26]. 
Enhanced release of S100B into the brain extracellular space is associated 
with inflammatory foci including traumatic cortical injury or focal cerebral 
ischemia, some psychiatric disorders [27] or Down’s syndrome [28], the 
latter being due to the extra copy of the S100B gene in chromosome 21. The 
connection of S100B with Alzheimer’s disease involves the two main 
proteins implicated in the pathology: Aβ and Tau. These two interactors 
represent the two cellular locations for S100B: intracellular (Tau) and 
extracellular (Aβ). The formation of extracellular Aβ amyloid deposits 
induces astrogliosis – a general response of the central nervous system (CNS) 
to neuronal injury [29-30] which consists in the enhancement of the size and 
number of GFAP-expressing astrocytes (i. e. reactive astrocytes) – around Aβ 
amyloid deposits [4] and local accumulation of S100B. S100B increases 
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amyloid precursor protein (APP) expression [31], it is implicated in the 
formation of dystrophic neurites in Aβ amyloid plaques [32] and exacerbates 
Aβ neurotoxicity [33]. Overexpression of S100B alone accelerates the onset 
of AD-like pathology in transgenic mouse models [34] through increasing the 
levels of the Aβ peptide and of brain parenchymal and cerebral vascular Aβ 
deposits. On the other hand, Aβ stimulates S100B synthesis [35]. 
The recent discovery of amyloid formation by S100A8/A9 within corpora 
amylacea in the prostate [1] established the proof of principle for the 
correlation of such structures and S100 amyloidogenesis. Notably, the 
healthy brain contains corpora amylacea [36] which contain numerous S100 
proteins: S100A1, S100A2, S100A3, S100A4, S100A5, S100A6, S100A8, 
S100A9 and S100A12 as well as APP [37]. The structure of these proteins in 
corpora amylacea is currently unknown. S100B is not detected in corpora 
amylacea but is found in the nearby tissue due to astrocytosis. Corpora 
amylacea become more abundant in Alzheimer’s [38] and ALS [39] patients’ 
brains. Their functions and what triggers their appearance is not clear. All 
these evidences strongly suggest that S100B is directly involved in the 
process of amyloid formation by Aβ. In fact, S100 proteins have intrinsic 
amyloidogenic potentials similar to Aβ peptides [40] and S100A8/A9 have 
been found to form amyloid in vivo [1]. 
Here we report groundbreaking data regarding amyloid formation by the 
S100 proteins which are overexpressed in the brain in AD and ALS: S100A6, 
S100A12 and S100B [2-5]. Building on our findings that these S100 proteins 
form amyloid structures, we correlate this behavior with the amyloidogenic 
properties of the Aβ1-40 peptide, forming the senile plaques in AD. Preformed 
Aβ1-40 fibrils seed amyloid formation by S100B. More interestingly, Aβ1-40 
fibrillization is enhanced specifically by preformed S100B fibrils in 
physiological-like conditions, as lysozyme fibrils had an effect similar to an 
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unseeded control. The possible implications of the involvement of S100B in 
AD through modulating Aβ fibrillization are discussed. 
11.3. Materials and methods 
11.3.1. Chemicals and proteins 
All reagents were of the highest grade commercially available. Thioflavin 
T was obtained from Sigma. Trace metals were removed from all solutions by 
solution treatment with a chelex resin. S100B was expressed in E. coli and 
purified to homogeneity as described previously [41]. S100B molar 
concentrations refer to the subunit. Hen egg white lysozyme was obtained 
from Fluka. Aβ1-40 was obtained from Alexotech (Umeå, Sweden). 0.5 mg 
were carefully dissolved in 10 mM NaOH pH 7.5, quickly frozen at liquid 
nitrogen temperature and stored at -80°C until usage. 
11.3.2. Protein fibrillization 
Protein fibrillization was promoted at different conditions, dependent on 
the intrinsic amyloidogenic potential of each protein. S100B solutions were 
prepared in 50 mM glycine pH 2.5 and set at 3 mg/ml using Bradford’s 
method [42]. Amyloidogenesis was promoted by quiescent incubation at 
42°C, 52°C or 57°C. Aβ1-40 fibrillization was promoted by incubation at 25°C 
in 10 mM NaOH pH 7.5. In either case, samples were kept at 4°C at all times 
before amyloid formation assays. Two cross-seeding experiments were 
carried out: (i) incubating S100B in 50 mM glycine pH 2.5 at 42°C in the 
presence of 5% (w/w) preformed Aβ1-40 fibrils; (ii) incubating Aβ1-40 in 10 
mM NaOH pH 7.5 at 25°C in the presence of 5% (w/w) preformed fibrils of 
S100B or lysozyme [43]. Before each assay, any pre-existing aggregates were 
pelleted and removed by centrifuging at 12000 g for 10 minutes. Lysozyme 
amyloid seeds were obtained by incubating 10 mg/ml protein in 50 mM 
glycine pH 2.5 at 57°C for two weeks [43]. Aβ1-40 amyloid seeds were 
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obtained by incubating 2 mg/ml Aβ1-40 in 10 mM NaOH pH 7.5 at 25°C for 3 
days. 
11.3.3. Thioflavin T fluorescence 
ThT binding assays were performed according to [43]. Briefly, 5 µl of 
protein sample (15 µg) was mixed with 65 µM ThT in 10 mM potassium 
phosphate (KPi), 150 mM NaCl, pH 7.0 at room temperature to a final volume 
of 1 ml. Samples were incubated under stirring for 1-2 min and ThT 
fluorescence at 482 nm was recorded with a Cary Varian Eclipse instrument 
with temperature set at 25°C using a peltier-thermostated cell support. 
Excitation wavelength was 440 nm, PMT voltage 600 V, and excitation and 
emission slits 10 nm. 
11.3.4. Atomic force microscopy 
After reaching the plateau phase in amyloid formation kinetics, samples 
were stored at 4°C. Before analysis, S100B (3 mg/ml) samples were diluted 
100 fold and Aβ1-40 (2 mg/ml) samples were diluted 50 fold in water and 
deposited on a mica surface. Morphology was analyzed by AFM on a PICO 
PLUS 5500 microscope (Agilent) as previously described [44].  
11.3.5. ATR FT-IR spectroscopy 
Secondary structural changes occurring during amyloid formation were 
monitored by ATR FT-IR measurements performed in a Bruker IFS 66/S 
spectrometer equipped with a nitrogen-cooled MCT detector using the 
thermostatized Harrick BioATR cell II. 3 mg/ml S100 proteins in 50 mM 
glycine pH 2.5 were incubated at 57°C while spectra were continuously 
acquired (2 min accumulation time, 12 mm aperture, 20 kHz scanner 
velocity). Spectral resolution was 4 cm-1. Amyloid formation was assessed by 
the absorption variation at β-sheet associated wavenumbers (1628 cm-1 for 
S100B, 1627 cm-1 for Aβ1-40) normalized by the absorption at the amide I 
spectral maximum (1653 cm-1 for S100B, 1649 cm-1 for Aβ1-40). To identify 
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the spectral components changing over time, spectra where deconvoluted 
using singular value decomposition implemented on Matlab [45]. 
11.4. Results 
11.4.1. Lower temperatures slow S100B amyloidogenesis without 
changing the morphology of oligomers 
To explore the hypothesis that the amyloidogenic processes of S100B and 
Aβ1-40 may be correlated, we have devised an in vitro experimental approach 
combining amyloid formation assays detected by thioflavin T (ThT) 
fluorescence, FT-IR and atomic force microscopy (AFM). This approach is 
based on cross-seeding assays, a methodology currently employed to detect 
proteins interacting with Aβ and regulating fibrillization [46]. More 
importantly, seeding is a fundamental characteristic of amyloidogenic 
processes [47] and allows analyzing the mechanism of amyloid formation. 
Our hypothesis is that spontaneous formation of amyloid species by S100B 
or Aβ – which are both overexpressed in the synaptic milieu in Alzheimer’s 
disease – may cross-seed amyloid formation, a process with potential 
implications in disease progression. 
 Amyloid seeding is a methodology wherein the lag phase preceding 
amyloid formation is shortened by the addition of pre-formed amyloid 
nuclei. We have previously determined that S100B rapidly forms oligomer or 
protofibrilllar amyloid species at 57°C and pH 2.5 (Chapters 9, 10). This 
limits the sensitivity of cross-seeding assays, which rely on the possibility of 
the amyloidogenesis kinetics being accelerated. Since amyloid formation is 
dependent on temperature, we have analyzed amyloid formation by S100B at 
lower temperatures than the one previously selected (Figure 11.1). By 
lowering the temperature from 57 to 42°C the kinetics of amyloid formation 
by S100B is significantly slowed down without important differences in the 
steady state ThT fluorescence intensity. More importantly, structural 
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Figure 11.1- Temperature dependence of S100B amyloidogenesis at pH 2.5. (Left) 
Kinetic traces from ThT fluorescence assays. S100B was 3 mg/ml in 50 mM glycine pH 2.5. 
Lysozyme 10 mg/ml in 50 mM glycine pH 2.5 is the positive control for amyloid formation. 
(Right) AFM images of S100B amyloid samples after incubation at the respective temperature. 
Scale bar: 1 µm. 
analysis of S100B samples at the end stage amyloid state revealed identical 
morphologies of the oligomers formed by S100B, independently of 
incubation temperature. 
11.4.2. Aβ1-40 fibrils seed S100B amyloidogenesis 
Using the conditions previously optimized for S100B amyloidogenesis (3 
mg/ml S100B, 50 mM glycine pH 2.5), we have assessed the seeding effects 
of Aβ1-40. Taking into account the structural diversity of Aβ amyloid 
structures [48], we have seeded S100B with oligomeric and fibrillar Aβ1-40. 
Lysozyme fibrils were used in a control assay. By monitoring S100B 
amyloidogenesis using ThT fluorescence, we observed that Aβ1-40 fibrils (5% 
w/w) specifically accelerated amyloidogenesis onset (Figure 11.2A), unlike 
oligomeric Aβ1-40 or lysozyme fibrils. Examination of the amyloid morphology 
after the seeding assay revealed that the oligomeric structure of S100B was 
kept irrespectively of the presence of seeds (Figure 11.3). This is direct 
evidence that amyloidogenesis seeding by Aβ1-40 is a purely kinetic effect and 
not an artifact arising from a distinct final structure in seeded S100B. 
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Figure 11.2 - Seeding of S100B amyloidogenesis with Aβ1-40. S100B 3 mg/ml in 50 mM 
glycine pH 2.5 was incubated at 42°C alone or in the presence of 1 or 5% (w/w) preformed 
Aβ1-40 fibrils, Aβ1-40 amyloid oligomers or lysozyme fibrils. Amyloidogenesis kinetics assessed 
by ThT fluorescence (A) or ThT fluorescence and FT-IR signal variation at 1628 cm-1, 
normalized by the absorption at 1653 cm-1 (B). Time-resolved FT-IR spectra of unseeded 
S100B (C) and S100B seeded with 5% Aβ1-40 fibrils (D). 
Nevertheless, the seeding effect is modest. To gather information about the 
secondary structure changes occurring in S100B during amyloidogenesis, we 
have examined the amyloidogenesis of S100B seeded with 5% Aβ1-40. In 
seeded and unseeded S100B, amyloid formation can be monitored by the 
increasing absorbance at 1628 cm-1 (Figure 11.2CD), arising by the buildup 
of intra and intermolecular β-sheet content. When amyloidogenesis assays 
were allowed to progress until a plateau phase was reached, higher ThT and 
FT-IR signals were recorded in the seeded sample (Figure 11.2B), which is an 
indication of enhanced β-sheet content. Since the endpoint morphology is not 
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Figure 11.3 - Morphology of seeded S100B amyloid oligomers. From AFM imaging. S100B 
was prepared at 3 mg/ml in 50 mM glycine pH 2.5 and incubated at 42°C in the absence and 
presence of 1 or 5% (w/w) preformed lysozyme fibrils, Aβ1-40 amyloid oligomers or Aβ1-40 
amyloid fibrils. Images were taken at the plateau phase of amyloid formation kinetics. Scale 
bar: 1 µm. 
affected (Figure 11.3), this result can be interpreted as an indication of 
enhanced amyloid oligomerization efficiency. 
We have obtained further information from FT-IR spectra using singular 
value decomposition (SVD) deconvolution [45]. This algebraic algorithm 
rearranges the succession of FT-IR spectra we have recorded during S100B 
amyloidogenesis into the temporal variation of its components. The relative 
intensity of each component indicates which ones contain data 
representative of the experimental result and which ones represent noise. 
From our analysis, only the first three SVD components of the unseeded and 
seeded S100B amyloidogenesis assays contained significant information 
(Figure 11.4AB). Using SVD we could obtain additional structural 
information. The first component is representative of the final amyloid state. 
The second component of both experiments contains a peak at a 
wavenumber associated with intermolecular β-sheets (1617 cm-1 unseeded, 
1623 cm-1 seeded), which are characteristic of protein aggregates and 
particularly amyloid [49]. The kinetic analysis of this component revealed 
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Figure 11.4 - Singular value analysis of FT-IR monitored S100B amyloidogenesis 
seeding by Aβ1-40. The spectra acquired during S100B amyloidogenesis (Figure 11.2CD) were 
deconvoluted using SVD and the spectral components changing with time were identified. 
Main spectral components of unseeded S100B (A) and S100B seeded with 5% Aβ1-40 fibrils 
(B). (C) Normalized variation of component 2, which contains a significant contribution at the 
β-sheet associated peak around 1620 cm-1 (arrows). 
that its intensity increased with time and that buildup of intermolecular β-
sheets is faster when fibrillar Aβ1-40 seeds are present (Figure 11.4C). 
11.4.3. S100B is a specific seed of Aβ1-40 fibrillization in vitro 
The seeding of S100B amyloidogenesis with Aβ1-40 fibrils is an indication 
of the interaction between these two proteins. In the case of amyloid 
formation, this interaction can be assumed to be based on the existence of a 
specific template provided by the seed. Accordingly, a comprehensive 
analysis of the interaction potential of S100B and Aβ1-40 requires the 
assessment of the converse seeding experiment: seeding Aβ1-40 
amyloidogenesis with preformed S100B fibrils. 
Following the same approach, we have monitored Aβ1-40 fibrillization at 
optimized conditions (2 mg/ml, 10 mM NaOH pH 7.5, 25°C) using ThT 
fluorescence and FT-IR. After fibrillization, samples were imaged using AFM. 
Aβ1-40 was seeded with 5% (w/w) preformed fibrils of S100B or lysozyme. 
Like S100B, Aβ1-40 fibrillization results in the development of an FT-IR 
absorbance band at 1627 cm-1 (Figure 11.5A-C), typical of intra and 
intermolecular β-sheets. AFM analysis of the wither sample after amyloid 
seeding assays did not allow an unequivocal structural characterization 
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Figure 11.5 - Aβ1-40 amyloidogenesis seeding. 5% (w/w) fibrils of S100B or lysozyme were 
used as seeds. (A-C) FT-IR spectra recorded during amyloid formation. (D-F) AFM images 
obtained after the seeding assays. (A,D) Unseeded Aβ1-40; (B,E) Aβ1-40 seeded with 5% S100B 
fibrils; (C,F) Aβ1-40 seeded with 5% lysozyme fibrils.  
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because of sample heterogeneity, with fibrillar and aggregate structures 
around 1 nm in height in all samples. AFM is not a quantitative technique, as 
the detected proteins are those which bind the negatively charged mica 
surface, possibly not accurately representing the whole solution ensemble. 
This excludes the possibility of a quantitative appreciation of the images. 
Heterogeneity also precludes the immediate identification of the identity of 
the proteins composting the fibrillar and the aggregate structures. 
Significant seeding effects occur in the amyloid formation kinetics (Figure 
11.6): S100B seeds both accelerate Aβ1-40 fibrillization and increase the β-
sheet content of the sample ensemble, as judged by the higher signal at the 
plateau phase. More importantly, comparing with the results obtained using 
lysozyme seeds, the effect is S100B-specific. 
11.5. Discussion 
The results reported herein show that S100B and Aβ1-40 amyloids can 
cross-seed the amyloid formation by the other protein, establishing the proof 
of concept for the possible functional implications of the interaction of the 
two proteins in vivo. We have based our analysis of S100B-Aβ interaction on 
cross-seeding assays because seeding requires specific structural templating. 
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Figure 11.6 - Aβ1-40 amyloid
seeding kinetics. Aβ1-40 (2mg/ml,
10 mM NaOH pH 7.5) was
incubated at 25°C with and without
5% (w/w) fibrillar S100B or
lysozyme. Fibrillization kinetics
was assessed from the absorbance
change at 1627 cm-1 normalized by
the absorbance at 1649 cm-1. 
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Such approach has already been pursued in the literature for identifying Aβ 
interacting partners. Stefin B was recently shown to modulate Aβ 
fibrillization [46]. Substoichiometric amounts of stefin B dimers, tetramers 
and high order oligomers inhibit Aβ fibrillization, while other oligomeric 
forms are not. Similar effects exist for Aβ1-40 and Aβ1-42 cross-seeding. 
Monomeric Aβ1-40 and Aβ1-42 can be seeded by fibrils of either peptide. 
However, Aβ1-42 protofibrils selectively seed amyloid formation by 
monomeric Aβ1-42 but not monomeric Aβ1-40. On the other hand, monomeric 
Aβ1-40 alters the kinetic stability, solubility, and morphology of Aβ1-42 
aggregates and prevents fibril assembly [50]. Accordingly, the ratio of Aβ1-40 
to Aβ1-42 influences the amyloidogenic and, consequently, toxic properties of 
Aβ. This demonstrates that seeding effects are not related to protein identity 
but to stringent structural determinants. 
Apart from the extensive data correlating S100B and Aβ in Alzheimer’s 
disease, reports also exist on the seeding effects of Aβ. Murine cortical 
neurons and human neuroblastoma cells (SHSY-5Y) can uptake Aβ1-42 (≥1 
nM) from the extracellular medium and concentrate it in late endosomes or 
lysosomes to micromolar levels, where aggregates with monomeric Aβ1-42 
seeding capacity assemble [51]. Such intracellular accumulation of Aβ1-42 in 
AD-sensitive brain areas precedes disease onset, suggesting an early role in 
AD neurodegeneration [52]. 
The importance of the regulation of fibrillization lag phase has been 
highlighted by the work of Eaton and co-workers in sickle cell anemia in the 
1970s. The aggregation of mutant hemoglobin which underlies disease is 
formally dependent on approximately the 30th power of the soluble 
precursor concentration [53], implying that even small variations in protein 
concentration or temperature have very significant effects in the aggregation 
kinetics. The still unaddressed kinetic description of S100B and Aβ1-40 cross 
seeding thus encloses important information about the relevance of such 
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effects. Of particular interest is the putative deregulation of S100B signaling 
by Aβ-related amyloid seeding. RAGE binds Aβ [54], S100B [55] and other 
S100 proteins [56]. In the case of Aβ, the RAGE interaction is involved in the 
translocation of circulating Aβ to the brain [57]. Also, RAGE binding 
potentiates Aβ-induced neuronal dysfunction [58]. Nanomolar S100B 
concentrations protect neurons against Aβ toxicity in a RAGE-dependent 
manner [59], involving the overexpression of anti-apoptotic protein Bcl2 
and, possibly, Aβ scavenging by enhanced soluble RAGE (sRAGE) secretion 
[60]. However, Aβ senile plaques initiate an inflammatory response leading 
to the local overexpression of proteins like S100A6, S100A8/A9, S100A12 
and S100B [56]. Micromolar S100B concentrations are characteristic of this 
condition and present additional toxicity relatively to Aβ alone [59]. 
In the same way that overexpression and extracellular co-localization of 
amyloidogenic S100B and Aβ in Alzheimer’s disease suggested us that the 
amyloidogenic processes of both could be correlated, similar inferences can 
be drawn for other S100 proteins with pathological relevance. In ALS, 
another neurodegenerative disease where intraneuronal Cu/Zn Superoxide 
Dismutase (SOD1) aggregation is associated with motor neuron loss [61]. In 
mice [36] and humans [5], ALS is accompanied by astrogliosis and 
overexpression of S100A6 in astrocytes. Like the normal population, ALS 
patients have corpora amylacea in the spinal cord [62-63] and brain stem 
[64-65], but present unique deposits in intramuscular nerves [63, 66], the 
composition of which is currently unknown. 
Alzheimer’s disease is characterized by an imbalancement in metal ion 
homeostasis. Specifically, zinc transporters co-localize with amyloid plaques 
of Alzheimer’s disease brain [67] and zinc induces Aβ amyloid formation. 
Like Aβ, S100B is also a zinc-binding protein. The other S100B metal ion 
ligands – calcium and copper – are abundant in the synaptic space where Aβ 
deposits form in AD. Similarly to the strictly metal-dependent amyloid 
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formation by S100A8/A9, metal ions may be relevant in this protein’s 
amyloid processes. 
Structural characterization of S100B and Aβ cross-seeded species was 
incomplete in this work. The elucidation of the structure of the seeded 
amyloid samples was hampered by structural heterogeneity because of the 
multiple species in solution. A detailed characterization of S100B and Aβ1-40 
cross-seeded amyloids will thus require characterization and identification 
of individual oligomeric and fibrillar species. Finally, the validation of our 
hypothesis on the cross-talk between S100 and Aβ amyloidogenesis in 
Alzheimer’s disease will require the investigation of the formation of S100B 
amyloids at physiological or physiological-like conditions and the 
examination of AD brain samples to determine if S100B deposition is 
observed in patients. 
11.6. Conclusions 
S100B has been recurrently implicated in Alzheimer’s disease. Our results 
suggest that a possible connection could consist in the direct involvement of 
this protein in Aβ fibrillization. By using a series of amyloid cross-seeding 
assays we have showed that Aβ1-40 fibrils speed amyloid formation by S100B 
and that fibrils of S100B – but not of the unrelated protein lysozyme – were 
able to eliminate the lag phase preceding amyloid formation by Aβ1-40. These 
observations support the hypothesis that spontaneous formation of amyloid 
species by either S100B or Aβ may establish a cross-seeding catalytical cycle 
promoting amyloid formation and disease progression. This may also apply 
with S100A6, S100A12 and S100A8/A9, which are overexpressed in 
Alzheimer’s disease as a consequence of the astroglial inflammatory 
response to the deposition of Aβ plaques. The currently proposed hypothesis 
will be tested in the future with the determination of the conditions where 
S100B is prone to amyloid formation, with the search of S100B/Aβ co-
deposition in vivo and with the identification of modulators of S100B 
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amyloidogenesis. Regarding the latter, zinc, which is an S100B ligand and 
promotes Aβ fibrillization is an a priori candidate (Figure 11.7).  
 
 
Figure 11.7 - S100 proteins in Alzheimer’s disease. Alzheimer’s disease is characterized by 
abundant deposition of extracellular plaques in the central nervous system. These recruit glial 
cells which secrete S100 proteins to the same extracellular space [56]. Zinc and copper, which 
are released as µM transients in the glutamatergic synapse [68], enhance fibrillation Aβ 
fibrillization [69] and bind to S100B. Co-localization of high concentrations of amyloidogenic 
Aβ and S100 proteins supports the hypothesis that the amyloidogenic processes of these 
proteins may be related. Thus, formation of Aβ or S100 amyloids may cross-template further 
fibrillization and favor disease progression. 
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12.1. Iron-sulfur proteins 
The studies presented in this thesis resorted mainly to biophysical, 
biochemical and spectroscopic techniques to perform a characterization of 
the interplay of metal ions with protein conformation and stability. In the 
case of iron-sulfur (FeS) proteins, research was focused on elucidating 
fundamental aspects of protein folding whereas in the study of S100 proteins 
our experimental approach was framed in the context of S100 biology and 
allowed formulating hypothesis regarding pathological processes involving 
these proteins. 
In the studies described herein, we have exploited the many spectroscopic 
probes available in iron-sulfur (FeS) proteins to assess protein folding 
properties using complementary methodologies. For the Acidianus 
ambivalens Rieske ferredoxin, the combination of fluorescence-monitored 
thermal unfolding, visible absorption-monitored redox titrations and visible 
CD-monitored pH titrations allowed us to correlate the redox status of a 
disulfide bridge with other properties. In the Desulfovibrio gigas rubredoxin 
and A. ambivalens seven iron ferredoxin, the deconvolution of temperature-
resolved FT-IR spectra allowed a quantitative description of the 
conformational events taking place during protein unfolding. For the 
rubredoxin, this included a model describing protein conformation as a 
function of temperature. For the ferredoxin, we were able to follow the 
thermal unfolding of distinct structure subsets depicted as spectral 
components and identify distinct unfolding behaviors. The cold unfolding 
occurring in ferredoxin represents an uncommon event which is 
experimentally accessible through our deconvolution methodology. 
12.2. Amyloid formation by S100 proteins 
The description of amyloidogenic properties of S100 proteins and the in 
vitro amyloid cross-seeding between S100B and Aβ enclose relevant 
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biomedical implications and are the most relevant findings presented herein. 
At the moment, the studies on S100 amyloidogenesis are preliminary. Due to 
the fully uncharacterized amyloidogenic properties of the S100 proteins in 
this study, we have restricted our studies to acidic pH. Although these 
conditions do not allow prompt assumption that S100 amyloid formation 
occurs in vivo, it nevertheless establishes the proof of concept for future 
studies. 
S100A6 [1], S100A12 [2] and S100B [3] are overexpressed in Alzheimer’s 
disease accumulating in the synaptic space as response to Aβ deposition. In 
this milieu there are high concentrations of metal ions which may facilitate 
amyloid formation by S100 proteins (e. g. Cu2+-induced S100B 
amyloidogenesis). Based on this possibility, we assessed the cytotoxicity of 
S100 amyloid species. Indeed, we detected cytotoxicity arising from S100A6 
oligomers as well as S100A12 and S100B mature amyloids, an indication of 
the pathological relevance of these species if they form in vivo. The molecular 
basis for cytotoxicity was not investigated, but membrane disruption is a 
common mechanism among different amyloid species. Specifically for S100 
proteins, the transduction of the extracellular protein accumulation into 
intracellular events may involve the Receptor for Advanced Glycation 
Endproducts (RAGE), a known S100 ligand [4]. Interestingly, RAGE also 
binds Aβ oligomers and fibrils, enclosing the possibility for RAGE-Aβ-S100 
cross-talk in cytotoxic events.  
Based on the abundant secretion of S100A12 and S100B and, to a lesser 
extent, S100A6, in the synaptic metal-rich milieu where Aβ oligomeric and 
fibrillar structure accumulate, we have hypothesized that S100-Aβ cross-
seeding could be instrumental in disease progression. If S100 proteins are 
amyloidogenic at physiological conditions, this interaction could constitute a 
mechanism facilitating onset of fibrillization. The imbalancement in metal ion 
homeostasis occurring in Alzheimer’s disease could act as a further factor 
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facilitating amyloidogenesis. Further, metal ions are known to influence Aβ 
amyloidogenesis [5]. Our results on the modulation of S100 amyloidogenic 
pathways by metal ions support this hypothesis. 
Subsequent studies on the biomedical implications of S100 amyloid 
formation should establish the conditions where S100 proteins are 
amyloidogenic and determine if amyloid formation is accessible under 
physiological conditions. This knowledge will allow formulating hypothesis 
on the conditions where the amyloidogenic process of S100 proteins and Aβ 
can be correlated. An identical approach may apply to the involvement of 
S100A6 in ALS [6]. Overexpression of this mainly intracellular protein in a 
disease characterized by aggregation of the also intracellular protein 
superoxide dismutase 1 (SOD1) may be analyzed in an analogous manner. 
The determination of the potential implication of S100 proteins in 
neurodegenerative diseases will build on the knowledge of the molecular 
basis of disease and be useful in the design of novel prophylactic therapeutic 
strategies. 
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